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ABSTRACT 
Tenacibaculum maritimum (formerly Flexibacter maritimus) is a well known pathogen in a 
number of cultured fish species worldwide. It is a marine bacterium that causes necrotic lesions 
on the body, head, fins and gills, with erosive lesions on the external surface as the prominent 
clinical sign. A large outbreak of the disease occurred in Tasmania over 15 years ago causing 
significant mortalities. Management strategies have reduced the incidence of outbreaks, 
however smaller outbreaks continue to occur. There is limited information on the biological 
factors that could initiate further outbreaks of the disease and patterns of infection are variable. 
Chemotherapeutants such as antibiotics are undesirable for use with problems of bacterial 
resistance, residence times in tissues and effects on other flora and fauna in the surrounding 
marine environment. Therefore, development of a safe and effective vaccine against T. 
maritimum is the focus of this research. 
To characterise and to understand the similarities and differences between T. maritimum 
_isolates, several physical characterisation tests were carried out. The Tasmanian isolates of T. 
maritimum appeared relatively homogeneous physically, but were antigentically different. All 
isolates were hydrophobic and produce a variety of extracellular product (ECP) profiles. There 
were two isolates that stood out in all assays (89/4747 and 01/0356-7) and were different from 
the other isolates. Based on their physical characteristics, three isolates (89/4747, 89/4762, 
00/3280) were chosen for further investigation in pathogenicity trials. 
Pathogenicity trials were carried out to test the effects of culture media, virulence of strains, 
confirm Koch' s postulates and develop a model of infection so that the efficacy of the 
experimental vaccines could be established. Culture media did not affect the pathogenicity of T. 
ii 
maritimum, but the presence of aeration within the culture broth revealed a dose effect caused 
by the cohesive nature of the bacteria. Isolate 89/4747 was found to be non-pathogenic, while 
the other isolates (89/4762, 00/3280) were highly pathogenic causing 100% mortalities within 3 
days. The more moderate isolate 89/4762 was chosen to develop the model of infection and to 
be used in the subsequent vaccination trial. A model of infection using immersion as the 
challenge method was established for Atlantic salmon (Salmo salar). An LD60 of approximately 
1 x 106 cells/mL was calculated for the experimental period and this was the dose used for the 
vaccination trial. 
The possible role of extracellular products (ECP) in the pathogenicity of T. maritimum and its 
toxicity was investigated in viva by injecting different doses of ECP into the peritoneal cavity of 
Atlantic salmon. The ECP was found to be toxic and caused internal necrosis and 
haemorrhaging. An LD50 calculated for the experimental period was 125 µg/fish. 
A vaccination trial was conducted using a formalin de-activated vaccine and the vaccine plus an 
adjuvant (Freund's incomplete). Some protection was provided with the vaccine alone (RPS = 
22.0-27.7%) but significant protection was achieved with the vaccine plus adjuvant (RPS = 
78.0- 79.6%). The adjuvant caused pigmentation and inflammation in the pyloric caeca of the 
fish. 
For future work it is suggested that further characterisation of isolates are required, that toxins 
such as extracellular products (ECP) and lipopolysaccharide (LPS) be investigated in more 
depth and that duration of protection for the vaccine and alternative adjuvants be examined. In 
the short-term, the vaccine preparation from this study may be useful to the salmonid 
aquaculture industry in Tasmania, Australia. 
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Chapter 1 
General Introduction 
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1.1 Nomenclature 
The nomenclature within the Cytophaga-Flavobacterium-Bacteroides (CFB) group has 
undergone significant changes over many years. Tenacibaculum maritimum, the subject of this 
thesis, has also previously been known as Flexibacter maritimus and Cytophaga marina. The 
bacteria were initially described from a disease affecting red sea bream (Pagrus major) and 
black sea bream (Acanthopagrus schlegeli) (Masumura and Wakabayashi 1977). Wakabayashi 
et al. (1986) proposed the name Flexibacter maritimus although it was later placed in the 
Cytophaga genus and given the name Cytophaga marina (Reichenbach 1989). However in 
1992, the name Flexibacter maritimus was restored (Holmes 1992). Recently, more changes 
have occurred within the CFB group with the introduction of a new genus Tenacibaculum 
(meaning 'holding fast' 'stick'). Through phylogenetic, chemotaxonomic and phenotypic 
characterisation, it was proposed that Flexibacter maritimus should be transferred to the genus 
Tenacibaculum and given the riame Tenacibaculum maritimum (Suzuki et al. 2001). This is the 
current status of the taxonomy of this bacterium and the name which will be used herein. 
However, :flexibacteriosis will be used to describe the disease rather than tenacibacteriosis since 
this is the term still used in Tasmania, Australia. 
1.2 Tenacibaculum maritimum as a pathogen of farmed fish 
Tenacibaculum maritimum is a fish pathogen causing significant mortalities in the commercial 
production of many fish species and therefore economic loss to the aquaculture industry. It was 
first described from a gliding bacterial infection affecting intensively cultured sea breams in 
Japan (Masumura and Wakabayashi 1977). Erosive skin disease was noted as the cause of 
mortalities (20-30%) among fry, a couple of weeks after transfer from hatchery tanks to inshore 
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net cages. After identification of the causative organism (Hikida et al. 1979, Wakabayashi et al. 
1984), subsequent isolation in other marine fish species were reported; Japanese flounder 
(Paralichthus olivaceus), leather jacket (A/uterus monoceros), rock bream (Oplegnathus 
fasciatus), plaice (Cleisthenes pinetorum herzenstenini), puffer (Takifugu rubripes), and 
yellowtail (Serio/a quinqueradiata) (Baxa et al. 1986, Wakabayashi et al. 1986). 
Subsequently, an infectious disease, 'black patch necrosis', appeared in cultured Dover sole 
(Solea solea) in Scotland causing mortalities of up to 10 % per day (Mc Vicar and White 1979, 
Mc Vicar and White 1982). Flavobacterium columnare-like bacteria were isolated from the 
diseased fish (Campbell and Buswell 1981, Campbell and Buswell 1982); these bacteria were 
later confirmed as T. maritimum (Bernardet et al. 1990). This was the first report of T. 
maritimum outside of Japan and in Europe. Further isolation of the same bacterium was reported 
from diseased sea bass (Dicentrarchus labrax) from farms along the Mediterranean coast of 
France, Malta and Greece (Pepin and Emery 1993, Bernardet et al. 1994, Bernardet 1998). It has 
also become a significant pathogen of cultured turbot (Psetta maxima), sole (Solea 
senegalensis), gilthead sea bream (Sparus aurata), Atlantic salmon (Salmo salar) and coho 
salmon (Oncorhynchus kisutch) on the Atlantic coast of Spain (Devesa et al. 1989, Alsina and 
Blanch 1993, Pazos et al. 1993, Pazos et al. 1996, Avendano-Herrera et al. 2004). Isolation of 
T. maritimum has continued outside of Europe in northern America, including in net-penned 
Atlantic salmon in British Columbia (Ostland et al. 1999) as well as chinook salmon 
(Oncorhynchus tshawytscha), white seabass (Atractoscion nobilis), Pacific sardine (Sardinops 
sagax) and the northern anchovy (Engraulis mordax) along the southern coast of California 
(Chen et al. 1995). Culturing of chinook salmon ceased at one site along the coast as a result of 
severe outbreaks (Chen et al. 1995). 
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In Australia, the main species affected are Atlantic salmon and rainbow trout ( Oncorhynchus-
mykiss) in sea-cage culture in Tasmania (Handlinger et al. 1997). After salmonid farming was 
established in 1985, the appearance of ulcerated skin lesions was observed, although these early 
cases were assumed to be a mixed Flexibacter/Vibrio spp. infection (Handlinger et al. 1997). 
The first major outbreak of T. maritimum occurred in the summer of 198 8/89. Fish in marine 
cage sites in south-eastern Tasmania, which were up to 30 km apart, were affected 
simultaneously. Morbidity levels were reported as high as 30% with significant losses to farms 
(Handlinger et al. 1997). Since that time, the disease has occurred in varying degrees of 
severity, but not to the same extent as the initial outbreak (Handlinger et al. 1997). There have 
been no studies on the prevalence of T. maritimum on Tasmanian farms and what is known is 
based on anecdotal evidence (J. Carson,pers. comm.). 
No patterns of disease have been established other than fish are more susceptible in the summer 
months. There is a lack of epidemiological information and no ability to predict the nature and 
severity of an outbreak on a year-to-year basis. A factor which could affect the detection of a 
disease pattern could be a chronic outbreak of amoebic gill disease (AGD) in Tasmanian 
salmonid farms. The main form of treatment for AGD is freshwater bathing which occurs on a 
regular basis throughout the year, but increases during summer (Parsons et al. 2001). Contact 
with freshwater kills T. maritimum within minutes (R. van Gelderen, unpublished) and treatment 
baths are used hours at a time which is likely to reduce the levels of T. maritimum associated 
with fish. The incidence of T. maritimum might be higher without the freshwater treatment 
against AGD. There have been no studies in this area and due to the lack of surveillance of T. 
maritimum there is no information available regarding the prevalence of T. maritimum on sites 
where AGD is also present. Tenacibaculum maritimum is an exclusively saltwater organism and 
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therefore detection at farms where they use freshwater bathing may mask any appearance of the 
organism. 
Striped trumpeter (Latris lineata), greenback flounder (Rhombosolea tapirina) and yellow-eyed 
mullet (Aldrichetta forsteri), have also been affected with this disease in Tasmania when kept in 
captivity (Carson et al. 1993). 
It is apparent that T maritimum is an important pathogen to different cultured fish species 
worldwide. In Japan, Australia and Spain in particular it is still a persistent problem, hindering 
the culture of fish species and causing significant economic losses for aquaculture 
(Wakabayashi et al. 1986, Magarifios et al. 1995, Romalde et al. 2005, Avendano-Herrera et al. 
2006, J. Carsonpers. comm.). · 
1.3 The causative agent- Tenacibactdum maritimum 
1.3.1 Morphological and culture characteristics 
The morphological and culture characteristics of T maritimum were defined by Wakabayashi et 
al. (1984) and are found to be consistent with other authors (Baxa et al. 1986, Wakabayashi et 
al. 1986, Bemardet and Grimont 1989, Bemardet et al. 1990, Schmidtke et al. 1991, Alsina and 
Blanch 1993, Chen et al. 1995). Tenacibaculum maritimum are Gram negative, flexible, slender 
aerobic rods measuring 0.5 µm x 2-30 µm in length (occasionally observed up to 100 µm long) 
which do not posses flagella but display gliding motility. On plate agar, colonies are flat, thin, 
pale yellow with a translucent appearance, uneven margin and rarely exceeding 5 mm in 
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diameter. The bacteria can be cultured between 15 and 34°C with the optimal temperature being 
30°C. Colonies will not grow in Cytophaga agar with NaCl as a seawater supplement; they have 
an absolute requirement for seawater with at least 30 ppt seawater needed in the media for 
growth. Different combinations of salts in growth media revealed a requirement of KCl and 
NaCl for growth, Ca2+ for enhanced growth and so/- to inhibit growth. In addition to these 
results, Soltani and Burke (1994) reported that Tasmanian isolates can grow between 8-35°C, 
with an optimal temperature range of 20-30°C and that growth is restricted to a pH range of 6-
8 .5. Results of physiological tests between exotic strains (Wakabayashi et al. 1984) and local 
strains (Schmidtke et al. 1991) are summarised in Table 1.1. Some discrepancies exist between 
individual strains in nitrate reduction and production of hydrogen sulphide for which there are 
contrasting results in the literature (Bemardet et al. 1990, Chen et al. 1995, Ostland et al. 1999, 
Avendano-Hererra et al. 2004). A small percentage of Tasmanian isolates were able to utilise 
sodium glutamate, while other reported strains do not (Wakabayashi et al. 1984, Wakabayashi et 
al. 1986). DNA base-compositions for T. maritimum ranged from 31.3 to 32.5 mol % G+C 
(Wakabayashi et al. 1984). 
1.3.2 Pathogenicity 
There have been many experimental infections of T. maritimum reported (Masumura and 
Wakabayashi 1977, Campbell and Buswell 1982, Wakabayashi et al. 1984, Baxa et al. 1987, 
Carson et al. 1992, Alsina and Blanch 1993, Bemardet et al. 1994, Soltani 1995, Soltani et al. 
1996, Handlinger et al. 1997, Powell et al. 2004, Avendano-Herrera et al. 2006). However, due 
to differences in the route of challenge, size of fish, species of fish and inoculum dose, 
comparisons between studies are difficult. What is apparent is that intramuscular and 
-6-
intraperitoneal injections are not efficacious methods of inducing disease (Tables 1.2, 1.3). 
Challenge via immersion has provided mixed results with salmonids in particular being 
susceptible to this method of challenge (Tables 1.2, 1.3). Disease can be induced with varying 
degrees of success through subcutaneous injection, direct application as well as scarification and 
smearing (Tables 1.2, 1.3). 
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Table 1.1 Physiological characteristics of Tenacibaculum maritimum. + = positive (100% of 
strains), - = negative ( 100% of strains), nt = not tested, and % = % of strains that were positive 
for a specified attribute. Modified from Wakabayashi et al. (1984) and Schmidtke et al. (1991). 
Physiological characteristic 
Degradation of: 
Agar 
Cellulose 
Chitin 
Starch 
Esculin 
Casein 
Gelatin 
Tributyrin 
Tyrosine 
Carbohydrate utilisation: 
Glucose 
Galactose 
Lactose 
Sucrose 
Sorbose 
Inulin 
Sorbitol 
Inositol 
Nitrogen source: 
Tryptone 
Casamino acids 
Yeast extract 
Sodium glutamate 
Ammonium sulfide 
Potassium nitrate 
Production of: 
Ammonium 
Hydrogen sulfide 
Indole 
Catalase 
Cytochrome oxidase 
Reduction of nitrate 
Congo red test 
Wakabayashi et al. 1984 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
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Schmidtke et al. 1991 
Nt 
+ 
+ 
Nt 
+ 
Nt 
Nt 
Nt 
Nt 
+ 
+ 
+ 
10% 
Nt 
Nt 
Nt 
6% 
+ 
+ 
96% 
+ 
\0 
Table 1.2 Summary of Tenacibaculum maritimum pathogenicity studies undertaken in salmonids 
Fish species Size of Temperature No. offish Method of challenge 
fish oer 1i:rouo 
Rainbow trout 63-218g 16-18°C 3 Immersion 
3 Scarification 
3 Subcutaneous iniection 
Atlantic salmon avg.225g 18°c 50 Immersion 
20-50g 16°C 15 Immersion 
20-50g 18°C 10 Intramuscular injection 
20-50g 18°C 10 lntraperitoneal injection 
Atlantic salmon 20-40g 17-18°C 12 Immersion 
Rainbow trout 50-140g l 7-18°C 12 Immersion 
Atlantic salmon 20-50g 18°c 83 Immersion 
Atlantic salmon 20-50g 20°c 25 Immersion 
Atlantic salmon 20-50g 15-16°C 20 Immersion after passaging 
Rainbow trout 50-140g 15-16°C 23 Immersion after passagmg 
Atlantic salmon avg. 77g 18°C 12 Direct application to gills 
12 Application to gills with abrasion 
a= control fish were also affected by the disease in this experiment 
b= experiments were conducted in water with a salinity of 15ppt 
c= the aim of this experiment was to determine and LD50 
na= information not available 
Concentration/dose 
of challem?e 
l x 10 7 cells/rnL 
l x 108 cells/rnL 
l x 10 7 cells/rnL 
2.5 x 106 CFU/rnL 
5.6 x 106 CFU/rnL 
2.3 x 106 CFU/rnL 
2.3 x 106 CFU/rnL 
l.6 x l 06 CFU/rnL 
l.6 x l 06 CFU/rnL 
2.5 x l 06 cells/rnL 
5.3 x 107 CFU/rnL 
4.3 x 106 CFU/rnL 
4.7x 106 CFU/rnL 
4 x l 011 cells/fish 
4 x 1011 cells/fish 
% mortalities Reference 
100• Carson et al. 1992 
100• 
na• 
2-4 Soltani 1995 
100 
0 
0 
74.9 Soltani et al. 1996 
50 
7.2 Handlinger et al. 1997 
lOb 
'97.5 
84.8 
50 Powell et al. 2004 
70 
....... 
0 
Table 1.3 Summary of Tenacibaculum maritimum pathogenicity studies undertaken in marine fish species 
Fish species Size of Temperature No. offish 
fish oer 1i:rouo 
Black sea bream 20-75 mm 23-24°C 10 
10 
10 
10 
Red sea bream 20-75 mm 23-24°C 10 
10 
10 
10 
Black sea bream 1-2 g 26-28°C 10-20 
20 
20 
Sea bass na na 10 
10 
10 
Dover sole 165 days 17.5°C 10 
10 
Greenback flounder l0-25g 20°c 25 
Turbot na na na 
Turbot 4-6g 18-20°C 12 
12 
a= control fish were also affected by the disease in this experiment 
b= experiments were conducted in water with a salinity of 15ppt 
c= the aim of this experiment was to determine and LD50 
na= information not available 
Method of challenge Concentration/dose 
of challemi:e 
Intramuscular injection na 
Immersion 
Direct application to mouth 
Direct application to tail 
Intramuscular injection na 
Immersion 
Direct application to mouth 
Direct application to tail 
Immersion l x I 04 - l x 108 cells/mL 
Subcutaneous injection l x 104 - l x l 08 cells/mL 
Smearing with immersion I x 104 - l x 108 cells/mL 
Intraperitoneal injection l x 107 & I x 108 cells/mL 
Scarification I x 107 & l x 108 cells/mL 
Scarification with smearing l x 107 & l x 108 cells/mL 
Scarification 5:95 x 107 cells/mL 
Subdermaliniection 5.95 x 107 cells/mL 
Immersion 5.3 x 107 CFU/mL 
Intramuscular injection na 
Intracoelomatic iniection 
Intraperitoneal injection 5 x 103 - 5 x 108 cells/mL 
Immersion 5 x 103 - 5 x 108 cells/mL 
% mortalities Reference 
20 Masumura and Wakabayashi 1977, 
10 Wakabayashi et al. 1984 
90 
100 
0 Masumura and Wakabayashi 1977, 
0 Wakabayashietal. 1984 
36.4 
30 
0 Baxa et al. 1987 
40.8 - 52.6. 
43.7 - 75.0 
0 Bernardet et al. 1994 
0 
100 
0 Campbell and Buswell 1982 
30 
2b Handlinger et al. 1997 
0 Alsina and Blanch 1993 
0 
0 Avendano-Herrera et al. 2006 
50° 
1.3.3 Mechanisms of pathogenicity 
The exact mechanisms of pathogenicity of T. maritimum are not known; however, most of the 
speculation is centred on toxins since these are suggested to play an important role in the 
pathogenesis of other CFB organisms in fish (Austin and Austin 1993, Dalsgaard 1993). Lack of 
inflammatory cells in the histological findings of diseased Atlantic salmon challenged with T. 
maritimum was suggested to be the result of toxins which prevented a host response (Soltani 
1995). Ostland et al. (1999) speculated on the role of toxins due to the presence of bacteria in 
connective tissue in the oral folds of Atlantic salmon. Flavobacterium columnare bacteria are 
also found in the connective tissue of oral folds and produce several extracellular proteases 
(Ostland et al. 1999). Evidence for the role of toxins in the pathogenesis of T. maritimum was 
provided through in vitro and in vivo study of a variety of toxins and enzymes in red and black 
sea breams (Baxa et al., 1988c ). Intraperitoneal injection of precipitated extracellular product 
(ECP) and hemolysin caused mortalities, severe internal pathological signs and had the lowest 
LD50 and mean time to death in comparison with other bacterial toxins. In contrast, both ECP 
and hemolysin showed insignificant in vitro activity. No definitive toxic factor was identified 
although ECP and hemolysin were suggested to play a part in the pathogenesis of T. maritimum 
(Baxa et al. 1988c ). 
1.4 The disease - flexibacteriosis 
1.4.1 Clinical signs and pathology 
Gross pathology of fish affected with a T. maritimum infection has been described for many fish 
species with remarkable similarity between descriptions (Mc Vicar and White 1979, Campbell 
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and Buswell 1982, Wakabayashi et al. 1984, Baxa et al. 1986, Devesa et al. 1989, Alsina and 
Blanch 1993, Pazos et al. 1993, Chen et al. 1995, Handlinger et al. 1997, Ostland et al. 1999). 
The development oflesions begins with the appearance of white/yellow patches or blisters. 
There is local scale loss in discrete areas which progresses (quite rapidly) into necrotic erosion 
of the dermis which expose underlying musculature. The lesions can further develop into eroded 
ulcers on the body, jaw erosion around the mouth, or tail rot; mortalities usually follow. 
Areas commonly affected are the head, mouth, fins and flanks, with no internal signs of disease 
reported. Necrotic gill lesions have been reported in chinook salmon (Chen et al. 1995), Atlantic 
salmon and rainbow trout (Handlinger et al. 1997), but are seldom observed. 
Some differences have been noted in relation to fish species. Pacific sardine did not show any 
lesions or gross pathological signs, but large areas of the body were covered in a tan-coloured 
pseudomembrane of gliding bacteria (Chen et al. 1995). Corneal lesions and eye rupture have 
been reported in salmonids in Australia (Handlinger et al. 1997), while in Atlantic salmon in 
British Columbia, the disease is usually associated with the mouth ('mouth-rot') with no other 
clinical signs apparent (Ostland et al. 1999). 
1.4.2 Isolation and identification of the causative organism 
Characteristic lesions caused by flexibacteriosis are usually associated with secondary infections 
and other opportunistic pathogens, in particular Vibrio spp. which produces a mixed infection 
(Kimura and Kusuda 1983, Carson et al. 1992, Chen et al. 1995, Handlinger et al. 1997, Kusuda 
and Kawai 1998). These other bacteria can overgrow T. maritimum during plate culture by 
producing substances that inhibit its growth, making confirmation of the disease difficult 
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(Carson et al. 1992, Pazos et al. 1996). However, a culture media, Flexibacter maritimus 
medium (FMM) was designed to inhibit other marine bacteria and therefore enhance the 
recovery of T. maritimum from diseased fish (Pazos et al. 1996). It has also proven effective in 
susceptibility testing (Avendafio-Herrera et al. 2005a). Media routinely used for the culture of T. 
maritimum in Australia are marine Ordal's and Shieh's with the addition of oxolinic acid or 
neomycin sulfate to enhance selectivity (Carson et al. 1992, Pazos et al. 1996). 
Isolation is frequently made from the external surfaces of the fish, although there have been 
reports of isolating bacteria from the kidney in severely affected fish (Alsina and Blanch 1993, 
Avendano-Herrera et al. 2004). Identification of the causative organism can be achieved through 
several methods, the most basic being Gram stain and selective agar cultivation. Phenotypic 
characterisation and DNA-relatedness studies based on bacteria from culture (Hikida et al. 1979, 
Wakabayashi et al. 1984, Baxa et al. 1986, Wakabayashi et al. 1986, Bemardet and Grimont 
1989, Bemardet et al. 1990, Schmidtke et al. 1991, Alsina and Blanch 1993, Pazos et al. 1993, 
Bemardet et al. 1994, Chen et al. 1995) as well as immunofluorescent antibody test (IFAT) 
(Baxa et al. 1988a) and PCR analysis from plate culture and fish tissues (Toyama et al. 1996, 
Cepeda et al. 2003, Avendano-Herrera et al. 2004) have all been employed to identify T. 
maritimum in diseased fish. 
Based mainly on the phenotypic characterisation, the species T. maritimum was considered to be 
a homogeneous taxon. Initial serological data using slide agglutination also indicated a 
homogeneous group (Wakabayashi et al. 1984); however, further investigation proved antigenic 
heterogeneity within the species (Pazos et al. 1993, Ostland et al. 1999, Santos et al. 1999), with 
two major serotypes described from turbot and sole isolates (Avendano-Herrera et al. 2004). 
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1.4.3 Predisposing factors of flexibacteriosis 
Several risk factors have been identified for flexibacteriosis and the management of these 
factors will affect the severity of losses and influence outbreaks (Bernardet 1998). As T 
maritimum is an external pathogen, a portal of entry appears to be required on the external 
surfaces of fish. Physical trauma provides an entry point for the bacteria into the host and 
optimal conditions for T maritimum growth increase the risk of infection. Higher than average 
water temperature is a consistent risk factor during outbreaks (Wakabayashi et al. 1984, 
Bernardet et al. 1994, Handlinger et al. 1997). Not only temperature, but in the case of 
salmonids in Tasmania, weather conditions such as cloudless sunny days were believed to 
influence an outbreak by causing skin damage through excess UV exposure (Handlinger et al. 
1997). Weather conditions had an indirect effect on an outbreak in sea bass by interrupting their 
feeding. Sea bass are cannibalistic and display antagonism at feeding times causing physical 
trauma to the fish (Chen et al. 1995). Similarly, poor feeding management in Atlantic salmon 
also contributed to the appearance of the disease through competition which caused scale loss 
(Handlinger et al. 1997). Other risk factors reported include physical trauma such as net and 
tank abrasions, wounding by birds and the presence of parasites such as amoeba or marine 
trichodinids in salmonids (Chen et al. 1995, Handlinger et al. 1997). Physical trauma and stress 
are also caused by excessive and traumatic handling (Alsina and Blanch 1993, Handlinger et al. 
1997). Handling stress can occur when fish are transferred from a hatchery to a sea location 
(Wakabayashi et al. 1984, Pepin and Emery 1993, Carson et al. 1994). 
Another consistent factor is the prevalence of the disease in younger fish which may be 
attributed to the relative pliability of scales and skin in comparison to larger, older fish 
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(Wakabayashi et al. 1984, Bernardet et al. 1994, Handlinger et al. 1997, Romalde et al. 2005). 
In Dover sole, control of the disease in young fish was achieved by including a layer of sand in 
the rearing tanks (Mc Vicar and White 1982). The authors have suggested that the addition of 
sand may have reduced stress in the fish and aided in the sloughing of moribund and dead skin 
cells from the body. 
1.4.4 Treatment and control 
Improved husbandry practices and/or chemotherapy are the main ways of controlling disease. 
Better management provides a natural defence for fish that can aid in reducing losses, but this is 
not always practicable in commercial production (Alderman and Michael 1992). Chemotherapy 
is an alternative strategy for treatment of disease that is necessary without a viable vaccine. 
Many substances have been used to treat T. maritimum, from chemicals such as formalin, 
copper sulphate, potassium permanganate as well as drugs/antibiotics such as nitrofurans, 
sulphonamides, furazolidone, oxytetracycline and oxolinic acid (McVicar and White 1979, Baxa 
et al. 1988b, Carson 1990, Vazquez-Bra:fias et al. 1991, Alsina and Blanch 1993, Bemardet et 
al. 1994, Kusuda and Kawai 1998). 
In Australia, the most common treatment recommendation is trimethoprim, to be used at 10 
mg/kg of body weight/day for 10 days (Cameron 1993a). However, it also has an unacceptably 
long withholding period of 500 degree days (S. Percivalpers. comm.). Amoxycillin (80 mg/kg 
of body weight/day for 10 days) is suggested as an alternative closer to harvest as it has a much 
shorter withdrawal time, but is not as efficacious (Cameron 1993b). 
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There are also many considerations and variables when using chemotherapeutants, such as the 
effect of prolonged use and bacterial resistance for antibiotics, toxicity and side effects to fish, 
administration routes, efficacy under outbreak conditions and whether the substance is available 
and registered for use (Toranzo et al. 1984, Baxa et al. 1988b, Danayadol et al. 1999). 
Chemotherapeutants are also used after the appearance of the disease, where a more desirable 
outcome would be a vaccine that would prevent the disease from initially occurring. A vaccine 
eliminates the problems and resource limitations of dealing with a bacterial outbreak once it has 
begun. 
1.4.5 Vaccine development 
Tenacibaculum maritimum is a significant pathogen to many fish species worldwide and a 
potential threat to the salmonid aquaculture industry in Tasmania, Australia. A safe and 
protective vaccine is desirable for disease prevention as it eliminates the threat before it 
becomes a reality. Vaccination has become an important tool in the prevention of bacterial 
diseases in farmed fish (Hastein et al. 2005). For salmonids, vaccines are already used for the 
prevention ofvibriosis, cold water vibriosis, yersiniosis, and furunculosis among others (Press 
and Lillehaug 1995, Hastein et al. 2005). Vaccination studies offish species against T. 
maritimum have presented contrasting results (Table 1.4). Recently, a vaccine for 
flexibacteriosis in turbot has been developed, patented and is commercially available in Spain 
(Romalde et al. 2005, Toranzo et al. 2005). This vaccine is delivered initially by immersion 
when the fish are 1-2 g, and then a booster injection is given when the fish are 20-30 g. 
Protection reaches 85% with the booster injection compared to 50% when fish are vaccinated 
via immersion only (Toranzo et al. 2005). In sole, a vaccine administered via intraperitoneal 
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injection gave a relative percent survival (RPS) value of 94% in laboratory trials (Romalde et al. 
2005). 
While salmonids in Australia are vaccinated against yersiniosis and vibriosis (Hastein et al. 
2005), there is currently no vaccine for Atlantic salmon against marine flexibacteriosis. Initial 
attempts using dip immersion for 30 seconds did not provide protection for Atlantic salmon or 
rainbow trout, even when an immersion booster was used (Carson et al. 1993). Further work 
using various immersion and injection vaccines in Atlantic salmon provided moderate levels of 
protection, but the results were not reproducible (Carson et al. 1994). 
All of the vaccines described above were produced from killed bacterial whole cells. Alternative 
vaccine preparations for T. maritimum using other antigens are currently being investigated in 
sea bass where lipopolysaccharide (LPS) is considered to be a potential vaccine component 
(Salati et al. 2005). Toxins have also been identified as a possible constituent in vaccine 
preparations (as a toxoid) due to their suspected role in pathogenesis and prevention of the host 
response (Handlinger et al. 1997). 
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Table 1.4 Summary of vaccination studies of Tenacibaculum maritimum in different fish species 
Fish species Size of Method of Concentration/dose Method of Concentration/dose 
fish vaccination of vaccination challem!e of challen2e 
Rainbow trout 27-74g Dip (repeated twice) 1.41 x l 09 cells/mL Immersion 2.3 x l 05 cells/mL 
Atlantic salmon 
Atlantic salmon 40-60g Immersion l x 108 cells/mL Immersion 2.5 x 104 cells/mL and 
Injection 7.5 x 106 cells/mL Immersion 3.5 x 104 cells/mL 
Turbot l-2g Immersion na na na 
20-30g Booster injection na na na 
Sole na Intraperitoneal injection na Intraperitoneal injection 1.1 x 108 cells/mL 
na=not available 
RPS(%) Reference 
0-9 Carson et al. 1993 
5-77 Carson et al. 1994 
0-23 
50 Hastein et al. 2005, 
>80 Romalde et al. 2005 
94.2 Romalde et al. 2005 
1.5 Aim and outline of the thesis 
The aim of this thesis is to develop a vaccine for Atlantic salmon against marine flexibacteriosis. 
The following approach was adopted to investigate this aim: 
Chapter 2: Identify similarities and differences in the physical characterisation of T. maritimum 
isolates and in particular, examine antigenic aspects and select isolates for further investigation. 
Chapter 3: Conduct a series of in vivo trials to study different aspects of the pathogenicity of T. 
maritimum in Atlantic salmon, confirm Koch's postulates and develop a model of infection. 
Chapter 4: Investigate the extracellular product (ECP) of T. maritimum for its toxicity in 
Atlantic salmon and possible role as a mechanism of pathogenicity and therefore potential 
incorporation into a vaccine. 
Chapter 5: Conduct a vaccine trial using experimental vaccine preparations and evaluate their 
efficacy under laboratory conditions. 
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1.6 Ethics requirements 
All investigations carried out were under the Australian Code of Practice for the Care and Use 
of Animals for Scientific Purposes 1997 and the Tasmanian Animal Welfare Act 1993. 
Approval was given by the University of Tasmania's Animal Ethics Committee under the 
project No. A0007722. This approval was given under the stipulation that fish should be 
collected for examination when the first signs of physiological disturbance were evident. 
Physiological disturbances were defined to occur when a fish was unable to control its position 
in the water column and/or when erosive lesions were apparent. This is a state from which fish 
were unlikely to recover. For the most part, fish were euthanized before mortality occurred but 
this was not always possible. For the purpose of this thesis the term mortality is used to coincide 
with the literature, even though morbidity would be a more accurate description. 
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Chapter2 
Physical characterisation of Tenacibaculum maritimum 
This chapter is modified from a paper to be submitted to Veterinary Microbiology. 
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2.1 Introduction 
In microbiology, a strain is the basic unit of taxonomy and is comprised of successive 
generations produced from a single isolation in pure culture (Garrity 2001). Strains having 
similar characteristics are then grouped as a species. One strain of a species is designated as the 
type strain (or reference), to which all others can be compared (Garrity 2001). The basis of this 
classification comes from knowledge of morphological, biochemical, physiological and genetic 
characteristics (Garrity 2001). In addition to species classification, a second approach is required 
when investigating pathogens. Strains of the same species can exhibit differences in virulence 
and therefore pathogenicity (Alcamo 1983). These pathotypes and potentially different 
subspecies need to be characterised and compared with each other and in the case of 
Tenacibaculum maritimum in Australia this has not been done. Selection of isolates for later 
pathogenicity and vaccine trials also requires the determination of similarities and differences 
below the species level, particularly properties that enable production of the disease in the host 
(antigenic differences) and those that can affect vaccine efficacy. 
Analysis of whole cell protein profiles is useful for determining taxonomic relationships at or 
below the species level (Schmidtke and Carson 1994). The separation and comparison of 
cellular proteins is used to determine the relatedness of strains and the degree of heterogeneity 
of phenotypes (Carson et al. 1993). Variation of strains at this level can equate to antigenic 
differences, which in turn can affect pathogenesis and vaccine efficacy (Perez-Perez et al. 
1987). 
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Pathogenesis, or the ability of bacterial pathogens to produce disease, is dependent on several 
mechanisms. One of these is the production of toxins, which are complex molecules that 
activate and stimulate the host response (Dalsgaard 1993). Toxins are examples of antigens that 
can be divided into particulate antigens ( endotoxin such as lipopolysaccharide) and soluble 
antigens (exotoxin such as extracellular products). Both play significant roles in the virulence of 
bacterial strains and therefore pathogenesis of infections (Dalsgaard 1993). A vaccine can be 
developed from either component or a combination of both (Ellis 1997a). 
The lipopolysaccharide (LPS) molecules of Gram-negative bacterial cell walls are the main 
antigen, a source of endotoxic activity, and are thought to be responsible for some of the 
characteristic signs of disease caused by Gram-negative bacteria (Dalsgaard 1993). These 
molecules are associated with the outer membrane of cell walls and consist of three covalently 
linked components: the core polysaccharide, polysaccharide side chains and Lipid A (Dalsgaard 
1993). Lipid A is the main endotoxic determinant, that is, the component of LPS that is 
responsible for the toxic activities (Bennett-Guerrero et al. 2000). Differences in toxicity have 
been related to the antigenicity of the pathogen, which is linked to the lipid component of the 
cell membrane (Dalsgaard 1993). Presence of the lipid component was associated with highly 
virulent strains, while absence or low abundance was correlated to low virulence isolates for 
Flavobacterium columnare (formerly 'Flexibacter columnaris~ (Amend 1982). Detection of 
differences of the antigentically active LPS will indicate different serotypes. Therefore not only 
will pathogenicity be affected but also vaccine development. A vaccine produced for one 
serotype may not be effective against another (Romalde et al. 2005). 
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Extracellular products (ECP) are compounds released from bacterial cells and are thought to 
have a role in the virulence of some bacteria (Gudmundsd6ttir et al. 1990, Zorrilla et al. 2003). 
They can act in two different ways: either by acting extracellularly or on cell membranes; or by 
entering cells and disrupting cellular processes through enzymes. Therefore, they can affect 
pathogenicity by directly causing tissue damage or by enhancing invasiveness (Dalsgaard 1993). 
Strain variation of bacterial species is related to differences in cytotoxic activity between 
isolates from diverse geographical locations and fish species (Madetoja et al. 2003). 
Another mechanism that facilitates bacterial pathogens to cause disease is their ability to adhere 
to cell or tissue surfaces. Adhesion of the bacterium takes two forms: non-specific or specific 
attachment (Ofek and Doyle 1994). Non-specific adherence involves the reversible attachment 
of the bacterium to the cell surface. One possible cause of this attachment is hydrophobic 
interactions between the host and bacterial cell. This reversible attachment and hydrophobic 
nature enables bacteria to interact with other living cells and avoid host defence mechanisms 
while adhesion to the host tissue facilitates bacterial antigen uptake and processing (Beachery et 
al. 1980, Daly and Stevenson 1987). Determination ofhydrophobicity is seen as necessary to 
understand the pathogenicity of the bacteria, particularly in the initial stages of infection (Vatsos 
et al. 2001). It will also be useful in determining possible vaccine administration routes. If the 
bacteria are found to be hydrophilic, then its use as an immersion vaccine may be limited. 
Some physical characterisation of different strains of Tenacibaculum maritimum has been done 
in Spain where flexibacteriosis is an emerging disease in the culture of sole (Solea solea and S. 
senegalensis) (Avendano-Herrera et al. 2004). Toxic activities and hydrophobicity of strains of 
T. maritimum from yellowtail (Seriola quinqueradiata) and red sea bream (Pagrus major) have 
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also been investigated (Baxa et al. 1988c, Kawahara and Kusuda 1998). However, to understand 
pathogenicity of strains from a defined geographic region and develop an efficacious vaccine for 
the Tasmanian Aquaculture industry, a study oflocal strains is necessary. 
The main aims of this study were to: 
1. Define and characterise various local isolates of T. maritimum, 
2. Characterise the major antigenic components of T. maritimum. 
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2.2 Materials and Methods 
2.2.1 Bacterial strains 
Eighteen T. maritimum isolates were cultured from diseased Atlantic salmon and rainbow trout 
in Tasmania during 1989-2001 (Table 2.1). Isolates were cultured on marine Shieh's agar (Song 
et al. 1988) or marine Ordal's medium (Anacker and Ordal 1959) and biochemically identified 
(Schmidtke et al. 1991). Two other strains were used for comparison: the type strain of T. 
maritimum (NCIMB 2154T) and a reference strain Baxa lyl-1 (Table 2.1). Stock cultures were 
stored frozen in peptone water with 8% glycerol (Ward and Watt 1971) at-80°C in single use 
cryovials. Bacteria were routinely cultured on marine Shieh's agar (MSA) at 25°C or in marine 
Shieh's broth (MSB) at room temperature (20°C). 
2.2.2 Indirect immunofluorescent antibody test (IFAT) 
All isolates were tested by IFAT as this technique would be used later in other trials as a 
confirmatory test for T. maritimum. The procedure described by Carson et al. (1992) was used. 
Smears were produced using bacteria from plate culture that were then air-dried and heat fixed. 
The smears were overlaid with 40 µL of rabbit anti-T. maritimum 8910329-5 (DPIW) diluted 
1:100 in PBS (pH 7.2, O.lM) and incubated in a moist chamber for 30 minutes at 37°C before 
rinsing in PBS for 15 minutes. After the removal of excess buffer by blotting, 20 µL of anti-
rabbit FITC (Silenus) diluted 1 :60 in PBS was added to each slide. Smears were incubated at 
37°C for 30 minutes and rinsed for 30 minutes in PBS, which was changed every 10 minutes. 
Slides were mounted using alkaline glycerol buffer (Johnson and Munday 1993), coverslipped 
and examined at x 40 magnification with epifluorescent microscopy using UV illumination. A 
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marine Flavobacterium sp. 99/1972-4b isolated from Atlantic salmon (DPIW), the primary 
antibody only and the anti-rabbit FITC only were used as negative controls. All isolates were 
tested in triplicate. 
Table 2.1 Tenacibaculum maritimum isolates used in this study. DPIW = Department of Primary 
Industries and Water. 
Accession No. Source Host Year Collection location 
00/0400-3 DPIW Atlantic salmon 2000 Pillings Bay, Tasmania 
00/0422-3 DPIW Atlantic salmon 2000 Brabazon Point, Tasmania 
00/0813 DPIW Atlantic salmon 2000 Nubeena, Tasmania 
00/1793-1 DPIW Atlantic salmon 2000 Port Arthur, Tasmania 
00/3280 DPIW Rainbow trout 2000 Rowella, Tasmania 
01/0356-7 DPIW Atlantic salmon 2001 Tinderbox, Tasmania 
89/0329-1 DPIW Atlantic salmon 1989 Dover, Tasmania 
89/0329-5 DPIW Atlantic salmon 1989 Dover, Tasmania 
89/1579-2G DPIW Atlantic salmon 1989 Recherche Bay, Tasmania 
89/4747 DPIW Atlantic salmon 1989 Nubeena, Tasmania 
89/4762 DPIW Atlantic salmon 1989 Penguin, Tasmania 
89/4913-6 DPIW Atlantic salmon 1989 Tinderbox, Tasmania 
90/1123 DPIW Atlantic salmon 1990 Port Arthur, Tasmania 
90/1445 DPIW Atlantic salmon 1990 Port Arthur, Tasmania 
91/0126 DPIW Atlantic salmon 1991 Nubeena, Tasmania 
91/0247 DPIW Atlantic salmon 1991 Nubeena, Tasmania 
96/0457-4 DPIW Atlantic salmon 1996 Tinderbox, Tasmania 
98/3186 DPIW Atlantic salmon 1998 Satellite Island, Tasmania 
Baxa lyl-1 DPIW Japanese flounder 1988 Japan 
NCIMB 2154T DPIW Sea bream 1988 Japan 
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2.2.3 Whole cell protein and lipopolysaccharide (LPS) profiles 
Whole cell and lipopolysaccharide (LPS) samples were prepared using a 48 h broth culture. 
After harvesting, whole cell suspensions were washed twice and re-suspended in PBS (pH 7.2) 
at 2900 x g for 30 minutes. The suspensions were only washed twice because agglutination 
would occur in most isolates in subsequent washes or re-suspension. Each suspension was 
standardised to an absorbance of 1.0 at 550 nm in a spectrophotometer. The main objective of 
protein staining is to determine the presence/absence of bands, not the intensity. Different 
absorbances were trialled and it was determined that an absorbance of 1.0 produced the best 
results and was more easily resolved. It is apparent that standardising absorbances made no 
difference in determining the presence or absence of bands. Aliquots of 1.5 mL were 
, centrifuged at 6500 x g for 3 minutes and the supernatant removed. Whole cell lysates were 
produced by resuspending the cell pellet in 500 µL of SDS solubilisation buffer (Laemmli 1970) 
and heating for 10 minutes at 100°C. Cell debris from extracts were centrifuged at 6500 x g for 
3 minutes; the supernatant removed and stored at -20°C. 
Lipopolysaccharide analysis was based on Hitchcock and Brown (1983) with minor 
modifications. Cells were harvested at 16,500 x g for 5 minutes and samples were washed once 
in PBSA (0.14 M NaCl, 0.01 M Na2HP04, pH 7.4, 1 mg of bovine serum albumin per mL) and 
adjusted to 1 x 109 cells/mL. The cell pellet was re-suspended in 100 µL of 2% SDS and mixed 
thoroughly. Glass beads (Sigma) were added to break up the bacterial pellet as T. maritimum 
appeared to aggregate when pelleted forming a clump that is difficult to disperse. To assist 
solubilisation of the pellet, in addition to the glass beads, samples were heated to 60°C. 
Proteinase K (Amresco) at a concentration of20 mg/mL was added to each sample to give a 
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final concentration of 5 mg/mL. Samples were then incubated in a thermomixer for an hour at 
60°C. The temperature was increased to 99°C for 30 minutes, after which the samples were 
stored at -20°C. Prior to loading, samples were thawed and mixed with 134 µL of 2 x SDS 
solubilisation buffer. Each sample was heated in a water bath at 100°C for 10 minutes and then 
centrifuged at 16,000 x g for 5 minutes. Controls for LPS analysis were Escherichia coli and 
Lactococcus garvieae. 
2.2.4 Extracellular products (ECP) 
Extracellular products (ECP) were produced by the cellophane overlay method (Liu, 1957). For 
each isolate, three plates were incubated for 72 h at 25°C. After incubation the culture was 
washed off the cellophane with 1 mL of PBS (pH 7.2) and centrifuged at 4000 x g for 20 
minutes. The supernatant fluid (ECP) was sterile filtered (0.2 µm) and stored in aliquots at 
-80°C. Protein content was determined using the bicinchoninic acid (BCA) assay kit (Pierce). 
2.2.5 Analysis of proteins and lipopolysaccharide (LPS) 
ECP and whole cell proteins were separated by SDS-PAGE (Laemmli 1970) with a 5% stacking 
gel and 12% resolving gel. Samples were heated to 100°C for 10 minutes prior to loading. 
Electrophoresis was carried out for 1hat40 mA and 200 V. Gels were stained with 0.125% 
Coomassie Blue R-250 (Sigma). 
LPS was run on a NuPAGE TM 12% Bis-Tris Gel for an hour at 200 V. Gels were originally 
silver stained according to the method of Tsai and Frasch (1982). However, as attempts at silver 
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staining were deemed unsatisfactory to distinguish differences between isolates (Figure 2.3), 
western blotting was used to detect LPS bands. 
Western blot was run using the method ofTowbin et al. (1979) with a single modification. As 
NuP AGE TM Bis-Tris gels were used, 10% methanol was added in the transfer buffer instead of 
20% methanol. LPS was transferred onto nitrocellulose membranes using an Invitrogen Novex 
XCell II Blot Module (semi-dry transfer) for an hour at 30 V. After transfer, the nitrocellulose 
membranes were rinsed in PBSA and then blocked for 30 minutes with 3% skim milk powder in 
Tris-saline (Ab SM). Membranes were washed with Tris-saline and incubated for 30 minutes 
with antisera against T. maritimum SFC 419 (FHU 89/.0578-4) in rabbit (dilution, 1: 100) in Ab 
SM. After being washed twice in Tris-saline-0.05% Tween20, and once in Tris-saline, the 
membranes were incubated for 1 h with anti-rabbit Horseradish Peroxidase (HRPO) diluted 
1: 1 OOO in Ab SM. Membranes were washed as previously described above. Bands were 
visualized by incubating the membranes in 30% w/v H20 2 in Tris-saline and a 4-chloro-1-
napthol tablet (Sigma) solubilised in 100% methanol which were combined immediately prior to 
use. The reaction was stopped with the addition of water. 
2.2.6 Hydrophobicity 
The hydrophobicity assay was modified from the method described by Rosenberg et al. (1980). 
Twenty-four hour broth cultures of T. maritimum were centrifuged for 30 minutes at 2000 x g. 
Cell pellets were resuspended and washed twice in PBS (pH 7.2) and diluted to an initial OD 
(OD1) of 0.6 within a spectrophotometer (/1. = 600 nm). In a glass test tube, 1.2 mL of each 
bacterial suspension was added along with 0.2 mL of the hydrocarbons n-hexadecane (Merck), 
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n-octane (Sigma) or p-xylene (Merck). Each bacterial suspension-hydrocarbon test tube was 
prepared and assayed in triplicate. The suspension was agitated vigorously for 2 minutes and 
then allowed to separate for 20 minutes into the hydrocarbon and aqueous phases. 
From each test tube, 1 mL of the aqueous phase was transferred to a cuvette and the final OD 
(ODF) of each suspension measured (A. = 600 nm). The hydrophobicity of each bacterial 
suspension to each hydrocarbon was expressed as the percentage partitioning into the 
hydrocarbon phase: 
Partitioning into hydrocarbon(%)= [(OD1 - ODp)/ ODI] x 100 
For each hydrocarbon of each isolate the percentage partitioning was ranked. Each rank was 
added together and then divided by three (i.e. three hydrocarbons). This gave a final rank that 
could be sorted in order of greatest to lowest overall hydrophobicity. 
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2.3 Results 
Out of the eighteen local isolates, 16 produced the same whole cell protein profile as the type 
strain and Baxa lyl-1 (Figure 2.1). These isolates showed banding patterns from 118.4 kDa 
down to 9.2 kDa. Major single bands were located around 12 kDa, 15 .5 kDa, 25 kDa, 45.6 kDa, 
and 99.5 kDa with a triplet at 20kDa. The two local isolates that varied (89/4747 and 01/0356-7) 
showed similarities to the other isolates, however, there was a distinct band at 17 .6 kDa for 
89/4747 and bands at 135 kDa, 22 kDa and 12.7 kDa for isolate 01/0356-7 which also indicated 
that they are also different from each other (Figure 2.1). 
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Figure 2.1 SOS-PAGE whole cell protein profile of Tenacibaculum maritimum isolates stained 
with Comassie Blue-R. Lanes: A, Broad-range molecular weight markers (kDa); B, 89/4762; C, 
89/4747; D, 00/0400-3; E, 00/0422-3 ; F, 00/0813; G, 00/1793-1 ; H, 89/0329-1; I, 89/0329-5; J, 
8911579-20; K, 89/4913-6; L, 90/1123; M, 90/1445; N, 91/0126; 0 , 91/0247; P, 01/0356-7; Q, 
96/0457-4; R, 98/3186; S, Baxa lyl-1; T, 00/3280; U, NCIMB 2154T. Numbers on the left 
indicate molecular sizes (in kilo Daltons). 
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Eight different ECP groupings were detected from all 20 isolates (Table 2.2). Bands that all 
isolates have in common occurred at 46.5 kDa and 73 kDa. Isolates 01/0356-7 and 89/4747 
showed the greatest variation, making up individual groups. Strains used for comparison, 
NCIMB 2154T and Baxa lyl-1 , showed identical profiles to each other, which was again 
different from the local isolates (Figure 2.2) . 
A B c D E F G H 
Figure 2.2 SDS-PAGE of ECP profiles of Tenacibaculum maritimum isolates stained with 
Comassie Blue R. Greyscale analysis of gels was used to establish differences. Lanes: A, Broad-
range molecular size markers (kDa); B, Group 1; C, Group 2; D, Group 3; E, Group 4; F, Group 
5; G, Group 6; H, Group 7; I, Group 8. Numbers on the left indicate molecular sizes (in kilo 
Daltons). 
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Table 2.2 ECP groupings of Tenacibaculum maritimum isolates based on SDS-PAGE analysis. 
Groups Isolates accession numbers 
1 89/1579-2G, 89/0329-5, 89/4762, 96/0457-4 
2 89/4913-6, 90/1445, 90/1123,9110126, 91/0247 
3 89/4747 
4 89/0329-1, 00/0813 
5 00/0422-3, 00/3280 
6 01/0356-7 
7 00/0400-3, 00/1793-1, 98/3186 
8 Baxa lyl-1, NCIMB 2154 1 
LPS profiles indicated that there are at Jeast two serotypes amongst the isolates; 89/4747 and 
01/0356-7 did not show any banding (Figure 2.4). It was not determined if these isolates had a 
shared serotype. Laddering appeared uniform across most other isolates; the major exceptions 
were 89/0329-5, Baxa lyl-1, 89/4762 and 91/0126 which had a distinct band at 55kDa and 
isolates 00/1793, 00/0400-3 and 98/3186 showed a different LPS profile. Based on differences 
in the profiles, isolates were grouped together (Table 2.3). 
Table 2.3 LPS groupings of Tenacibaculum maritimum isolates based on Western blot analysis. 
Groups 
1 
2 
3 
4 
Isolates accession numbers 
89/0329-1, 891579-20, 89/4913-6, 96/0457-4, NCIMB 21541, 
00/3280, 91/0247, 00/0813, 00/0422-3, 90/1445, 90/1123 
98/3186, 00/1793, 00/0400-3, 89/0329-5 
Baxa lyl-1, 89/4762, 91/0126 
89/4747, 01/0356-7 
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A B C D E F G 
Figure 2.3 SDS-PAGE of silver stained LPS profiles of Tenacibaculum maritimum isolates. 
Lanes: A, Low-range molecular size markers (kDa); B, 89/0329-1; C, 89/0329-5; D, 89/1579-
2G; E, 89/4913-6; F, 98/3186; G, 96/0457-4;. Numbers on the left indicate molecular sizes (in 
kilo Daltons). 
A B c D E 
Figure 2.4 Nu-PAGE™ western blot of LPS profiles of Tenacibaculum maritimum isolates. 
Lanes: A, Low-range molecular size markers (kDa); B, Group 1; C, Group 2; D, Group 3; E, 
Group 4. Numbers on the left indicate molecular sizes (in kilo Daltons). 
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All isolates of T maritimum are hydrophobic (Figure 2.6). In all cases, isolates showed the 
lowest hydrophobicity towards n-hexadecane and the highest to p-xylene, with moderate 
hydrophobicity ton-octane. After final rankings, isolate 89/4762 was found to be the most 
hydrophobic. Isolates 89/4747 and 01/0356-7 were IFAT negative; all other 18 isolates were 
IFAT positive (Figure 2.5). 
Figure 2.5 IFAT for Tenacibaculum maritimum; A, positive response, B, negative response. 
Scale bars 30 µm. 
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Figure 2.6 Graph showing the partitioning of each Tenacibaculum maritimum isolate into the 
three hydrocarbons(± S.E): 
- p-xylene '""'"""'' n-octane - n-hexadecane 
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2.4 Discussion 
Based on the cell envelope, including whole cell analysis, T. maritimum has been described as a 
homogeneous species (Bemardet et al. 1994, Avendano-Herrera et al. 2004). Initial 
observations of the T. maritimum isolates using whole cell protein profiles indicate a relatively 
homogeneous-group. These findings are similar to that of Pazos (1997), who reported T. 
maritimum isolates with a large amount of similarity between the isolates studied and a 
molecular mass between 14.4 and 97.4 kDa. While light banding does appear above 100 kDa 
with the isolates, major bands appear at 99.5 kDa down to 12 kDa. With the exception of two 
isolates (89/4747 and 01/0356-7), all other local isolates showed the same profile to that of the 
type strain NCIMB 2154T. Department of Primary Industries and Water (DPIW) records 
indicate that both 89/4747 and 01/0356-7 are PCR positive for T. maritimum and have been 
characterised using morphological and physiological tests (Schmidtke et al. 1991, Carson 1998). 
Therefore, we have detected differences below the species level, possibly different strains or at 
least different serotypes. The results from IF AT and LPS indicate these isolates have different 
outer membrane components to which both antigens were unable to bind; a result that is 
reflected in the whole cell protein profiles. Whether these two isolates are the same or different 
serotypes is yet to be determined. 
Avendano-Herrera et al. (2004) reported different serotypes according to the source of the 
isolation. For example, strains isolated from turbot reacted only with the antiserum derived from 
turbot isolates. Similar findings were noted for sole and gilthead sea bream strains against the 
antiserum obtained against the sole isolate. No such pattern was found in this investigation. The 
serum used in the current study was raised against an Atlantic salmon strain. Isolate 00/3280 
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was collected from rainbow trout, Baxa lyl-1 from Japanese flounder and NCIMB 2154T strain 
from red sea bream, all of which reacted to the antiserum. 
LPS analysis revealed further antigenic heterogeneity within the species, with three other 
patterns evident. Antigenic differences have previously been demonstrated among T. maritimum 
isolates from Atlantic salmon using immunoblot analysis ofLPS (Ostland et al. 1999) where 
differences were detected among isolates and between the isolates and reference strains 
(NCIMB 2153, 2154T). Although initially described as antigenically homogeneous 
(Wakabayashi et al. 1984), T. maritimum is antigentically heterogenous (Ostland et al. 1999, 
A vendafio-Herrera et al. 2004). In addition, these differences have been attributed to the 0-
antigen side chains which may be associated with different strains from outbreaks on both 
temporal and geographical aspects (Ostland et al. 1999). The current study supports these 
findings; however, further investigation is required, particularly into defining serotypes. 
Agglutination studies were not attempted due to the cohesive nature of T. maritimum. It has 
been consistently found that isolates from this species clump together regardless of the method 
in which they were grown (broth or agar). Producing a homogeneous suspension proved 
difficult and when spun down, the pellet formed at the bottom of the microcentrifuge tube would 
adhere to itself (become 'sticky') and required additional physical agitation (e.g., glass beads) to 
ensure dispersal into suspension. An interesting point to note is that initially there was an 
attempt to determine LPS profiles using silver staining. While this method produced clear 
laddering for Escherichia coli and Lactococcus garvieae isolates, it proved unsatisfactory for T. 
maritimum isolates as banding was undistinguishable within the profile (Figure 2.3). Some 
proteins are thought to be resistant to digestion with proteinase K (S0rensen et al. 1992) and T. 
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maritimum could contain such proteins. Probing the LPS profiles with antiserum was required to 
reveal the detail of the banding pattern. 
Extracellular products (ECP) are compounds secreted by bacteria and thought to facilitate 
invasion of the host (Dalsgaard 1993). Although toxic activities of T maritimum have been 
investigated previously (Baxa et al. 1988c), this is the first account ofECP protein profiles for 
T maritimum. In the present study, all isolates were harvested in the stationary phase (72 hours), 
as this yielded the greatest quantity of ECP (R. van Gelderen, unpublished). This also allowed 
minimal growth-phase effects as different proteases are produced at different times of the 1 
growth curve (Gudmundsd6ttir 1996). Duplicate strains of bacteria to produce ECP were used to 
confirm reproducibility of results. The ECP findings suggest significant heterogeneity within the 
species. Exotic isolates NCIMB 2154T and Baxa lyl-1 produced the same profile, while all local 
isolates were divided into seven groups separate from the exotic isolates. The two isolates which 
consistently differed from all others (89/4747 and 01/0356-7) also showed individual profiles 
different from each other. There was no correlation between year groups or geographical 
locations. 
Heterogeneity of.ECP is present in other marine pathogenic bacterial species including 
Aeromonas salmonicida (Gudmundsd6ttir 1996). Out of 32 strains analysed, six different 
protease groups were detected. All typical strains belonged to a single group, while atypical 
strains showed significant differences from the typical strains and between each other. It was 
suggested that ECP production was more strongly associated with geographic locations than the 
host fish species. Our results indicate that host is not an important factor as isolate 00/3280 
(from rainbow trout) grouped with 00/0422-3 (from Atlantic salmon), although both fish species 
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are closely related. The type strain NCIMB 2154T and Baxa lyl-1 are also from different host 
species, yet are grouped together having identical protein profiles. However, from a 
geographical perspective, they are distinct from our local isolates. 
The diversity of profiles brings up an interesting question: what does this variation mean? This 
is not a topic discussed in the literature and is based on more than just protein profiles. All 
isolates share proteins at 46.5 and 73 kDa. These two proteins may be important and require 
further investigation to determine their significance for pathogenicity. It may be that there is no 
significance at all; isolate 89/4747 contains these two proteins but is believed to be non-
pathogenic (Powell et al. 2004). It has been previously stated that ECP may contribute to the 
pathogenicity of T. maritimum in red and black sea bream although there were no strong 
correlations between in vivo and in vitro effects (Baxa et al. 1988c ). The association between 
ECP and toxicity in vivo is reported in Chapter 4 of this thesis. 
Attachment by bacterial pathogens to different substrates is considered to be an important step 
in successful colonisation of host cells as this has the potential to lead to a disease outbreak 
(Vatsos et al. 2001). A number of techniques are employed to assess non-specific and specific 
attachment to different substrates e.g., salt aggregation test (SA t), phase partitioning with 
hydrocarbon solvents, and adherence to nitrocellulose filters (NCF). In the present study, 
adherence to three hydrocarbons was used to assess the surface hydrophobicity of T. maritimum. 
It is recommended that more than one assay be used to obtain a reliable measurement of 
hydrophobicity (Dillon et al. 1986, Saptos et al. 1990). Only one assay was used here because 
the focus of this study was to assess similarities and differences between isolates. The one assay 
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allowed a comparison of isolates not variations of the one isolate. There was also no attempt to 
link hydrophobicity to attachment and virulence in vivo. 
In the current study, most of the T. maritimum isolates possessed a weak hydrophobicity when 
tested with n-hexadecane. Moderate to strong hydrophobicity was apparent with n-octane, while 
isolates showed strong hydrophobicity when tested with p-xylene. Two exceptions were isolates 
89/4762 and Baxa lyl-1 that possessed strong hydrophobic tendencies with all three 
hydrocarbons. Overall, all isolates were hydrophobic and as surface area of the alkane molecule 
decreased, hydrophobicity increased. Variations in assay type, isolate and growth media used 
will invariably provide disparity in results. Previous work by Kawahara and Kusuda (1998) on 
the hydrophobicity of T. maritimum described their isolate as weakly hydrophobic while, as 
with this study, there was an increase in hydrophobic tendencies related to the surface area of 
the hydrocarbon used. In another study, while there was variation in tendencies between assays 
and isolates, it was concluded that all T. maritimum isolates used were hydrophobic (Sorongon 
et al. 1991). Hydrophobicity of bacterial isolates can also be affected by different growth media 
(Magarifios et al. 1996). In the current study marine Shieh's broth (MSB) was used as the 
culture medium. Kawahara and Kusuda (1998) did not state which growth medium they used, 
while Sorongon et al. (1991) used Chrome Azurol S (CAS) medium in different forms. 
However, in general, T. maritimum can be described as hydrophobic. 
However, does the hydrophobicity of isolates translate to attachment to the host or virulence? 
Measures of hydrophobicity do not always correlate well to either attachment or virulence. 
Lopez-Cortes et al. (1999) reported no significant relationship between hydrophobicity and cell 
attachment with Vibrio tapetis in clam cells. It was concluded that there were other attachment 
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specific mechanisms that play a role in cell adhesion. There also needs to be consideration as to 
whether attachment equates to virulence as well. The virulence of the bacterium Photobacterium 
damselae subsp. piscicida (formerly 'Pasteurella piscicida') was found not to correlate with its 
ability to attach to host cells. Attachment was related to the presence of a capsule layer around 
the bacterial cells of virulent strains (Magarifios et al. 1996). In contrast, a strong association 
was found between virulence and surface hydrophobicity of Renibacterium salmoninarum 
(Grayson et al. 1995). Association between surface hydrophobicity, attachment and virulence 
has not been investigated for T. maritimum. A comparison of surface hydrophobicity and 
virulence using three of the isolates used in this study are reported in a pathogenicity trial in 
Chapter 3. For the purpose of this study, the isolates were ranked to determine their selection in 
this experiment. 
In conclusion, the Tasmanian strains of T. maritimum appear relatively homogeneous 
physically, but antigentically different. All isolates are hydrophobic and produce a variety of 
ECP profiles. There are two isolates that stand out in all assays (89/4747 and 01/0356-7) and 
show great variation from the other isolates. All isolates have been confirmed_ as T. maritimum. 
Three isolates have been chosen for subsequent pathogenicity trials: 89/4747, 89/4762, 00/3280. 
Isolate 89/4747 was chosen due to its differences with other isolates from the characterisation 
tests. While not yet confirmed, it is likely that this strain is a different serotype to the others. 
Strain 89/4747 appeared only moderately hydrophobic, ranked 14th out of the 20 isolates, with 
similar properties to the 1 oth ranked strain 00/3280, also considered moderately hydrophobic. 
Both 00/3280 and 89/4762, however, showed similarities to each other and most other isolates 
in whole cell protein profile and serotype. In the ECP groupings, 89/4762 occurred within a 
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common group, whereas 00/3280 was grouped with only one other isolate with a distinct 
electropherotype. This contrasts with the LPS groupings, where 00/3280 was similar to most 
other isolates while conversely 89/4762 was different and placed into a minor group. Isolate 
89/4762 was the most hydrophobic of all the isolates and was included to determine if this 
characteristic was a marker of virulence. 
However, there is an interesting quandary concerning isolate 89/4747. Carson et al. (1992) used 
this isolate as part of its investigation into pathogenicity of T. maritimum in rainbow trout. They 
employed IFAT as a confirmatory test for the presence of the pathogen with the same anti-
serum used in the present study. Isolate 89/4747 in this case was IFAT positive and pathogenic. 
Over ten years later and the same isolate is conclusively IF AT negative based on current 
findings. This change has also appeared to have affected pathogenicity; use of the same isolate 
and serum for an experimental induction of gill disease in Atlantic salmon reported an IF AT 
negative result and a non-pathogenic response (Powell et al. 2004). It is unknown wether 
pathogenicity can be restored and how many passages it took to cause the non-pathogenic effect. 
It is likely that an outer membrane component has changed, but what part/s and the mechanisms 
involved are unknown. Age of isolate, preservation, attenuation and culture media are possible 
causes and require further investigation. 
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Chapter 3 
Pathogenicity of Tenacibaculum maritimum to Atlantic salmon 
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3.1 Introduction 
Pathogenicity relates to the ability of bacteria to produce disease in a host organism. Bacteria 
express pathogenicity via virulence, which refers to the degree of damage to the host (Alcamo, 
1983). The interaction between a pathogen and its host is dynamic as both are able to modify the 
activities and functions of the other. Infection of the host will depend not only on virulence of 
the pathogen, but also infectivity of the pathogen and susceptibility of the host (Madigan and 
Martinko, 2006). Understanding the pathogenicity of Tenacibaculum maritimum could result in 
prevention of the disease, improved treatment or development of a vaccine. 
The development of a vaccine against T maritimum requires the pathogenicity of the organism 
to be confirmed by Koch's postulates. These state that a disease causing organism isolated from 
their host must be able to be grown in vitro and then reintroduced to a naive susceptible host. 
The resulting challenge should produce similar disease signs and the organism must be 
recovered from the host. Additionally, a model of infection should be developed in order to 
determine the efficacy of experimental vaccines and in particular to establish an LD60 for 
challenge in the vaccine trial (Chapter 5). The development of infection models under different 
parameters (growth conditions, strains and doses) would also provide insight into the nature of 
the pathogen. 
Growth media can affect the expression of bacterial characteristics including those that 
determine virulence. Marine Shieh's (Song et al. 1987) and Ordal's (Anacker and Ordal 1959) 
are the two growth media used to previously investigate T maritimum in Tasmania. Pilot studies 
using marine Shieh's (MS) as the growth medium initially yielded non-pathogenic results (R 
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van Gelderen, unpublished). It is believed that attenuation of the bacteria through routine 
bacteriology caused the non-pathogenic results observed in earlier trials of the current study. As 
previous studies used marine Ordal's (MO) as the growth medium (Soltani 1995, Carson et al. 
1992), it was determined that a comparison of media using the one strain (89/4762) was worth 
investigating. In addition, anecdotal evidence from the current study growing T. maritimum in 
broth revealed a difference in the 'clumping' of strains. Aeration of broth cultures appeared to 
assist in obtaining a homogeneous suspension. This has the potential to affect pathogenicity as it 
is suspected that 'clumping' is associated with virulence; passaged strains became stickier on 
agar while attenuated strains lost adherence (R van Gelderen, unpublished). Therefore, the 
presence of aeration during broth culture was also investigated. 
Differences in pathogenicity can also be observed between isolates or strains of the same species 
depending on the presence or absence of different virulence factors (Alcamo, 1983). In the 
previous chapter, 18 local isolates were characterised. Three of these strains were chosen for 
comparison of pathogenicity (89/4747, 89/4762, 00/3280). This was based on their physical 
characterisation (Chapter 2). Strain 89/4747 was chosen due to its differences with other isolates 
from the characterisation tests. While not yet confirmed, it is likely that this strain is a different 
serotype to the others. Strain 89/4747 appeared only moderately hydrophobic, ranked 14th out 
of the 20 isolates, with similar properties to the 10th ranked strain 00/3280, also considered 
moderately hydrophobic. However, both 00/3280 and 89/4762 showed similarities to each other 
and most other isolates in whole cell protein profile and serotype. In the ECP groupings, 
89/4762 occurred within a common group, whereas 00/3280 was grouped with only one other 
isolate with a distinct electropherotype. This contrasts with the LPS groupings, where 00/3280 
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was similar to most other isolates while conversely 89/4762 was different and placed into a 
minor group. Strain 89/4762 was the most hydrophobic of all the isolates and was included to 
determine if this characteristic was ~ marker of virulence. One strain will be selected to compare 
doses since virulence can be better understood by investigating dose and comparing the number 
of cells required to kill different proportions of the population (Madigan and Martinko, 2006). 
The comparison will be used to establish an LD60 which will subsequently be used in a vaccine 
trial. 
There has been previous work investigating the pathogenicity of T. maritimum in several fish 
species in Australia (Carson et al. 1992, Soltani 1995, Handlinger et al. 1997). In particular, 
Soltani (1995) challenged Atlantic salmon under various ~onditions including culture media 
(shaken vs. stirred), age of fish, seawater salinity, dose, exposure, and methods of challenge. 
However, questions in the current study relate to anecdotal evidence regarding the growth of the 
pathogen and its relationship to pathogenicity and a single goal; to produce an experimental 
vaccine. 
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The aims of this study were to: 
1. Determine the pathogenicity of T. maritimum under different culture conditions; 
a) using different culture media, 
b) using aeration, 
2. Assess differences in pathogenicity between three strains, 
3. Assess virulence by measuring differences in challenge doses for one strain, 
4. Describe the pathogenesis of the disease using an experimental infection, 
5. Assess the pathology due to T. maritimum under experimental conditions, 
6. Determine an LD6o for future assessment of the efficacy of an experimental vaccine. 
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3.2 Materials and Methods 
3.2.1 Pathogenicity experiments 
Three different methods were used to assess the pathogenicity of T. maritimum in Atlantic 
sal,mon (Table 3 .1 ). The first experiment was a comparison of methods not only of different 
growth media, marine Shieh's (MSB) and marine Ordal's (MOB), but also with (+A) or without 
(-A) aeration during culture of bacteria; the assessment was made with strain 89/4762. The 
second was a comparison of pathogenicity of strains (89/4762, 89/4747, 00/3280) and the third 
compared effects of dose for the \:me strain (89/4762). Assessment of culture media and strains 
on pathogenicity was made in a semi-static experiment. As a recirculation system was used in 
the third experiment there were two different control treatments. One control treatment was 
within the recirculation system (control in) and another, which was still part of the system, but 
had a separate water source (control out). The system was set up with a filter bank down to 0.8 
µm for incoming water and two UV lights (400 J/m2, 4000 L/h) to reduce bacterial load. 
Table 3.1 Methods used to assess pathogenicity of Tenacibaculum maritimum using bath 
challenge. 
Experiment Isolates Dose (cells/mL) Method of Tanks 
challenge 
1 89/4762 1x107 Bath 10 x 100 L 
semi-static 
89/4762 10 x200 L 2 89/4747 1x107 Bath 
00/3280 semi-static 
3 89/4762 1 x 10
5
' 1 x 106' Bath 12 x200 L 1 x 107, 1 x 108 recirculation system 
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3.2.2 Experimental fish 
Atlantic salmon (Salmo salar) smolts were obtained from a commercial hatchery. Fish were not 
graded prior to experimentation due to the limited availability of fish supplied by commercial 
hatcheries. However, fish were assigned to tanks in order to keep density consistent between 
tanks. The fish were initially kept in fresh water and then acclimated to seawater (35 ppt) over a 
week starting at 5 ppt. They were fed on a commercial diet (Atlantic HP - Skretting) at 
maintenance (1 % body weight) during acclimation and feeding ceased 48 hours before 
challenge. Numbers offish, replicates, weight, lengths and water conditions for each experiment 
are summarised in Table 3 .2. 
Table 3.2 Fish information for each pathogenicity experiment and water parameters. 
Experiment Fish No. Weight range (g) Length range (cm) Temp. (°C) and 
and (tanks) (mean) (mean) Salinity (ppt) 
1 8 (2) 29.2- 150.8 (86.2) 14.5 -25.2 (23.5) 16.5, 35 
2 15 (2) 14.6- 214.6 (72.4) 11.7 - 27.6 (19.1) 18.5, 35 
3 15 (3) 47.6-138.3 (88.1) 16.2- 23.9 (20.9) 18.0, 35 
3.2.3 Bacteria cultures 
Three strains of T. maritimum, two collected from Atlantic salmon (89/4762, 89/4747) and one 
from rainbow trout (00/3280) were used in this study. Stock cultures were stored frozen at 
-80°C in single use cryovials. Bacteria were initially cultured on marine Shieh's agar (MSA) at 
25°C for 24 hours and used as inoculum in 500 mL (in a 2 L glass conical flask) marine Shieh's 
broth (MSB) at room temperature (20°C) for another 48 hours. The culture was decanted and 
washed three times in filtered seawater by centrifugation at 3000 x g for 30 minutes and 0.2 µm 
sterile filtered with seawater. Cell concentration was estimated using a spectrophotometer at 
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550 run. The only variation to this method was in experiment 1 where marine Ordal's broth 
(MOB) was used in addition to MSB to grow strain 89/4762. Each medium was also divided 
into two treatments: with and without aeration. With aeration meant that air was supplied by an 
air pump without a diffuser through a 0.2 µm filter at a rate of 120 L/hr. Without aeration meant 
the 2 L conical flask was placed on an orbital shaker (90 rpm) with no addition of air. 
3.2.4 Challenge procedures 
Fish were bath challenged in I 00 L semi-static tanks in 35 ppt seawater for 1 hour before being 
randomly distributed into assigned tanks. 
3.2.5 Sampling procedures 
Fish were checked 3 times a day for morbidity/mortality and those affected were anaesthetised 
using clove oil (0.03 mL/L seawater). The experiment was concluded when there were 3 
consecutive days of no mortalities. All fish were examined bacteriologically by culturing skin 
lesions or sites of erosion (no internal organs were sampled) on plates ofMSA (Figure 3.1 b) 
containing 4 µg/mL neomycin sulfate (Pazos et al. 1996). Smears (1cmx1 cm) were prepared 
for staining by Gram's method and by immunofluorescence (IF AT) (Figure 3 .1 a, c ). Cultures 
were incubated at 25°C for 2 days and the colonial morphology typical of T. maritimum was 
recorded. Flexibacteriosis lesion distribution and lesion size were also documented, except for 
experiment 1 where only lesion distribution was recorded. The numbers of lesions recorded at 
each body site were divided by the total number of lesions recorded for each treatment, thereby 
indicating differences in areas being affected. Lesion size was measured as length of lesion 
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along the longest axis and was recorded to the nearest half centimetre. Pectoral and pelvic fins 
as well as the immediate surrounding skin area were considered a single site (i.e., pectoral site) 
since one was not affected without the other. Photographs were taken of the fish to document 
gross pathology and samples of skin lesions or sites of erosion were taken for histological 
examination. 
3.2.6 Case definition 
The criteria for accepting that a fish was diseased involved two parts: recovery and 
quantification of colonies and cells. Tenacibaculum maritimum had to be recovered from 
mortalities by culture and in smears by IF AT as these methods are more specific than Gram 
stain. The minimum abundance of cells required for a positive result was 10-50 bacteria per 25 
fields for IF AT and Gram stain. The minimum abundance required to record a positive result in 
culture was growth of colonies extending to the first streaking lines. 
3.2. 7 Histological examination 
Initially the samples were fixed in seawater Davidson's (Shaw and Battle 1957, Speilberg et al. 
1993) for 72 hours before being transferred into 70% ethanol. Samples were embedded in 
paraffin wax, sectioned at 5 µm and stained with haematoxylin and eosin (H&E). Sections were 
viewed under a light microscope at magnification x40 - xl OOO for examination of lesion 
necrosis and the results were compared with gross lesion photographs. 
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3.2.8 Survivors 
Any fish surviving at the end of the challenge period were euthanised using an overdose of 
clove oil (0.06 mL/L seawater) and lesions or sites of erosion examined bacteriologically as 
described. 
3.2.9 Immunofluorescence (IFAT) 
The procedure described by Carson et al. (1992) was used. Smears taken from samples were 
initially air-dried and heat fixed. The smears were overlaid with 40 µL ofrabbit anti- T. 
maritimum 8910329-5 (DPIW) diluted 1: 100 in phosphate buffered saline (PBS) (pH 7.2, O. lM) 
and incubated in a moist chamber for 30 minutes at 37°C before rinsing in PBS for 15 minutes. 
After the removal of excess buffer by blotting, 20 µL of anti-rabbit FITC (Silenus) diluted 1 :60 
in PBS was added to each slide. Smears were incubated at 37°C for 30 minutes and rinsed for 30 
minutes in PBS, which was changed every 10 minutes. Slides were mounted using alkaline 
glycerol buffer (Johnson and Munday 1993), coverslipped and examined at x 40 magnification 
with epifluorescent microscopy using UV illumination. 
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Figure 3.1 Methods of confirmation for 
the presence of Tenacibaculum 
maritimum: A, IFAT (scale bar 10 µm); 
B, colony morphology grown on 
marine Shieh 's at 25°C (scale bar 1 
cm); C, Gram stain at x40 
magnification (scale bar 20 µm). 
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3.2.10 Immunohistochemistry 
Histological sections were probed immunhistochemically based on the method by Adams and 
Nowak (2003). Tissue used in this procedure was fixed as previously described and sections 
were cut (5 µm) and mounted on polylysine coated slides (Menzel-Glaser, Braunschweig, 
Germany). Sections were hydrated and heat-induced epitope retrieval (HIER) performed: slides 
were placed into citrate buffer solution (pH 6) and microwaved on high (700 W) for 10 minutes 
then allowed to stand for a further 20 minutes. Following HIER and a brief rinse in deionized 
water (DIH20), sections were blocked for endogenous peroxidase (10 min in 3% H202 in 100% 
methanol) washed in PBS and incubated (20°C) with 0.1% bovine serum albumin (BSA) for 20 
minutes. Sections were then incubated at room temperature with a primary antibody in 0.1 % 
BSA (rabbit anti-T. maritimum 8910329-5, DPIW) at a concentration of 1:100. Sections were 
rinsed in PBS, incubated with anti-rabbit IgG (Sigma) in PBS (concentration 1: 1 OOO for 30 min) 
at room temperature, and then washed again in PBS. Slides were flooded with 
3,3'- diaminobenzidine (DAB) in peroxide buffer (Zymed) for 1.5 minutes, then rinsed in 
DIH20, counterstained with Mayer's haematoxylin for 30 seconds, rinsed in H20, differentiated 
in PBS, dehydrated, cleared and mounted. The use of normal rabbit se_rum served as a negative 
control (Figure 3.2b). A plug made from 200 µL of2% agarose (w/v) in PBS (pH 7.4) 
containing 200 µL of T. maritimum cell pellet (fixed and processed as above) was used as a 
positive control (Figure 3.2a). 
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B 
Figure 3.2 Irnmunohistochemistry for Tenacibaculum maritimum; A, positive control; B, 
negative control. Scale bars 10 µm. 
3.2.11 Statistical analysis 
Data were analysed using Kaplan-Meier survival analysis and a pair-wise comparison over 
strata with a Bonferroni correction of p-values using SPSS 11.5 for Windows. The LD60 for the 
experimental period was calculated based on the work of Reed and Muench (1938). An LD60 
was determined rather than an LD50 since it has become a standard in testing vaccines against a 
higher mortality rate to ensure efficacy of vaccines. 
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3.3 Results 
3.3.1 Experiment 1 
Fish challenged with T. maritimum grown in either MO or MS with aeration had cumulative 
mortalities of93.75 % and 87.5 %, respectively (Figure 3.3). The MS grown bacteria produced 
mortalities in a shorter amount of time than MO after the ten day experimental period. The MO 
infected fish, however, had a higher mortality rate. Tenacibaculum maritimum grown in either 
MO or MS without aeration caused similar mortality profiles to each other and achieved 
cumulative mortality rates of 68. 75 % and 73.3 %, respectively within the 10 day experimental 
period. There were no mortalities in the control treatment. Kaplan-Meier survival analysis 
showed significant differences between curves (p:S0.0001). Pair-wise comparison showed that a 
\ 
statistical difference occurred between the control treatment and all challenge treatments 
(p:S0.005). There was no significant difference between all challenge treatments (i.e. no 
significant difference between all MO and MS cultures) even though a distinct divergence in 
mortalities appeared between bacteria grown with and without aeration. 
The gross pathology of these fish included skin erosion around the jaw and sites adjacent to the 
fins, discrete areas of raised skin, erosion on the skin and fraying and hyperaemia of the fins. 
The percentage of gross pathology at the various sites (e.g. jaw) was the same between all 
treatments and therefore the data were pooled together (Figure 3.4). Most fish displayed skin 
erosion on the jaw (16%), pectoral (20.8%) and pelvic (14.2%) sites as well as the dorsum 
(19.8%). Pectoral and pelvic sites include the fins and the skin area surrounding them since both 
areas were affected. Lesions on the ventral and lateral sites were prevalent (7.5% and 8.5%, 
respectively) as was gill necrosis (8.5%). Rarer cases of absent or ruptured eyes (1.9%) and 
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lesions on the caudal site (2.8%) were also noted (Figure 3.4). All sites of erosion were 
consistent with lesions associated with natural infections. Although lesion size was not recorded 
for this experiment it was apparent that larger lesions developed on fin sites while smaller 
lesions occurred on the body, in particular the dorsum. It was also noted that infected fish 
darkened (mainly fin margins) and became listless. Of the survivors, no lesions were present, 
only small breaks in the skin in isolated areas. 
Methods to detect the presence of T. maritimum showed that plate culture was less sensitive 
than Gram stain or IFAT (Table 3.3). MS culture plates containing 4 µg/mL neomycin sulfate 
was used to select for T. maritimum and while growth of other organisms were rarely observed, 
a lack of growth on the plates was more common. 
Table 3.3 Comparison of media culture, Gram stain and IFAT preparations for the detection of 
Tenacibaculum maritimum in Atlantic salmon. MS= marine Shieh's medium, MO= marine 
I 
Ordal's medium, +A= with aeration, -A= without aeration. 
Treatment Culture(%) Gram(%) IFAT (%) Lesion 
mean (± S.E.) mean(± S.E.) mean(± S.E.) 
MS-A 58.3 (8.3) 83.3 (16.6) 100 (0) + 
MO-A 78.6 (7.1) 92.8 (7.1) 92.8 (7.1) + 
MS+A 66.9 (4.6) 100 (0) 93.3 (6.2) + 
MO+A 78.6 (7.1) 92.8 (7.1) 100 (0) + 
Control 0 (0) 0 (0) 0 (0) -
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Figure 3.3 Cumulative mortality(%) of Atlantic salmon challenged with Tenacibaculum 
maritimum strain 89/4762 grown on different media and with different aeration conditions. 
Lines with different letters are significant (p::S0.005). 
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Figure 3.4 Distribution of lesions in Atlantic salmon challenged with Tenacibaculum maritimum 
strain 89/4762 grown on different media and with different aeration conditions. 
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3.3.2 Experiment 2 
Mortalities reached 100% for strains 00/3280 and 89/4762 within three days of challenge 
(Figure 3.5). On the second day, strain 00/3280 had mortalities of 81.4% while strain 89/4762 
only had mortalities of 31.1 %. In contrast, the control treatment and strain 89/4747 had no 
mortalities within the experimental period. No statistical operations were performed on this data 
as the differences between treatments were obvious. Results for detection of T. maritimum were 
( 
consistent between treatments and with challenge results, showing high re-isolation values 
except in the non-pathogenic strain 89/4747 (Table 3.4). At the end of day three, water samples 
from all tanks were serially diluted in filtered seawater, plated onto Shieh's medium, incubated 
at 25°C for three days and then counted. The results revealed that the bacterial concentration of 
T. maritimum in the tanks with 00/3280 and 89/4762 were approximately 3.1 x 108 and 2.8 x 108 
cells/mL, respectively. 
Table 3.4 Comparison of media culture, Gram stain and IF AT preparations for the detection of 
Tenacibaculum maritimum in Atlantic salmon. 
Treatment Culture(%) Gram(%) IFAT (%) Lesion 
mean (± S.E.) mean (± S.E.) mean (± S.E.) 
00/3280 100 (0) 100 (0) 100 (0) + 
89/4762 100 (0) 96.6 (3.3) 100 (0) + 
89/4747 43.3 (10.0) 23.3 (10.0) 0 (0) -
Controls 0 (0) 0 (0) 0 (0) -
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In terms of gross pathology, the main·clinical sign was disintegration of the epithelial layer. Tail 
necrosis was found in all cases ranging from moderate tail necrosis to absence of caudal fin. All 
fish had extensive scale loss, areas of raised skin and erosion sites. The distribution of lesions 
was similar between the different strains (Figure 3.6). The pectoral site and dorsum were the 
main areas affected. There was a higher proportion of pectoral sites affected in the fish 
challenged with 89/4762 (29.3%) than 00/3280 (22.8%). It was also noted that there was a 
greater proportion of gill necrosis, particularly with strain 89/4762 (12.1 %), while the number of 
lesions around the jaw area and pelvic site was lower in this experiment. Most of the lesions 
were 1.5 cm in size or less for both strains (Figure 3.7). Few lesions appeared above that size. 
For strain 00/3280, the majority oflesions appeared between 0.5-1.0cm (43.8%), while for 
89/4762, most were found between l.O-l.5cm (40.0%). 
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Figure 3.5 Cumulative mortality(%) of Atlantic salmon challenged with different strains of 
Tenacibaculum maritimum. 
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Figure 3.7 Lesion size(%) in Atlantic salmon challenged with Tenacibaculum maritimum 
strains 89/4762 and 00/3280. 
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3.3.3 Experiment 3 
Fish challenged with the highest dose of 1 x 108 cells/mL had mortalities that reached 100% 
within 4 days of the experiment commencing (Figure 3.8). The percent mortality decreased with 
decreasing dose size and no mortalities were recorded in the control treatment that was outside 
of the immediate experimental system. Controls within the system recorded mortalities of 17%, 
however, only one mortality was recorded for this treatment before day sixteen; 7 fish 
subsequently died within the last 5 days of the experiment. A dose of 1 x 106 cells/mL yielded a 
60% mortality rate and therefore established an LD60 for the vaccine trial based on this 
experimental system. Kaplan-Meier survival analysis showed significant differences between 
curves (p:S0.0001). Pair-wise comparisons showed that significant differences occurred between 
the highest dose (1 x 108 cells/mL) and all other doses as well as both control treatments. There 
was no difference between doses 1 x 10 7 cells/mL and 1 x 106 cells/mL. Similarly there was no 
significant difference between the 1 x 105 cells/mL dose, controls (in) and controls (out). All 
other combinations were statistically significant (p:S0.0033). Methods used to detect the 
presence of T. maritimum showed that the bacteria could be easily re-isolated from the fish with 
most of the tests achieving at or just below 100% (fable 3.5). 
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Figure 3.8 Cumulative mortality(%) of Atlantic salmon challenged with different doses of 
Tenacibaculum maritimum strain 89/4762. Lines with different letters are significantly different 
(p~0.0033). 
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Table 3.5 Comparison of media culture, Gram stain and IF AT preparations for the detection of 
Tenacibaculum maritimum in Atlantic salmon. 
Treatment Culture(%) Gram(%) IFAT (%) Lesion 
mean (± S.E.) mean (± S.E.) mean (± S.E.) 
1x105 100 (0) 97.8 (2.1) 100 (0) + 
1x106 100 (0) 97.8 (2.1) 100 (0) + 
1x107 100 (0) 100 (0) 100 (0) + 
1x108 100 (0) 100 (0) 100 (0) + 
Control (in) 100 (0) 97.8 (2.1) 95.6 (4.3) + 
Control (out) 0 (0) 0 (0) 0 (0) -
In this experiment, progression of the disease was clearly defined and two different effects 
evident. The first was the acute effect which occurs in the first few days of the experiment 
(Figure 3.9). The entire body of the fish was affected and the same response occurred in 
experiment 2. Disintegration of the epithelial layer was a consistent condition. There was 
extensive scale loss, areas of raised skin and some fish had erosion sites present. Cutaneous 
erosions were superficial in early mortalities, with some fish showing white areas of scale loss. 
The second effect was chronic, took longer to develop and resulted in large lesions. It started 
with scale loss in discrete areas (Figure 3.1 Oa). Swelling began to appear over the site and this 
swelling appeared to be of epithelial origin (Figure 3.1 Ob ). The destruction of the epithelium 
continued within a discrete area until the necrotic tissue was shed to reveal a lesion which 
continued to erode (Figures 3 .1 Oc, d). The underlying musculature was exposed and necrosis 
and oedema were evident (Figure 3.lOe). 
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Pectoral , dorsal and lateral sites were the main areas where lesions developed (Figure 3.11 ). In 
the highest dose (I x 108 cells/mL), the pectoral, dorsal and lateral sites showed simjlar 
percentages compared to the other doses. In most cases, the dorsum was the predomjnant lesion 
site in each treatment except in the 1 x 105 cells/mL treatment where the lateral site was the 
domjnant area (28.9 %). The percentage of lesions in the pectoral sites decreased with dose. Of 
interest is the increase in jaw and caudal site lesions in the control (in) group. Gill necrosis was 
also present in small numbers in the two highest doses as well as the control (in) group. Lesion 
size was smaller in the higher doses (Figure 3.12). There is a shift to larger lesions as dose 
decreases; however, a peak in growth of lesion was apparent in the group challenged with 1 x 
106 cells/mL. 
Figure 3.9 An acute effect of a Tenacibaculum maritimum infection; A, control Atlantic salmon; 
B, Atlantic salmon exposed to I x 108 cells/mL where mortality occurred within 48 hours. The 
control fish were euthanized at the end of the experiment. Any scale Joss would have been a 
result of handling the fish prior to taking the photograph. Scale bars 2 cm. 
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Figure 3.10 Formation of lesions in 
Atlantic salmon caused by 
Tenacibaculum maritimum: A, 
scales loss in discrete areas; B, 
swelling appears over site (arrow); 
C, destruction of the epithelium 
continues within a discrete area; D, 
necrotic tissue is shed to reveal 
lesion; E, lesion continues to erode, 
musculature is exposed and 
necrosis and oedema are evident. 
Scale bars 1 cm. 
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Figure 3.11 Distribution of lesions in Atlantic salmon challenged with different doses of 
Tenacibaculum maritimum strain 89/4762: A; 1 x 108 cells/rnL; B, 1 x 107 cells/rnL; C; 1 x 106 
cells/rnL; D, 1 x 105 cells/mL; E, control (in) . 
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Figure 3 .12 Lesion size (%) in Atlantic salmon challenged with different doses of 
Tenacibaculum maritimum strain 89/4762: A; 1x108 cells/mL; B, I x 107 cells/mL; C; Ix 106 
cells/mL; D, 1 x 105 cells/mL; E, control (in). 
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Histological examination of infected gills showed diffuse necrosis starting from the tips of the 
filaments progressing towards the gill arch and there was no inflammatory response in affected 
lamellae. All gill lesions were erosive with necrosis affecting distal areas of individual lamellae 
(Figure 3. l 3d) with instances of heavy filamentous bacterial mats encompassing several 
lamellae (Figure 3.13b). The presence of T. maritimum filamentous rods was confirmed by 
immunohistochemistry (Figure 3.13g) and Gram stain (Figure 3.13f). Adjacent uninfected 
lamellae showed minimal to no reaction. 
Control fish skin showed normal skin structure of an epidermis with mucous cells and scales, 
the dermis, underlying fat and musculature (Figure 3.14a). The first step in the progression of a 
lesion began with scale loss and disintegration of the epidermis with scale pockets evident 
(Figure 3.14b). Loss ofthe epidermis (Figure 3.14c) preceded erosion ofthe dermis and 
exposure of the underlying musculature (Figure 3.14d). Muscle fibres appeared to be replaced 
by fat in the latter stages of lesion development (Figure 3. l 4d). Bacteria were seldom observed 
in skin samples and were never seen invading the dermis or muscle. Due to the lack of bacterial 
numbers in these samples, confirmation by immunohistochemistry and Gram stain was 
impractical. The material that sloughed off the eroded area to reveal underlying musculature was 
made up of scales, necrotic material and bacteria (Figure 3.15a). Immunohistochemistry 
confirmed the bacteria to be T. maritimum (Figure 3.15c). 
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Figure 3.13 Necrosis of the gill in Atlantic salmon; A, gross pathology of gill necrosis (scale bar 
1 cm); B, necrosis of several larnellae (scale bar 100 µm); C, control gill; D, necrosis of an 
individual filament; E, H&E stained section of gill showing the large mass of bacteria associated 
with the necrosis; F, Gram stain; G, positive immunohistochemistry result; H, negative 
immunohistochemistry result. All other scale bars 10 µm. 
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Figure 3.14 Histological examination of the progression of lesion development; A, control skin; 
B, scales were lost leaving scale pockets (arrow) underneath the epidermis; C, epidermis was 
eroded away by bacteria; D, dermis was eroded leaving the underlying musculature exposed. All 
scale bars 100 µm. 
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ii 
Figure 3.15 Necrotic material from Tenacibaculum maritimum infection; A, necrotic material is 
made up from (i) bacteria, (ii) necrotic tissue and (iii) scales (scale bar 100 µm) ; B, Gram stain; 
C, positive immunohistochemistry result; D, negative immunohistochemistry result. All other 
scale bars 10 µm . 
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3.4 Discussion 
Different aspects of pathogenicity were studied not only to confirm Koch's postulates but also 
to compare the effects of bacterial culture conditions, virulence of strains and to establish a 
model of infection. 
Marine Shieh's (MS) and Ordal's (MO) are the two growth media used previously to investigate 
T. maritimum in Tasmania. Bacteria cultured from both media were able to cause infection and 
mortalities in Atlantic salmon (Salmo salar) within the 10 day experimental period thereby 
confirming Koch's postulates. No significant difference in cumulative mortality was detected 
between the two media at the end of the experimental period. The nutrient concentration is the 
major difference between both media with the addition of citric acid and sodium pyruvate in 
marine Shieh's medium. This apparently did not significantly affect the pathogenicity of T. 
maritimum strain 89/4762. A comparison of marine Ordal's broth culture with natural seawater 
and synthetic seawater (Schmidtke et al. 1991) showed no significant effect on the expression of 
virulence (Carson et al. 1992). The authors recommended more sensitive assay procedures to 
confirm this observation. In contrast, T. maritimum cultured on marine Ordal's broth with a 
limited essential inorganic ion supplement (Schmidtke et al. 1991), failed to infect fish (Carson 
et al. 1993). The broth using the supplement produced a more homogeneous suspension than 
that produced with marine Ordal's medium. The authors speculated that there was a connection 
between agglutination in broth and expression of virulence factors (Carson et al. 1993). 
There was however an effect of aeration during bacterial culture on the pathogenicity, even if 
the effects were not considered statistically significant. During broth culture, without aeration, 
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the bacteria form a dense layer at the air-water interface. The addition of constant aeration 
allows a thinner layer of bacteria at the air-water interface with long thread-like masses moving 
throughout the broth as well as a fine film apparent on the inside flask wall. Clumping of 
bacteria was also evident around the inlet of aeration. Tenacibaculum maritimum is an obligate 
aerobic bacterium (Wakabayashi et al. 1984), and is therefore likely to grow best where oxygen 
is readily available, that is, at the air-water interface and where there is an input of oxygen. It 
appears, however, that the difference observed between aeration and non-aeration may simply 
be a dose effect. While care was taken to accurately estimate cell concentration using a 
spectrophotometer, the clumping nature of the bacteria proved problematic. Physical agitation 
was employed to break up aggregated material, but this was not completely successful. It was 
observed that during the culture process, those bacteria grown without aeration formed stickier, 
more cohesive cell masses while growing at the air-medium interface. These cell masses could 
not be broken apart during re-suspension as those grown with aeration. Differences between 
challenge doses prepared with and without aeration may simply represent differences in cell 
concentrations derived from the two different culture methods. Carson et al. (1992) noted the 
presence of adherent macroscopic clumps in broth culture made up with marine Ordal' s with 
natural seawater. The use of artificial seawater produced a homogeneous suspension and this did 
not appear to affect the pathogenicity of T. maritimum in rainbow trout (Carson et al. 1992). 
Also of interest was the effect that the anaesthetic, clove oil, had on the re-isolation of T. 
maritimum. The use of culture was far less sensitive than Gram and IF AT with little or no 
bacterial growth on many plates for the first experiment in which clove oil was used as an 
anaesthetic. It was not only the absence of T. maritimum colonies on the plates but a lack of 
growth of bacteria that was interesting. Chemical components of anaesthetics could potentially 
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kill off bacteria if the dosage is too high or the exposure time too long. This problem has been 
observed with field investigations of T. maritimum in farmed salmonids (J. Carson pers. 
comm.). Therefore, the use of carbon dioxide or another non-chemical anaesthetic may be more 
suitable to ensure better isolation of T. maritimum. A subsequent decrease in dosage (0.025 
mL/L seawater) and time (<2 minutes) in the anaesthetic provided better and more consistent 
results in the following two experiments. 
The second experiment was undertaken to observe differences in the pathogenicity of strains. 
Strain 89/4747 was non-pathogenic causing no infection or mortalities throughout the 
experimental period, which is consistent with the findings of Powell et al. (2004). In contrast, 
Carson et al. (1992) described this strain as highly virulent with all fish becoming infected and 
developing lesions, including controls. All fish were kept in a single flow through tank and were 
identified using branding and tagging techniques. The high level of infectivity was suggested to 
be the result of the use of a single tank, insufficient water turnover and a virulent strain. In the 
current study, pilot studies of pathogenicity using strain 89/4762 found non-pathogenic results. 
It is suggested that attenuation was the probable cause. Loss of virulence due to subculturing 
occurs during routine bacteriology, storage and preservation (Michel and Garcia 2003, O'Keefe 
et al. 2006). Anecdotal evidence from this study suggests that attenuation occurs quickly in T. 
maritimum isolates (R van Gelderen, unpublished). It is most likely that attenuation is the cause 
of the current non-pathogenic results of strain 89/4747, but this requires further investigation. 
Preservation techniques, age ofisolate, culture media and storage could affect the pathogenicity 
of bacteria (Michel and Garcia 2003, O'Keefe et al. 2006). 
- 80 -
In contrast, strains 00/3280 and 89/4762 were highly virulent reaching 100% mortalities in three 
days. Both strains have previously been demonstrated as highly pathogenic (Carson et al. 1992, 
-
Handlinger et al. 1997, Powell et al. 2004). Experimental application of T. maritimum to the 
gills of Atlantic salmon using strain 00/3280 caused high levels of mortalities within 48 hours 
(Powell et al. 2004). Strain 89/4 762 was highly pathogenic in rainbow trout and Atlantic salmon 
when challenged by immersion (Carson et al. 1992, Soltani 1995, Handlinger et al. 1997). The 
study undertaken by Soltani (1995) also noted that strains ofT. maritimum could be host 
specific and found that a strain isolated from mullet (Aldrichetta forsteri) did not cause disease 
in Atlantic salmon. The strain 00/3280 (from rainbow trout) was highly virulent in Atlantic 
salmon but as both are salmonids, cross species susceptibility was more likely. 
Of interest was the growth of the strains in culture. The virulent strains 89/4762 and 00/3280 
were highly adherent to the agar in initial culture and produced a highly aggregated suspension 
in broth culture. Strain 89/4747 was easy to remove from agar plates and also produced a far 
more homogeneous suspension in broth. This phenomenon has also noted by others (Carson et 
al. 1992, Carson et al. 1993, Soltani 1995) who, like the current study, suggest that this 'sticky' 
clumping nature may facilitate an adhesion mechanism that plays a role in the pathogenicity of 
T. maritimum. Attachment to the host surface could result in increasing bacterial populations 
(Home and Baxendale 1983, Ostland et al. 1995) at a site where other virulence factors such as 
toxins and enzymes can be released (Soltani 1995). 
In the previous chapter, hydrophobicity was used as a test for the selection of isolates for the 
pathogenicity studies. One of the aspects of this was to test hydrophobicity and whether it is a 
good measure of virulence. Strain 89/4762 was ranked highest and therefore was deemed to be 
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the most hydrophobic. Strains 89/4747 and 00/3280 were ranked mid-range and were 
considered moderately hydrophobic compared to all other isolates. The most virulent strain was 
00/3280 followed by 89/4762 and 89/4747 which was non-pathogenic. The results from the 
pathogenicity trial suggest that for T. maritimum, hydrophobicity is not a good measure of 
virulence. However, this should be confirmed with more isolates of known virulence and 
employing other methods of measurement for hydrophobicity (Santos et al. 1990). 
The virulence of these strains does need to be put into perspective. The available experimental 
systems for the initial experiments were semi-static with a full water change every 24 hours. 
Water used during these experiments was filtered down to 0.8 µm. The inoculum was 
approximately 1x107 cells/mL. After three days (when mortalities had reached 100% in two 
groups) the concentration of T. maritimum cells was determined to be 3.1 x 108 cells/mL for 
00/3280 and 2.8 x 108 cells/mL for 89/4762 per tank. It is possible that the fish were subjected 
to an increasing dose over time, which may have contributed to the high mortality rate observed. 
Semi-static conditions would have assisted in the attachment of the pathogen to the host by 
providing greater opportunity for contact with the host. However, all strains were under the 
same conditions and therefore virulence differences can be observed. The semi-static conditions 
would also account for the high levels of mortality (68.75 - 93.75%) observed in the first 
experiment (comparison of culture methods). However, mortalities did not reach 100% in the 
first experiment and this was probably due to a colder water temperature and a less dense fish 
population (Table 3.2) (Carson et al. 1992, Soltani 1995). 
Virulence of strains was compared to select a strain for use in the vaccine trial. Strain 00/3280 
reached mortalities of 81.4% within 48 hours while 89/4762 only had mortalities of 31.1 %. The 
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highly pathogenic nature of strain 00/3280 that can cause mortalities within 24 h post-
inoculation has been noted previously (Powell et al. 2004, R van Gelderen, unpublished). It 
seemed more appropriate to use a strain that was mild in its capacity to cause disease rather than 
using a strain that was obviously highly pathogenic and could cause mortalities in a shorter 
amount of time (a possible 'hot strain'). It may also be more difficult to assess dose effect and 
vaccine efficacy using a highly virulent strain. Therefore the more moderately virulent strain 
89/4762 was selected for the dose experiment and subsequent vaccine trial. 
The comparison of different doses of the strain 89/4 762 of T. maritimum was carried out to 
develop a model of infection and to determine an LD60 for a subsequent vaccine trial. Death of 
fish occurred between 48 hours and 18 days post-challenge depending on the dose used. 
Controls that were kept within the system had a cumulative mortality of 17%. The LD60 for the 
experimental period worked out to be 1 x 106 cells/mL, the dose required as the challenge dose 
for the vaccine trial. 
It is difficult to compare the current findings with other pathogenicity investigations due to 
differences in routes of challenge, size of fish and inoculum dose. What is apparent is that a 
challenge model of infection has been established for Atlantic salmon. The current study is 
further supported by the work of Soltani (1995) who produced a similar model of infection with 
LC50 values calculated at 2.3 x 105 CFU/mL for rainbow trout and 1.6 x 106 CFU/mL for 
Atlantic salmon at the same salinity and similar temperatures. 
Another model of infection using immersion has been produced for turbot (Avendano-Herrera et 
al. 2006). Fish weighing 4-6 g required 18 hours of inoculum (5 x 103 to 5 x 108 cells/mL) 
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exposure time to generate a successful infection. The authors reported that they were unable to 
infect turbot with only a 1 or 2 hour bath. The immersion challenge was repeated with 15-20 g 
fish and similar findings were noted. They suggested that the exposure time is not sufficient for 
the development of a biofilm on the skin/gills which is required for successful infection. In 
contrast, the current study, Carson et al. (1992) and Soltani (1995) only required a one hour bath 
to produce an infection using challenge inoculum within the same range as Avendano-Herrera et 
al. (2006). This could be the result of either using a more virulent strain or that salmonids are 
more susceptible to T. maritimum than turbot. 
While immersion challenge provided a suitable method of infection of T. maritimum in Atlantic 
salmon, it was deemed unsuitable in red and black sea bream (Wakabayashi et al. 1984, Baxa et 
al. 1987). Indeed many authors have found that successful disease induction occurs only 
following scarification and smearing (Masumura and Wakabayashi 1977, Wakabayashi et al. 
1984, Baxa et al. 1987, Bernardet et al. 1994). Flexibacteriosis could also be induced by 
subcutaneous injection of the pathogen in Dover sole and red and black sea bream (Campbell 
and Buswell 1982, Baxa et al. 1987), but this was not demonstrated when tested in Atlantic 
salmon (Soltani 1995). However, there is agreement with the use of intraperitoneal injection as a 
method of inducing experimental infection. There is strong evidence from a number of fish 
species that this method does not induce disease (Wakabayashi et al. 1984, Alsina and Blanch 
1993, Bernardet et al. 1994, Soltani 1995, Avendano-Herrera et al. 2006). Through the use of 
nested-PCR, Avendano-Herrera et al. (2006) demonstrated that most of the intraperitoneal 
injection is released into the water within the first 6 hours post-injection. This is suggested as 
the reason why intraperitoneal injection is not an efficient method of inducing disease. It is also 
likely that as an external pathogen, the conditions within the peritoneal cavity do not support the 
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growth and proliferation of T. maritimum. The bacteria have a requirement for NaCl for growth 
and at least 30 ppt seawater is needed in culture media (Wakabayashi et al. 1984, Baxa et al. 
1986, Wakabayashi et al. 1986, Bernardet and Grimont 1989, Bernardet et al. 1990). 
From the work of Carson et al. (1992) it was apparent that horizontal transmission occurred, and 
in the current study as well as Soltani (1995) controls were kept separate from the main system, 
even using a separate biofilter system. Another set of controls was used within the system to 
evaluate the level of horizontal transmission in the current study. The system was set up with a 
filter bank down to 0.8 µm for incoming water and two UV lights to reduce bacterial load. After 
16 days, fish with lesions appeared and consequently some mortalities occurred. Considering 
the experiment only lasted 21 days and 3 days of no mortalities had to occur before terminating 
the experiment, the level of horizontal transmission was quite low. 
The development of a lesion started with small discrete areas of scale loss which progressed into 
cutaneous erosion. At high concentrations the progress of the disease was rapid and highly 
aggressive resulting in 100% mortalities within 2-3 days post-challenge. In contrast, lower 
concentrations required several days to weeks to cause host mortalities. Comparable patterns of 
infection were noted in turbot using similar doses with higher concentrations causing mortalities 
within days and lower doses requiring days to weeks for mortalities to occur (Avendano-Herrera 
et al. 2006). The main clinical signs of the disease from the current study are necrotic lesions of 
the skin and gills, jaw erosion, frayed fins and tail necrosis. The lesions could be in various 
stages of development and the degeneration of fins was consistently associated with erosion in 
the surrounding areas. These gross pathological findings are consistent with natural and 
experimental infections previously recorded in Atlantic salmon (Carson et al. 1992, Handlinger 
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et al. 1997). There are also similarities to the gross pathology described in other affected fish 
species (Masumura and Wakabayashi 1977, Campbell and Buswell 1982, Wakabayashi et al. 
1984, Baxa et al. 1986, Alsina and Blanch 1993, Pazos et al. 1993, Bemardet et al. 1994, 
Handlinger et al. 1997, Avendano-Herrera et al. 2006). 
In natural infections, damage to the epithelium is seen as a pre-disposing factor to an infection 
caused by T. maritimum (Handlinger et al. 1997). Experimental infection in the current study 
occurred without the addition of scarification or deliberate damage. Handlinger et al. (1997) 
suggested the presence of a toxin which causes superficial skin damage thereby initiating further 
progression of the disease. Indeed, at high concentrations infection, erosion and death occurred 
within 72 hours of challenge without the formation of necrotic erosive lesions. Superficial 
degeneration of the epithelium was apparent over the entire body. In addition, as T. maritimum 
is an external pathogen, it could be able to exist and proliferate in the mucus of the host fish. In 
the current study, T. maritimum could be re-isolated from surviving fish in all groups with no 
clinical signs present. In turbot, T. maritimum could be recovered from the mucus of surviving 
fish which was suggested to indicate the existence of a carrier state of the bacterium (Avendano-
Herrera et al. 2006). The mucus of turbot does not contain compounds that inhibit the growth of 
T. maritimum (Magarinos et al. 1995), and therefore the bacteria can exist in the water while 
utilizing the mucus of its host (Avendano-Herrera et al. 2006). The presence of inhibitory 
compounds in the mucus of Atlantic salmon is unknown at this time and an anti-microbial 
investigation proved inconclusive (Soltani et al. 1996). 
Physical abrasion can also provide a habitat for bacterial localisation and colonisation, which 
would allow proliferation of the bacteria and their infiltration into epithelial tissue (Handlinger 
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et al. 1997). The teeth and fins ofteleost fish contain calcium ions which are considered 
important in the growth of flavobacteria (Hikida et al. 1979). Pectoral fins cause constant 
irritation to the surrounding area, and along with the jaw are the two areas that come into 
frequent contact with the tank walls which allows damage to occur (e.g. cherry fin). In all 
experimental treatments the pectoral and dorsal sites predominately showed signs of erosion. 
The jaw was consistently affected except in experiment 2 where there was a decrease in jaw 
erosion. This was most likely the result of the short experimental time frame (3 days). It is also 
possible that under experimental conditions, behavioural traits such as aggression play a role in 
the susceptibility of Atlantic salmon to T. maritimum. Atlantic salmon are known to charge and 
bite each other (Mork et al. 1999). Fin damage, in particular dorsal fin damage, is primarily 
cause by aggression (MacLean et al. 2000). The many small lesions observed on the dorsum of 
the fish along with fin damage and jaw erosion could be the direct result of biting from other 
fish and from net/tank abrasion (Ostland et al. 1999). Larger lesions observed with fin sites can 
be attributed to the irritation and spreading nature of fin movement. 
Lesions are formed in Atlantic salmon through scale loss and the build up of necrotic material, 
which sloughs away to reveal underlying musculature. The necrotic material consists of scales, 
necrotic tissue and bacteria. The progression of the disease has been established not only 
through gross pathology but also histology. It appears as though T. maritimum acts to dislodge 
the scales from the dermis and breakdown the epithelial material through to the dermis. It is 
likely at this point that bacteria exist in the mucus layer of the host. Standard histological 
techniques do not preserve the mucus layer and therefore bacteria were not observed during 
lesion development. It is suggested that the bacteria proliferate in this necrotic material (as 
shown by the mat-like bacteria observed in the gills and slough material) and once through to 
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the musculature this material detaches, leaving the musculature exposed. The reason why the 
lesions can continue to erode outwards is most likely the result of continuing the process of 
breakdown in tissues that are not vascularised. Soltani (1995) suggested that T. maritimum is not 
able to survive in well vascularised living tissue, probably because oflow Na+ levels, which 
would hinder T. maritimum growth (Wakabayashi et al. 1984). This may be the reason why it 
does not progress past the musculature and why it is confined to the epidermis. 
Through immunohistochemistry, T. maritimum has been identified within the slough material 
and gills. Gills showed diffuse necrosis that can affect individual or encompass several lamellae. 
Bacteria were not observed in the connective tissue or musculature in skin lesions. It is 
suggested that this is the result of the preference of T. maritimum bacteria to exist within the 
necrotic material (slough). Handlinger et al. (1997) noted large mats of T. maritimum that 
invaded the connective tissue and occasionally in the musculature of late lesions which is 
inconsistent with current findings. A possible explanation for the discrepancies observed was 
that late lesions were collected from fish that could have been dead for between 12-15 hours. 
Fish were not dead for more than a couple of hours in the current study with the majority offish 
euthanised before mortality occurred. As previously stated, Soltani (1995) suggested that T. 
maritimum was not able to survive in well vascularised living tissue and therefore it is proposed 
that colonisation of the tissue and musculature had not taken place in the tissue of fish in the 
current study. 
Of interest was the lack of an inflammatory response, particularly in fully formed lesions. This 
was also observed by Handlinger et al. (1997) who proposed that the prevention of a host 
response was due to the production of exotoxins. The toxin may act to interfere with the host 
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immune response as a whole or at the site of infection (Thune et al. 1993). This together with 
the suggestion of toxin involvement with the initial skin damage to facilitate bacterial 
proliferation makes exotoxins an area of interest. Baxa et al. (1988c) suggested extracellular 
products (ECP) play an important role in the pathogenesis of T maritimum, which is 
investigated in the next chapter. 
In conclusion, T maritimum is pathogenic to Atlantic salmon using both marine Shieh's and 
marine Ordal' s media for culture. The use of aeration in broth culture produced a dose effect in 
challenge. Differences in virulence between three strains was apparent with one of the strains 
(89/4747) being non-pathogenic and unable to produce disease in the host. The two other strains 
(89/4762, 00/3280) were highly virulent recording 100% mortalities within three days. The high 
mortality rate may have been assisted by the use of semi-static water tanks. Koch's postulates 
were confirmed, a model of infection established and an LD60 was determined using strain 
89/4762. Measurements ofhydrophobicity did not appear to be a good indicator of virulence for 
T maritimum strains. 
The progression of the disease began as small superficial blisters of the epidermis, which 
develop into ulcerative lesions that leave musculature exposed. The predominant lesion sites 
were the dorsum and pectoral fins. Jaws were commonly affected and gill necrosis was also 
noted. Behaviour of Atlantic salmon as well as the conditions under which they were kept 
contribute to the size and distribution of lesions observed. Lack of an inflammatory response in 
pathology and rapid and destructive mortalities observed in higher inoculum doses suggested a 
role of toxins in the pathogenesis of T maritimum. 
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Chapter 4 
Toxicity of extracellular products produced by Tenacibaculum 
maritimum in Atlantic salmon 
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4.1 Introduction 
Toxins are believed to play an important role in the pathogenesis of bacterial diseases in a 
number offish species (Austin and Austin 1993, Dalsgaard 1993). Extracellular products (ECP) 
are toxins that are excreted into the external environment by bacterial cells (Alcamo 1983, 
Madigan and Martinko 2003), and are considered to be virulence factors and contribute to the 
pathogenesis of bacterial disease (Dalsgaard 1993, Liu et al. 1996, Zorrilla et al. 2003). These 
microbial products are types of aggressins that directly affect the tissues, organs and 
physiological processes of the host (Alcamo 1983, Madigan and Martinko 2003). For 
pathogenic bacteria they can cause tissue damage and enhance invasiveness (Dalsgaard 1993). 
Toxigenesis, or the ability of bacteria to produce toxins, may be an important mechanism in the 
ability of bacterial pathogens to produce disease (Liu et al. 1996, Zorrilla et al. 2003). 
Exotoxins are products of metabolism and their production can be species specific (e.g., Bacillus 
anthracis produces the anthrax toxin) (Griffiths 2005). The virulence of a bacterial species can 
be affected by the production of exotoxins. Virulent strains produce exotoxins and non-virulent 
strains do not (Griffiths 2005). Exotoxins are highly antigenic which means they have the 
capacity to stimulate an immune response by a host (Ellis 1997b ). In addition, ECP are heat-
labile proteins and therefore can be denatured (Dalsgaard 1993). The resulting toxoid may retain 
its ability to induce an immune response and therefore can be incorporated into vaccines 
(Magarifios et al. 1994, Santos et al. 1995). 
Results of a:p. earlier pathogenesis experiment (Chapter 3) showed that challenge with 
Tenacibaculum maritimum at higher doses (approximately lx108 cells/mL) had an acute lethal 
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effect on Atlantic salmon (Salmo salar). Mortalities occurred within days, and the clinical sign 
was the disintegration of the epithelium. In vitro, T. maritimum is relatively slow growing with 
at least 48 hours at 25°C required before growth was evident in culture (R van Gelderen, 
unpublished). In addition, a lack of an inflammatory response is characteristic of early 
flexibacteriosis lesions. Handlinger et al. (1997) suggested that this was the result of powerful 
exotoxins that prevent a host response. These findings pointed to a possible role of toxins in the 
pathogenicity of T. maritimum in Atlantic salmon. 
Activities of T. maritimum toxins have been explored in red and black sea bream (Pagrus major 
andAcanthopagrus schlegeli) (Baxa et al. 1988c). In both fish species, ECP showed 
insignificant in vitro activity, however, this did not correspond with the toxic effects observed in 
vivo with ECP recording the lowest LD50• Baxa et al. (1988c) did indicate that the pathogenicity 
of T. maritimum in black and red sea bream may be ascribed in part to ECP. Extracellular 
products produced by T. maritimum have also been studied in vitro to determine immune 
response in sea bass (Dicentrarchus labrax) and to investigate the potential use of ECP in 
vaccine preparations (Salati et al. 2005). While ECP were immunogenic and stimulated a 
secondary immune response, lipopolysaccharide (LPS) showed increased antibody titres and 
enhanced phagocytosis. Lipopolysaccharide was identified by the authors as the antigen 
requiring greater attention for further vaccine investigations. 
From previous work (Baxa et al. 1988c ), it is apparent that in vitro activity and in vivo effects do 
not always correlate. The current study investigated ECP toxicity in vivo to observe direct 
effects rather than in vitro activity of different toxins. Further, this study provides the first 
observations of T. maritimum ECP toxicity in Atlantic salmon. 
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The aims of this study were: 
1. Determine toxicity and the LD50 (for the experimental period) ofT. maritimum ECP in 
Atlantic salmon by injection with different ECP doses, 
2. Describe the pathology in Atlantic salmon due to T. maritimum ECP under experimental 
conditions. 
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4.2 Materials and Methods 
4.2.1 Bacteria and ECP 
The ECP of T maritimum strain 89/4762 was prepared following the cellophane overlay method 
of Liu (1957) using marine Shieh's agar (23 cm x 23 cm) at 25°C. Bacteria were washed off the 
cellophane using minimal amounts of phosphate buffered saline (PBS, pH 7.4) after 72 hours 
incubation. The harvested bacterial suspension was then centrifuged at 4000 x g for 30 mins at 
4°C; the pellet was discarded. The supernatant fluid was sterilised using 0.2 µm filters and the 
resulting ECP was aliquotted and stored at -80°C until used. To ensure that any toxic effect 
observed was from the ECP and not from either the cellophane overlay or agar medium, fluid 
that dialysed across the cellophane overlay from marine Shieh' s mediu~ alone (MSF) was 
harvested using PBS. Protein concentration was determined with the bicinchoninic acid (BCA) 
assay kit (Pierce) using bovine serum albumin as a standard. 
4.2.2 Experimental design 
Seventy Atlantic salmon averaging 40 g (30.4 g- 56.5 g) were held in 14 aerated static 
freshwater circular tanks (100 L) at 15-16°C. Each treatment had 2 replicate tanks with 5 fish 
per tank. 
4.2.3 ECP injection 
Fish were anesthetised using 0.03 mL/L clove oil in seawater. Ten fish per treatment were 
injected intraperitoneally with 0.1 mL ofECP of five different doses: 1000, 500, 250, 125 and 
62.5 µg protein/fish. There were also two control treatments: a group ofunhandled controls 
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(Control) and a group of controls (Control IP) that were injected with 0.1 mL ofMSF. 
Intraperitoneal injection was used for the route of challenge as the production of ECP was 
insufficient for bath challenge. Immersion would have been the preferred method of challenge 
as it reflects the natural course of the disease. Subcutaneous injection ofECP could also be used 
as a method to trial in the future. However, the test via injection allows a basis for comparison 
with previous work (Baxa et al. 1988c) and ensures an accurate dose. 
4.2.4 Sampling procedure 
Gross pathology of each fish was determined using the method of Baxa et al. (1988c). The gill, 
liver, spleen, heart, kidney, stomach and intestine were examined and each organ was assigned a 
classification based on its gross pathology: Discoloured; Suppurated; Hypertrophied; 
Haemorrhaged; Normal. Pathology was also graded according to the severity of the changes. 
Histopathology was assessed by collecting organ samples and fixing in seawater Davidson's for 
an initial fixation of 72 hours before being transferred into 70% ethanol. Samples were 
embedded in paraffin wax, sectioned at 5 µm and stained with haematoxylin and eosin (H&E). 
Sections were viewed under a light microscope at magnification x40 - xlOOO for examination 
and interpretation. 
4.2.5 Fish sampling and determination of LD50 
Fish were removed from the tanks when there were clear signs of morbidity (fish were unable to 
control position in the water column). Survivors were euthanased 24 hours post-injection with 
an overdose of clove oil (0.06 mL/L seawater). The LD50 for the 24 hour experimental period 
was calculated according to Reed and Muench (1938). 
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4.3 Results 
Within the 24 hour experimental period, the three highest doses resulted in 100% mortality with 
the time taken to morbidity increasing with a decrease in dose (Figure 4.1). No mortalities were 
observed in the 61.2 µg and control groups. A 50% mortality rate was recorded in fish injected 
with 125 µg, which is 3.125 µg of protein/g offish body weight. This was determined to be the 
LD5o for the experimental time period. Severity of pathological signs appeared to be related to 
the dose of the ECP toxin; the lower the dose, the less severe the gross pathology. 
The prevalent sign of the reaction to the ECP was hemorrhaging and ascites in the peritoneal 
cavity (Figure 4.2). Fish in both control groups did not show any pathological signs. The gills, 
heart and liver were all discoloured, appearing to be drained of blood (Figures 4.3 and 4.4). In 
three cases the liver of surviving fish in the 125 µg group appeared yellow, indicating jaundice 
(Figure 4.4). The spleen was haemorrhagic, hypertrophic, and dark in colour (Figure 4.5), but 
moreover was abnormally firm at the highest dose and became more pliable (similar to controls) 
with decreasing dose. Blood was present in the stomach which together with the intestines was 
hypertrophied (Figure 4.5a). This enlargement caused the swim bladder to appear smaller and in 
some cases, particularly in the higher doses, the swim bladder appeared to be 'bubbled' (Figure 
4.5b). The kidney was haemorrhagic (Figure 4.5b) and the anus inflamed in most cases while 
bleeding from the anus occurred in the two highest doses (Figure 4.5c ). The severity of 
pathological signs reduced with decreasing dose; minor signs were present in fish injected with 
61.2 µg that survived the 24 hour experimental period. 
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Figure 4.1 Cumulative mortality(%) of Atlantic salmon injected with Tenacibaculum 
maritimum ECP toxin. 
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Figure 4.2 Internal organs of Atlantic salmon: A, control; B, injected with 1 mg of 
Tenacibaculum maritimum ECP 3 hours post injection. Note the haemorrhaging inside and 
outside of the peritoneal cavity. The spleen is firm and rigid and all organs are enlarged. Scale 
bars 1 cm. 
Figure 4.3 Gills of Atlantic salmon: A, control; B, injected with 1 mg of Tenacibaculum 
maritimum ECP 2 hours post injection. Note the lack of colour in the gill, appearing to be 
drained of blood. Scale bars 0.5 cm. 
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Figure 4.4 Heart and liver of Atlantic salmon: A, control ; B, injected with 125 µg of 
Tenacibaculum maritimum ECP 24 hours after injection. Note the discolouration of the heart 
and the yellow appearance of the liver. Scale bars 0.5 cm. 
Figure 4.5 Internal organs of Atlantic salmon injected with 1 mg of Tenacibaculum maritimum 
ECP 3 hours post injection: A, hypertrophied stomach, intestine and spleen with haemorrhaging 
in the stomach; B, haemorrhagic kidney with ' bubbled ' swim bladder (arrow); C, bleeding anus. 
Scale bars 1 cm. 
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Histological examination of the gills showed epithelial lifting, hypertrophy of cells, necrotic 
epithelium and there appeared to be an increase in the number of chloride cells (Figure 4.6). 
The cardiac muscle was necrotic and vacuolated and an infiltration of inflammatory cells was 
observed in the heart (Figure 4.7). There was a degeneration of kidney tubules (Figure 4.8), an 
increase of red blood cells in the spleen (Figure 4.9), and focal inflammation and necrosis in the 
liver (Figure 4.10). The lumen of the pyloric caeca was not visible due to hyperplasia and the 
central mucosal epithelium appeared necrotic (Figure 4.11). The intestine showed infiltration of 
submucosa with inflammatory cells (Figure 4.12b, d), a thickening of the muscularis circularis 
with separation of the smooth muscle by inflammatory infiltrate (Figure 4. l 2b, c). Pancreatic 
tissue and fat appeared normal. 
Figure 4.6 Atlantic salmon gill section: A, control; B, injected with 1 mg of Tenacibaculum 
maritimum ECP 2 hours post injection. Note the apparent increase in chloride cells, seen as 
large eosinophilic cells (arrow) and epithelial lifting and necrosis. Scale bars 10 µm. 
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Figure 4.7 Atlantic salmon heart (cardiac muscle) section: A, control; B, injected with 1 mg of 
Tenacibaculum maritimum ECP 2 hours post injection. Note the necrotic and vacuolated nature 
of the tissue and aggregation of inflammatory cells (arrow). Scale bars 10 µm. 
Figure 4.8 Atlantic salmon kidney section: A, control; B, injected with 1 mg of Tenacibaculum 
maritimum ECP 2 hours post injection. Note the focal necrosis. Scale bars 10 µm. 
- 101 -
Figure 4.9 Atlantic salmon spleen section: A, control; B, injected with 1 mg of Tenacibaculum 
maritimum ECP 3 hours post injection. Note the increase in the number of red blood cells. Scale 
bars 10 µm. 
Figure 4.10 Atlantic salmon liver section: A, control; B, injected with 1 mg of Tenacibaculum 
maritimum ECP 2 hours post injection. Note the focal necrosis. Scale bars 10 µm. 
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Figure 4.11 Atlantic salmon pyloric caeca section: A, control; B, injected with 1 mg of 
Tenacibaculum maritimum ECP 2 hours post injection. Note the blockage of lumen and necrosis 
of the central mucosal epithelium. Scale bars 100 µm. 
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Figure 4.12 Atlantic salmon intestine sections: A, control (scale bar 100 µm); B, injected with 1 
mg of Tenacibaculum maritimum ECP 2 hours post injection (scale bar 100 µm); C, thickerung 
of the muscularis circularis and the presence of inflammatory infiltrate (scale bar 10 µm); D, 
infiltration of submucosa with inflammatory cells (scale bar 10 µm). 
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4.4 Discussion 
Results from the ClllTent study confirm the toxicity of T. maritimum ECP in Atlantic salmon. 
Toxicity in black and red sea bream has previously been established (Baxa et al. 1988c). LD50 
values were 25.5 µg/fish and 44.0 µg/fish in black and red sea bream, respectively. The current 
study determined an LDsoof 125 µg/fish for Atlantic salmon. However, the size offish was 
different; 2.5 g black and red sea bream compared to 40 g Atlantic salmon. Taking the weight 
into account, the LD50 for black and red sea bream was 10.2 µg ofprotein/g offish and 17.6 µg 
ofprotein/g offish, respectively. The LD50 for Atlantic salmon was 3.125 µg ofprotein/g of 
fish. Therefore, the ECP produced from strain 89/4762 was more potent, or alternatively, 
Atlantic salmon more susceptible. Factors such as extraction method, growth media, incubation 
times and strain used could affect potency because they can affect the expression of virulence 
factors (Ellis 1991, Gunnlaugsd6ttir and Gudmundsd6ttir 1997, Zhang and Austin 2000). The 
current study used the cellophane overlay method of Liu (1957) to produce ECP while Baxa et 
al. (1988c) used ammonium sulfate precipitation. The differences observed between the studies 
may have been the result of using different production methods. In order to compare results 
more accurately between studies it would be beneficial to standardise the procedure to control 
variables. In addition, evaluation of the factors that have the potential to affect toxicity could be 
an area of future research. 
Following injection of Atlantic salmon with ECP the toxic effect occurred only internally and 
did not induce clinical signs of flexibacteriosis. The lack of external clinical signs is consistent 
with Baxa et al. (1988c ). The ECP of several pathogenic bacteria administered by injection have 
caused clinical signs of the disease which resembled those from an infection with live cells. 
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These include Vibrio harveyi (Zhang and Austin 2000, Zorrilla et al. 2003), Aeromonas 
salmonicida (Munro et al. 1980, Ellis et al. 1981) and Vibrio alginolyticus (Balebona et al. 
1998). All of these bacterial pathogens cause a systemic infection unlike T. maritimum, which is 
an external pathogen. This could be a reason why the ECP of these pathogens can cause external 
clinical signs of the disease and T. maritimum could not. Gross and histopathological results 
from natural and experimental infections in Atlantic salmon have shown necrosis of the gills 
(Soltani 1995, Handlinger et al. 1997). Gross pathology in this study showed discoloured gills 
while histology showed necrosis of the gill filaments. Even though the gills do not show clinical 
signs of the disease, the histology provides a link between the pathology of the disease and the 
ECP. 
Considering T. maritimum is a marine bacterium with an absolute requirement for seawater 
(Wakabayashi et al. 1986), it is conceivable that the use of freshwater inhibited external 
expression of the disease. Keeping fish in freshwater was primarily due to the use of 40 g 
Atlantic salmon that would not yet be able to tolerate seawater. Baxa et al. (1988c) did not 
report under what conditions their fish were held, but as red and black sea bream are marine 
fish, it can be assumed that their experiments used seawater. Since both studies show consistent 
results and no external clinical signs were reported it can be concluded that freshwater most 
likely had no effect on the outcome. 
Another possibility is that external clinical signs of flexibacteriosis were not observed in the fish 
because the effect was too acute. However, there are similarities between the mortality rates in 
the current study and Baxa et al. (1988c). Mortalities began within 2-3 hours post injection at 
the highest doses (1 mg and 250 µg respectively) and time to death increased with decreasing 
- 106 -
dose. Survivors showed no external clinical signs of the disease in the current study; the status 
of survivors in Baxa et al. (1988c) was not reported. 
It is also necessary to consider the possibility that ECP may not be the cause of topical changes 
seen with naturally occurring infections. These changes may be caused by local proteolysis. It is 
also possible that ECP might spread systemically from the sites of the infection and into the 
body of the fish causing early mortalities without causing clinical signs of disease. The current 
study is speculating that ECP plays a role in the pathogenesis of T. maritimum and further 
research is required to fully elucidate its role. 
Gross pathology was similar between the current study and Baxa et al. (1988c) with the 
prevalent sign being excessive fluid in the peritoneum. Blood associated with the ascites was 
also found in the current study. Most organs showed similar signs in both studies with the 
exception of the liver. Baxa et al. (1988c) reported the liver to be suppurated. In the current 
study, all morbid fish had a discoloured liver and in 3 of the surviving fish in the 125 µg group, 
the liver appeared yellow, indicating jaundice. There was no sign of pus internally in any fish. 
This reaction may be a host specific or age specific response. The suppurated liver was reported 
to be the result of a tissue reaction, which blocked blood supply causing necrosis and secretion 
(Baxa et al. 1988c). Histology was not undertaken in the study of Baxa et al. (1988c) and 
therefore the extent of tissue damage is unknown. However, the discoloured liver was consistent 
in fish from both studies and the current study in Atlantic salmon provides histological evidence 
to support liver necrosis. 
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Histological examination of the internal organs showed focal inflammation and necrosis in the 
liver. These sections were taken from fish injected with 1 mg ECP which represents the greatest 
toxic effect. All fish within this group were morbid within 8 hours indicating an acute effect and 
there was insufficient time to observe a gross response other than discolouration. In 3 of the 
surviving fish from the 125 µg group, a jaundiced liver was observed. The focal necrosis and 
inflammation in this case was enough to damage the hepatocytes and prevent the removal of 
bilirubin from the liver causing jaundice (Maeno et al. 1995). A jaundiced liver was observed in 
these fish because they were still alive whereas the morbid fish had succumbed to the damage 
caused not only to the liver but also all other internal organs. 
The toxin caused necrosis of the cells within organs as observed in the gills, heart, liver and 
pyloric caeca. The toxin is either causing autolysis or rapid lysis of the cell (Mallatt 1985). It is 
suggested that the fish attempts to mount a defence response; epithelial lifting and hyperplasia 
could serve as a defence mechanism by increasing the diffusion distance between the toxin and 
the bloodstream (Mallatt 1985), and there is also the infiltration of inflammatory cells into the 
heart and intestine. Haemorrhaging into the peritoneum is a result of bleeding from the organs, 
which are breaking down. The spleen may be increasing red blood cell production in order to 
counteract the blood loss or alternatively to store blood cells for later use. 
Overall, the ECP produced by T. maritimum caused necrosis in Atlantic salmon. Therefore, it 
has the potential to play a significant role in the formation of lesions on the external surfaces of 
fish. Necrotic lesions on the external surfaces offish with flexibacteriosis are characterised by 
destruction of the epithelial cells and connective tissue which leaves musculature exposed to the 
external environment (Carson et al. 1992). It has been demonstrated that the ECP caused cell 
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necrosis in the internal organs of Atlantic salmon; the same affect that occurs on the external 
surface during infection. This, together with the short survival times recorded in the 
pathogenicity studies (Chapter 3), provides evidence that this bacterium probably utilise the 
ECP to facilitate cellular breakdown and by acting synergistically are an effective pathogenic 
system. 
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Chapter 5 
Vaccination of Atlantic salmon against Tenacibaculum maritimum 
This chapter is modified from a paper prepared for publication in Aquaculture. 
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5.1 Introduction 
Tenacibaculum maritimum is a well-established fish pathogen worldwide (Wakabayashi et al. 
1986, Devesa et al.1989, Bernardet et al. 1990, Chen et al. 1995, Kusuda and Kawai 1998, 
Ostland et al. 1999). Apart from a major outbreak in 1988/89, it has been a relatively minor yet 
persistent problem in the Tasmanian salmonid aquaculture industry. Previous management 
strategies such as improved handling practices have significantly decreased the incidence of the 
disease in Tasmania (Handlinger et al. 1997). 
However, with seawater temperatures continuing to rise around Tasmania, the incidence of T. 
maritimum may increase from minor outbreaks to a chronic problem. There is also limited 
information on the biological factors that could initiate further outbreaks of the disease. Patterns 
of infection are variable and effective management strategies would be difficult to implement 
(Carson et al. 1992). Antibiotics are undesirable as a long term strategy with problems of 
bacterial resistance and tissue residence times (Cabello 2006). The most common treatment, 
trimethoprim, has a withholding period of 500 degree days which is unacceptable in commercial 
production (S. Percival pers. comm.). Amoxycillin is an alternative that has a short withdrawal 
time of 50 degree days, but is less efficacious than trimethoprim (Cameron 1993b ). 
Oxytetracycline was efficacious during the initial outbreak of T. maritimum, but is known to 
have several long term detrimental effects (Soltani et al. 1996). While in vivo evaluation of 
amoxycillin and trimethoprim against T. maritimum has been validated by clinical trials (Soltani 
et al. 1996), there is no evidence of their efficacy under severe outbreak conditions. It is also 
necessary to consider the environmental impacts of antibiotic use. Antibiotic resistant bacteria, 
an increase in the bacterial resistance in fish pathogens, changes to the bacteria flora of the 
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marine environment and their flow on effect to other animals and humans are a result of using 
chemotherapeutants heavily or long term (Cabello 2006). 
In order to reduce the reliance on chemotherapeutants and to prevent future unforseen outbreaks 
from occurring, development of a safe and effective vaccine against T maritimum in salmonids 
is the focus of this study. Other bacterial diseases such as yersiniosis and vibriosis have been 
successfully managed with the development of a vaccine (Hastein et al. 2005). As yet, a vaccine 
is not available for T maritimum for salmonids. Previous attempts to develop a vaccine for 
salmonids in Tasmania proved unsuccessful due to inconsistency ofresults (Carson et al. 1993, 
Carson et al. 1994), because numbers of mortalities were different between experiments that 
were repeated. Recently, promising results for an injectable vaccine for species of sole (So/ea 
solea and S. senegalensis) in Spain were reported (Romalde et al. 2005). However, an effective 
vaccine for the Tasmanian salmonid aquaculture industry will likely need to be based on local 
strains of T maritimum affecting local Atlantic salmon (Salmo salar) stocks. Since T 
maritimum is an external pathogen, it may be assumed that immersion vaccination would be 
initially trialled. However, while immersion vaccination has shown to be effective for other 
external pathogens such as Vibrio anguillarum and Yersinia ruckeri, it is not effective for 
Aeromonas salmonicida which requires intraperitoneal injection with adjuvants to produce a 
moderate level of protection (Ellis, 1988). Intraperitoneal injection is also the industry standard 
for vaccination and with the development ofpolyvalent vaccines, intraperitoneal injection would 
be the most suitable method of delivery. 
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The aims of this study were to: 
1. Determine the cumulative mortality of Atlantic salmon challenged with T. maritimum 
that have been inoculated with experimental vaccines. 
2. Determine vaccine efficacy using Relative Percent Survival (RPS). 
3. Determine the short-term side effects of vaccination following challenge with T. 
maritimum. 
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5.2 Materials and Methods 
5.2.1 Vaccine preparation 
A strain of T. maritimum (8914 762) isolated from diseased Atlantic salmon (see Table 2.1) was 
grown in an aerated 10 L carboy using Shieh's medium formulated with natural seawater. The 
bacteria were grown in 5 L of broth at room temperature (20°C) with aeration (120 L/h) and 
harvested after 48 hours incubation. Cell concentration reached a mean of 1.27 x 109 cells/mL as 
determined by direct counts using a Helber counting chamber. The bacteria were inactivated by 
the addition of formalin to a final concentration of 5 mL/L. After 48 hours refrigeration, the 
cells were collected by centrifugation at 3000 x g for 30 minutes and washed three times using 
phosphate buffered saline (PBS, pH 7.4). Cells were resuspended in PBS to a final concentration 
of 1.08 x 1010 cells/mL and formalin added to a final concentration of 0.1 % v/v as a 
preservative. A vaccine preparation containing Freund's incomplete adjuvant (FIA) (Sigma) was 
also produced. The adjuvant was mixed 50:50 with the vaccine suspension just prior to use. 
Both vaccine preparations used for this study contained approximately 1.79 x 109 cells/0.1 mL 
inoculum. 
The vaccine was tested for sterility using a modified version of the British Pharmacopoeia 
standard (Anon. 2005). Ten millilitres of tryptone soy broth (TSB, Oxoid) and marine Shieh's 
broth (MSB) and 25 mL of fluid thioglycollate medium (FTM, Oxoid) were inoculated with 500 
µL of the formalin-inactivated suspension. After 7 days incubation at 25°C for TSB and MSB 
and 35°C for FTM, the broth media were subcultured on to tryptone soy agar (TSA, Oxoid), 
marine Shieh's agar (MSA) and FTM and incubated for a further 5 days at the same 
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temperatures as previously stated. Absence of growth on the agar plates or FTM was interpreted 
as absence of culturable bacteria in the vaccine preparation; five replicates for each broth were 
used for testing. 
A fertility test of the enrichment broths was made using cultures of Staphyloc_occus aureus, 
(ATCC 6538) Pseudomonas aeruginosa (ATCC 9027) (supplied by the Department of Primary 
Industries and Water) and the strain 89/4762 of T. maritimum. Broth cultures, 24-48 hold of the 
test organisms were diluted to a density McFarland 0.5 and diluted 10-5 in sterile PBS (pH 7.4). 
TSB was inoculated with 100 µL of P. aeruginosa; the FTM with 100 µL of S. aureus and MSB 
with the T. maritimum. All cultures were incubated for 48 h and then P. aeruginosa was 
subcultured to TSA, S. aureus to FTM and T. maritimum to MSA for another 48 h at 25°C for 
TSA and MSA and 35°C for FTM. Growth on the agar plates or FTM was taken to mean that 
inhibitors were not present in the enrichment media and was capable of supporting the growth of 
bacteria; five replicates were used for testing. 
5.2.2 Experimental fish and challenge conditions 
Atlantic salmon (approximately 100 g) were obtained from a commercial hatchery and 
maintained in 12 x 200 L tanks in an aerated freshwater flow-through system. The fish were 
assigned to tanks to ensure consistency of density between tanks. Fish were held for one week 
prior to vaccination. Post vaccination, fish were held at 15°C for 6 weeks in freshwater. 
Acclimation to seawater was achieved by the gradual increase (5 ppt/day) of seawater over 
seven days and the fish acclimated to 18°C over another 7 days. The system was switched over 
to re-circulation once acclimation commenced. Fish were fed a commercial diet (Atlantic HP -
Skretting) at maintenance (1 % body weight) until challenged, 8 weeks post vaccination. The 
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fish were randomly assigned to tanks and divided into 4 treatments which were tested in 
triplicate (Table 5.1). 
Table 5.1 Treatments used for Tenacibaculum maritimum vaccination experiment. Each 
treatment was undertaken in triplicate. 
Treatment Description Fish No. 
Control Fish not injected and not handled 32 
until challenge 
Fish injected with sterile PBS to 
Control IP examine the effects of handling 37 
and injection 
Vaccine Fish injected with formalin inactivated 38 bacteria vaccine 
Vaccine + Adjuvant Fish injected with formalin inactivated 36 bacteria vaccine containing 
Freund's incomplete adjuvant 
Water quality variables such as temperature, salinity (maximum 35 ppt), pH (max. 8.0), total 
ammonia (max. 2 mg/L), nitrates (max. 10 mg/L) and nitrites (max. 0.5 mg/L) were monitored 
throughout the experiment and controlled accordingly. Throughout the study, the freshwater pH 
was consistently around 6.0 and even though flow was decreased and sodium bicarbonate 
added, maintaining a higher pH was difficult. The problem of low pH levels was exacerbated by 
the high chlorine levels of the incoming water that was controlled by the use of sodium 
thiosulphate. The use of sodium thiosulphate caused the pH of the freshwater to decline, but not 
below 6.0. During maintenance in freshwater, some non-specific mortalities occurred due to the 
occasional decreases in water pH. Fish were unable to be moved between tanks since mortalities 
occurred after treatment (vaccination) had been applied. This affected the number offish per 
treatment (see Table 5.1). No mortalities occurred during acclimation or holding in seawater. 
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5.2.3 Vaccination 
Fish were anaesthetised using clove oil (0.03 mL/L of seawater) and vaccinated using Luer 
Lock glass syringes (2 mL capacity) with 23 gauge needles. The vaccine was injected as 0.1 mL 
volumes per fish into the peritoneal cavity, 1 cm anterior to the pelvic fins and approximately 
0.5 cm in depth. A separate tank with aerated freshwater was used to ensure the recovery of the 
fish before returning them to their experimental tanks. 
5.2.4 Challenge procedures 
The challenge strain (89/4762) was cultured using an aerated 10 L carboy at room temperature 
(20°C) in MSB. The bacteria were grown in SL of broth with aeration (120 L/h). After 48 hours 
the cells were collected by centrifugation at 3000 x g for 30 mins at 4°C and washed three times 
using 0.22 µm filtered seawater. Cell concentration was determined microscopically using a 
Helber counting chamber and adjusted to a final concentration of 1.0 x 106 cells/!11-L which was 
used as the challenge dose. This dose was calculated to give a 60% mortality rate in control 
treatments. Fish were placed in 100 L seawater tanks and challenged for 1 h by bath exposure. 
Following challenge, the fish were returned to their original tanks. Mortalities were monitored 3 
times a day for the experimental period which was deemed to have ended when there were 3 
consecutive days of no mortalities. 
5.2.5 Sampling procedure 
All fish were examined bacteriologically by culturing skin lesions or sites of erosion on plates of 
MSA containing 4 µg/mL neomycin sulfate (Pazos et al. 1996). Direct smears (1 cm x 1 cm) 
were prepared for staining by Gram's method and by immunofluorescence (IFAT). Cultures 
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were incubated at 25°C for 2 days and the colonial morphology typical of T. maritimum 
recorded. Internal organs were examined grossly since fish had been vaccinated by 
intraperitoneal injection. Flexibacteriosis lesion distribution and lesion size were recorded for all 
fish. Lesion size was measured as length of lesion along the longest axis and was recorded to the 
nearest half centimetre. The numbers of lesions recorded at each site were divided by the total 
number of lesions recorded for that treatment, thereby indicating differences in areas being 
affected. Any fish surviving at the end of the challenge period were euthanased with clove oil 
(0.025 mL/L) and lesions or sites of erosion examined bacteriologically as described. 
Photographs were taken of the fish to document gross pathology and samples of skin lesions or 
sites of erosion were taken for histological examination. 
5.2.6 Case definition 
The criteria for accepting that a fish was diseased involved two parts: method of recovery and 
quantification of colonies and cells. Tenacibaculum maritimum had to be recovered from 
mortalities by culture and in smears by IF AT as these methods are more specific than Gram 
stain. The minimum abundance of cells required for a positive result was 10-50 bacteria per 25 
fields for IF AT and Gram stain. The minimum abundance required to record a positive result in 
culture was growth of colonies extending to the first streaking lines. 
5.2. 7 Histological examination 
Initially the samples were fixed in seawater Davidson's (Shaw and Battle 1957, Speilberg et al. 
1993) for 72 hours before being transferred into 70% ethanol. Samples were embedded in 
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paraffin wax, sectioned at 5 µm and stained with haematoxylin and eosin (H&E). Sections were 
viewed under a light microscope at magnification x40- xlOOO for interpretation. 
5.2.8 Immunofluorescence (IFAT) 
The procedure described by Carson et al. (1992) was used. Smears taken from samples were 
initially air-dried and heat fixed. The smears were overlaid with 40 µL ofrabbit anti-T. 
maritimum 89/0329-5 (DPIW) diluted 1 :100 in PBS (pH 7.2, O. lM) and incubated in a moist 
chamber for 30 minutes at 37°C before rinsing in PBS for 15 minutes. After the removal of 
excess buffer by blotting, 20 µL of anti rabbit FTIC (Silenus) diluted 1 :60 in PBS was added to 
each slide. Smears were incubated at 37°C for 30 minutes and rinsed for 30 minutes in PBS, 
with a change of buffer every 10 minutes. Slides were mounted using alkaline glycerol buffer, 
(Johnson and Munday 1993), coverslipped and examined at x 40 magnification with 
epifluorescent microscopy using UV illumination. 
5.2.9 Vaccine efficacy and statistical analysis 
Vaccine efficacy was determined using Relative Percent Survival (RPS) (Amend 1981). 
RPS = 1 - (% vaccine mortality I % control mortality) x 100 
Data were also analysed using Kaplan-Meier survival analysis and a pair-wise comparison over 
strata with a Bonferroni correction of p-values using SPSS 11.5 for Windows. 
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5.3 Results 
Fish injected with Vaccine+ Adjuvant showed significantly better survival than other 
treatments based on pair-wise comparisons (Figure 5.1). Within the experimental period, 
cumulative mortalities of the different treatments were: Controls IP, 54%; Controls, 50%; 
Vaccine, 39%; Vaccine+ Adjuvant, 11 % (Figure 5.1) which Kaplan-Meier survival curve 
analysis deemed to be significant (p:'.50.0010). Mortality rates in the control treatments were 
lower than the expected rate of 60%. Low RPS values were found between the Vaccine and both 
control treatments. In contrast, against both control treatments, high RPS values were found for 
the Vaccine+ Adjuvant treatment (Table 5.2). Methods used to confirm the presence of T 
maritimum from mortalities were sensitive with bacteria being detected from all tests (Table 
5.3). 
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Table 5.2 Relative percent survival of Tenacibaculum maritimum vaccine mixtures injected into 
Atlantic salmon. 
Treatment Compared to: Relative Percent Survival (RPS) 
Vaccine 
Control IP 27.7% 
Control 22.0% 
Vaccine + Adjuvant Control IP 79.6% Control 78.0% 
Table 5 .3 Comparison of media culture, Gram stain and IF AT preparations for the detection of 
Tenacibaculum maritimum in Atlantic salmon. 
Treatment Culture(%) Gram(%) IFAT (%) Lesion 
mean (± S.E.) mean (± S.E.) mean (± S.E.) 
Control 100 (0) 100 (0) 100 (0) + 
Control IP 100 (0) 100 (0) 100 (0) + 
Vaccine 100 (0) 100 (0) 100 (0) + 
Vaccine + Adjuvant 100 (0) 100 (0) 100 (0) + 
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Figure 5 .1 Cumulative mortality (%)of Atlantic salmon given intraperitoneal vaccination of 
experimental vaccine mixtures against Tenacibaculum maritimum. Lines with different letters 
are significantly different (p~0.0083). 
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Gross pathology in the challenge of fish was similar to natural infections and previous 
pathogenicity trials. Lateral sites were dominant in lesion distribution; however, pectoral sites 
were more predominant in the Vaccine and Vaccine+ Adjuvant treatments (Figure 5.2). Tail 
necrosis was common among all treatments while gill necrosis only appeared in one case 
(Control IP) throughout the entire study. Skin missing from the jaw area was notable in all 
treatments and eye damage were, also present; eyes were either absent from the eye socket or 
had ruptured within the eye socket (Figure 5.4a). Tenacibaculum maritimum could be recovered 
from affected sites, but lack of corneal tissue prevented histological assessment to be made to 
discern if T. maritimum was involved in the eye pathology. Larger lesions tended to be found in 
the Vaccine and Vaccine+ Adjuvant treatments, while both control treatments displayed smaller 
lesions (Figure 5.3). The number oflesions between vaccinated treatments and unvaccinated 
control treatments was 4.3 lesions/fish and 5.6 lesions/fish respectively. Similar to previous 
pathogenicity trials (Chapter 3), larger lesions were found around pectoral, pelvic and caudal 
sites. Smaller lesions tended to be found on the dorsal, lateral or ventral surfaces. The majority 
of surviving fish did not show any clinical signs of flexibacteriosis, with inflamed fins and small 
blisters noted on rare occasions. 
Histological examination of lesions and erosive sites showed the same pathology as those 
observed in chapter 3, and therefore are not repeated in this chapter. 
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Figure 5.2 Distribution of lesions in Atlantic salmon challenged with Tenacibaculum maritimum 
strain 89/4762 post-vaccination: A, Control IP; B, Control; C, Vaccine; D, Vaccine+ Adjuvant. 
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Figure 5.3 Lesion size(%) in Atlantic salmon challenged with Tenacibaculum maritimum strain 
89/4762 post-vaccination: A, Control IP; B, Control ; C, Vaccine; D, Vaccine+ Adjuvant. 
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Internal organs were also examined to investigate any side effects due to intraperitoneal 
injection. A consistent finding in fish injected with the Vaccine+ Adjuvant treatment was the 
presence of black/brown pigment associated with the stomach and an associated inflammatory 
response (Figure 5.5a). It was not found in fish from any other treatment. By histological 
examination it was apparent that the black/brown pigmentation was most likely melanin (Figure 
5.5b). Associated with this pigmentation was also chronic inflammation, abnormal accumulation 
of fat, granulomas, inflammatory cells and cysts. Another gross clinical sign was observation of 
lesions through the abdominal musculature (Figure 5.4b). This only occurred when large 
ulcerative lesions were observed on the external surface of the fish and was not associated with 
sites of injection. No gross pathology was observed at injection sites in all treatments. 
Figure 5.4 Gro s pathology from the vaccine trial : A, ruptured eye of Atlantic salmon; B, 
flexibacteriosis lesion of the abdominal musculature. Scale bars 1 cm. 
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Figure 5.5 Gross and histological 
pathology of adjuvant induced 
side-effect: A, black/brown 
pigment associated with the 
stomach of fish injected with 
Vaccine+ Adjuvant (scale bar 1 
cm); B, histological section of the 
stomach showing (i) black/brown 
pigmentation (ii) vacuole (scale 
bar 30 µm); C, granuloma among 
fat tissue (scale bar 50 µm). 
5.4 Discussion 
Within the challenge period of 27 days, significant protection was demonstrated in fish injected 
with the Vaccine + Adjuvant compared to all other treatments. In fact, RPS values were 
calculated at 79.6% and 78.0% which according to Amend (1981) is close to the RPS value 
required for a vaccine to be used under practical field conditions (80%). The vaccine without 
adjuvant did show lower mortalities than control treatments, however, it was not significantly 
different from both control treatments. Low RPS values at 27.7% and 22.0% indicate that the 
vaccine without adjuvant could not provide sufficient protection from a moderate challenge of 
T. maritimum. It is important to note that the current study did deviate from the criteria set by 
Amend (1981). Treatments were set up in triplicate, not duplicate and there was not a total of 50 
fish per treatment. There was also only one level of challenge. However, survival curve analysis 
reinforces the results obtained by RPS which reflect the comparisons of each treatment group 
with each control group. The Vaccine+ Adjuvant treatment was significantly different, while 
the Vaccine treatment was not. Based on RPS values and survival curve analysis the Vaccine + 
Adjuvant treatment provided significant protection against T. maritimum. 
Previous work on a vaccine for Atlantic salmon against T. maritimum provided inconsistent 
results (Carson et al. 1993, Carson et al. 1994). Initial studies using strain 89/4762 failed to 
protect fish against moderate to severe levels of challenge using the dip process as a vaccination 
technique. Further studies included a formalin inactivated injection vaccine using strain 
89/4762. Based on gross clinical signs, two RPS values were calculated at 0% and 23%. The 
vaccination dose in this case was lower than the current study at 7.5 x 106 cells/mL, however, 
the fish were booster vaccinated two weeks after initial vaccination (Carson et al. 1994). A 
- 128 -
booster was not provided in the current study. Another point to note was that the challenge dose 
used by Carson et al. (1994) was also at lower concentrations (1.4 x 104 - 3.9 x 104 cells/mL) 
than the current study and yet both studies used 60% endpoints based on previous work for the 
same strain (89/4762). It is clear though that in this and other studies a vaccine based on 
formalin inactivated bacteria is not sufficient to provide adequate protection via injection for 
Atlantic salmon. 
In contrast, injection of sole using a formalin inactivated bacterin reported a RPS value of 94%, 
6 weeks post-vaccination (Romalde et al. 2005). Mortality ~ates of 5% were recorded for 
vaccinated and 85% for non-vaccinated fish. However, the challenge dose of 1.1 x 108 cells/fish 
was injected intraperitoneally which does not reflect the natural course of the disease. 
Interestingly, it has been demonstrated that Atlantic salmon vaccinated against furunculosis 
(causative agent Aeromonas salmonicida) by intraperitoneal injection and then subsequently 
challenged via the same method resulted in high protection and RPS values (Nordmo and 
Ramstad 1997). The protection is suggested to be local immunity in the abdominal cavity and 
with a secondary water-borne infection the RPS values decrease (Nordmo and Ramstad 1997). 
Comparison of intraperitoneal injection and immersion challenges in Atlantic salmon using the 
same inoculum doses showed that immersion provided lower cumulative specific mortality 
(Nordmo and Ramstad 1999). The authors suggested that RPS guidelines should consider the 
method of challenge when evaluating vaccine efficacy. In addition, the inability to cause 
mortalities or induce disease using intraperitoneal injection of T. maritimum has been reported 
in Atlantic salmon (Soltani 1995); red and black sea bream (Wakabayashi et al. 1984) and turbot 
and sole (Alsina and Blanch 1993, Avendafio-Herrera et al. 2006). There is insufficient 
information from the vaccination of sole (Romalde et al. 2005) to determine the parameters by 
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which the fish were deemed to have died from an infection. Furthermore, the duration of 
protection after vaccination is also variable with species and size of fish, as well as bacterin 
concentration (Johnson et al. 1982). Sole were challenged 6 weeks post vaccination (Romalde et 
al. 2005) which may be a significant factor in achieving high levels of protection. Timing of 
challenge after vaccination is important since protection from vaccination changes over time and 
is dependent on variables such as fish species, water temperature and the inclusion of booster 
vaccinations (Bricknell et al. 1999). After initial vaccination, time is needed for the 
development of the immune response which will peak and then diminish over time (Bricknell et 
al. 1999). Given that sole were maintained in water temperatures of20°C and that a booster was 
provided, a challenge 6 weeks post vaccination could achieve higher protection values than 
would be anticipated. Therefore, at this time conclusions about the duration of protection of the 
sole vaccine are uncertain 
Gross pathology was consistent with previous findings in terms of development of lesions and 
areas affected. An important point that requires emphasis here is that vaccination gives better 
protection in terms of mortalities, but not necessarily in terms of lesion formation. Both 
vaccinated treatments showed a tendency of lesions being present at pectoral sites, with larger 
lesions observed compared to control treatments (Figures 5.2 and 5.3). This does not mean that 
the disease in vaccinated fish was worse compared to unvaccinated fish, only that the disease in 
these fish were focussed in these areas and that in comparison to other sites, pectoral sites 
constantly had larger lesions associated with them. It is suggested that sites where there is 
constant irritation, such as pectoral fins, facilitate the development of the lesion. Skin damage is 
a predisposing factor for the colonisation of T. maritimum (Handlinger et al. 1997), and the 
pectoral fin can scar a larger area of the body. The pectoral fin can abrade the surface of the skin 
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faster and affect a larger area in a shorter amount of time compared to other areas of the body. 
Smaller lesions were consistently found on the dorsal, ventral and lateral sites and they tended to 
be greater in number. Eye pathology observed throughout the experiment was either ruptured or 
missing eyes from which T. maritimum could be recovered. Handlinger et al. (1997) also 
reported complete eye collapse and corneal rupture in experimentally infected salmonids and 
noted the presence of T. maritimum at the affected sites. Eye pathology in the study of 
Handlinger et al. (1997) was reported not be the result of a T. maritimum infection but the result 
of other non-specified causes. In the current study, it is suggested that the eye pathology is an 
experimental artefact until further evidence is obtained. 
Incorporated into this experiment was an observation into differences in handling stress by using 
an 'unhandled' control treatment (Control) and another that was subjected to handling, 
intraperitoneal injection and anaesthesia (Control IP). Previous studies have indicated stress as a 
significant factor for pathogenicity due to T. maritimum (Handlinger et al. 1997). However, 
there was only a 4% difference in the cumulative mortality between the Control treatment and 
the Control -IP treatment over the experimental period, which was not significantly different. 
There was an 8 week interval between when fish were vaccinated and when they were 
challenged. This amount of time appears to be sufficient to negate any stress or damage that 
may have occurred during the initial vaccination of the Control IP treatment and therefore no 
differences in cumulative mortality could be detected between control treatments. 
Both control treatments had mortalities of 50% and 54% which was less than the 60% mortality 
rate that was anticipated. While immersion challenge offers a more natural method of exposure 
than intraperitoneal and intramuscular injection, it is more difficult to standardise and control 
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(Nordmo 1997). Variables such as temperature and density affected the outcome of co-
habitation challenges in Atlantic salmon infected with Aeromonas salmonicida and Vibrio 
salmonicida (Nordmo and Ramstad 1999). In the current study there was no difference in the 
temperature used in both the pathogenicity and vaccine experiments, however, there was a lower 
density offish in the vaccine experiment compared to the pathogenicity trial. Further 
experimentation of immersion challenges would be useful to determine dose effect and 
vaccination efficacy. 
However, it is evident that the Vaccine + Adjuvant treatment provided protection for Atlantic 
salmon against T. maritimum and warrants further research. Due to limited resources, a group of 
fish vaccinated with only the adjuvant was not included. It was deemed more important to have 
sufficient replication of tanks due to previous inconsistent results using T. maritimum (Carson et 
al. 1993, Carson et al. 1994). There was also a concern relating to handling stress and 
controlling for the use of injection; particularly as a portal of entry for the bacteria when the fish 
were challenged by bath. Carson et al. (1992) noted that skin damaged by scarification, 
branding and tagging developed into the focal point of the infection for rainbow trout challenged 
with T. maritimum. These were made a priority over an adjuvant only treatment because 
adjuvants are not known to provide specific immunity (Agius et al. 1983) and are added to 
vaccines in order to enhance the immune response (Evensen et al. 2005, Schijns and Tangen'is 
2005). However, there may be short term confounding effects due to non-specific factors 
(Olivier et al. 1985). Therefore, future work should include an adjuvant only treatment to fully 
determine its role in vaccination, thereby confirming the results of this trial. 
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The significant difference in cumulative mortality between the Vaccine and the Vaccine + 
Adjuvant treatments suggest the need for an adjuvant in the T. maritimum vaccine to elicit an 
immune response and provide protection. Vaccination oftilapia (Oreochromis niloticus) with 
Flavobacterium columnare required the use ofFreund's complete adjuvant (FCA) to mount a 
humoral response in both plasma and cutaneous mucus (Grabowski et al. 2004). It is likely that 
an effective T. maritimum vaccine will require an adjuvant to produce an immune response. 
Investigations into different adjuvants will be important because even though high levels of 
protection were provided by Freund's incomplete adjuvant (FIA) in the current study, there were 
apparent side-effects. 
Oil based adjuvants used in injectable vaccines are usually associated with side-effects observed 
in the peritoneal cavity (Evensen et al. 2005, Hastein et al. 2005). This can include 
inflammatory responses, the formation of granulomas, fibroblastic response and adhesions in the 
abdominal cavity. Long-term severe effects can include growth and spinal deformities (Evensen 
et al. 2005, Hastein et al. 2005). All fish injected with the Vaccine+ Adjuvant had black/brown 
pigment associated with the stomach, which did not appear in any of the other treatments of fish. 
Histological examination revealed this material to be black/brown pigmentation most likely 
caused by melanin. An inflammatory response was noted around this material with the 
formations of granulomas and cysts. A granulomas inflammatory response with localised 
inflammatory reactions has been well described and are a common side affect of mineral oil-
adjuvant vaccines (Lillehaug et al. 1992, Midtlyng 1996, Mutoloki et al. 2004). However, 
pathology such as this is not usually found in fish vaccinated with Freund's Incomplete 
Adjuvant (FIA). Currently, there are no reports in the literature that document FIA related 
pathology. Care was taken to ensure that the vaccine was administered in the peritoneal cavity, 
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just under the skin without touching any organs. The stomach is located in close proximity to 
the injection site and the vaccine may have been administered over the stomach which could 
have lead to the observed side-effects. However, Koppang et al. (2005) suggested that 
components of the adjuvant vaccine are dispersed from the injection site and cause foreign body 
inflammatory responses in organs and tissue throughout the body that are unpredictable and 
generalised. In contrast, pigmentation has been noted in pre-smolt Atlantic salmon vaccinated 
against furunculosis at the site of injection (Midtlyng 1997). In the current study, there was no 
pigmentation or any inflammatory response surrounding the injection site. 
More importantly, the effect of the adjuvant being associated with the stomach could have 
serious consequences as growth may be retarded and/or feed intake and digestibility be impeded 
(Poppe and Breck 1997, Midtlyng and Lillehaug 1998, S0rum and Damsgard 2004). Side-
effects of injectable vaccines with oil adjuvants have been widely reported and are_ undesirable 
as they reduce flesh quality and raise questions over animal welfare (Poppe et al. 2002, 
Koppang et al. 2005). The need for oil adjuvants may be reduced in the future through further 
investigation into the antigenic properties of T. maritimum and development of vaccine types 
and administration techniques. Other vaccine formulations to be tested could include adjuvants 
which do not produce side effects and the ECP toxoid. 
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Chapter 6 
General Discussion 
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Before this study, there had been some attempts to produce a viable vaccine to T. maritimum for 
the Tasmanian salmonid industry; however, they had not been successful (Carson et al. 1993, 
Carson et al. 1994). The current study not only provided a vaccine formulation that showed 
significant protective value in Atlantic salmon (Chapter 5), but also provided insight into many 
important aspects of the nature of T. maritimum including its physical characterisation (Chapter 
2), its pathogenicity (Chapter 3) and its ECP toxicity (Chapter 4). 
Tasmanian isolates are relatively homogeneous at the whole cell level although there appear to 
be at least two serotypes present (Chapter 2). However, the serotypes are not host or 
geographically specific, unlike the Spanish isolates (Avendano-Herrera et al. 2004, Avendano-
Herrera et al. 2005b ). Initial phenotypic characterisation described T. maritimum as a 
homogeneous taxon (Wakabayashi et al. 1984, Bernardet et al. 1994), although further 
serological characterisation proved the existence of antigenic differences within the species 
(Ostland et al. 1999, Avendano-Herrera et al. 2004). Further characterisation of isolates are 
required not only for Tasmanian isolates but also in comparison with European and Japanese 
isolates. Of particular interest are the two isolates (89/4747 and 01/0356-7) that showed not only 
antigenic differences but whole cell differences as well, even though they have been 
biochemically and phenotypically identified as T. maritimum (Schmidtke et al. 1991, Carson 
1998). There is still the unanswered question of where 89/4747 and 01/0356-7 fit in and what 
the differences mean for the taxon and potential vaccine development. The ramifications for 
vaccine development are that homogeneity within the species is more likely to produce a viable 
vaccine across strains and fish species. Antigenic differences pose a problem as a vaccine based 
on one serotype may not provide protection for another serotype (Romalde et al. 2005). Host 
specific differences in serotype was the basis for the development of separate vaccines for turbot 
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and sole as it was believed that a vaccine produced for one would not be effective in the other 
(Romalde et al. 2005). In the current study, while differences in LPS have been detected 
(Chapter 2), the importance of these differences and how they relate to a protective antigen are 
currently unknown. So far there is only information on three Tasmanian isolates with respect to 
virulence of strains and heterogeneity of the molecule. Further characterisation of more isolates 
and investigations into the antigenic properties of T. maritimum LPS are areas of further 
investigation. 
A similarity between all isolates was that they were hydrophobic in nature (Chapter 2), which is 
consistent with other findings for T. maritimum (Sorongon et al. 1991, Kawahara and Kusuda 
1998). Pathogenic bacteria such as Renibacterium salmoninarum (Bruno 1988), Vibrio 
anguillarum and Aeromonas salmonicida (Santos et al. 1991) are also hydrophobic. The 
pathogenesis of the disease may be assisted by the hydrophobic nature of the bacteria as it 
would facilitate host cell attachment, which is an important step in colonisation (Ofek and Doyle 
1994). Pathogenicity does not appear to be affected by the culture medium in which the bacteria 
are grown, but is affected by the presence of aeration within broth culture (Chapter 2). This 
phenomenon has also been observed between static and shaken cultures of T. maritimum isolate 
(89/4762), where the static culture produced fewer mortalities than the shaken culture (Soltani 
1995). Tasmanian isolates produce rough suspensions; the cells aggregate into clumps rather 
than disperse into a homogeneous suspension (Chapters 2 and 3). Tenacibaculum maritimum is 
an obligate aerobe (Wakabayashi et al. 1984) and the presence of aeration appears to allow more 
dispersal within the broth rather than clumping at the air-water interface, thereby producing a 
more homogeneous suspension. Differences in pathogenicity may simply be related to physical 
conditions. The clumping of bacteria produced in a non-aerated broth would not expose fish to 
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I 
the same number of bacteria as an aerated broth even though spectrophotometric measurements 
appear similar. It is suggested that the adhesive nature of the bacteria is associated with 
pathogenicity/virulence. Under natural conditions it is unlikely that the bacteria would clump 
together as they do in artificial broth culture. The artificial broth culture demonstrates the sticky 
nature of the bacteria which under natural conditions might be of benefit in attachment to the 
host, rather than each other. Attachment to the host is an important first step in the disease 
process (Ofek and Doyle 1994) and would allow proliferation on the host tissue and facilitate 
dispersal of any toxin the bacteria produces. The stickier the isolate the more virulent it is likely 
to be as it would be more adherent to the host. Agglutination would not be the only virulence 
factor, but on the basis of what has been found in this study, it is an extremely important one 
that requires greater attention. Virulence factors have been suggested to be critical for 
stimulating an immune response in the host and a vaccine produced from an isolate without 
expression of such factors can render a vaccine ineffective and therefore provide no protection 
of the host against disease (Carson et al. 1993). 
Differences in the virulence of isolates were observed in the current study (Chapter 3) and have 
been noted in many others (Masumura and Wakabayashi 1977, Campbell and Buswell 1982, 
Wakabayashi et al. 1984, Baxa et al. 1987, Carson et al. 1992, Alsina and Blanch 1993, 
Bemardet et al. 1994, Soltani 1995, Soltani et al. 1996, Handlinger et al. 1997, Powell et al. 
2004, Avendano-Herrera et al. 2006). Tasmanian isolates from salmonids appear to have a 
higher rate of pathogenicity than European and Japanese isolates tested in other fish species 
(Tables 1.2, 1.3). This leads to the question of whether the bacteria are more virulent or the host 
more susceptible. It is well known that salmonids are competitive and will bite and harass each 
other when held in captivity (Mork et al. 1999, MacLean et al. 2000). This behaviour is likely to 
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facilitate bacterial invasiveness as damage to the epithelium would create a portal of entry for 
the bacteria to colonise and proliferate (Handlinger et al. 1997). However, problems of 
aggregation in broth culture of T maritimum have only been reported in Tasmanian isolates 
(Soltani 1995, Chapters 2 and 3). It is not known whether other non-Tasmanian T maritimum 
isolates produce rough suspensions, which may increase pathogenicity. Some authors have used 
agglutination for serotyping (Wakabayashi et al. 1984, Vazquez Brafi.as 1991, Ostland et al. 
1999, Avendano-Herrera et al. 2004), which is not possible with Tasmanian isolates due to the 
cohesive nature of the bacteria. It appears that overseas isolates do not produce rough 
suspensions. 
Further evidence supporting the virulent nature of rough suspensions is the fact that salmonids 
in Tasmania only require a 1 hour bath in a bacterial suspension to produce the disease. Bath 
concentrations reported by other studies are comparable with the current study (Tables 1.2, 1:3), 
but there was one study that had a shorter exposure time. In this case, the 1-2 g black sea bream 
were only exposed for 20 minutes (Baxa et al. 1987). No mortalities were recorded when fish 
were challenged via immersion, however, moderate to high levels of mortalities were achieved 
in the same study with direct application and subcutaneous injection. It is suggested on the basis 
of observing no mortalities via immersion challenge and high levels through direct contact 
c~allenge that immersion was likely to produce low levels of mortality even if the fish were 
exposed for a longer time. This would still not compare to the high levels of mortalities 
observed using the Tasmanian T maritimum isolates in salmonids. 
An exception to the high mortality levels observed in Tasmanian isolates was when artificial 
seawater was used instead of natural seawater in culture. While T maritimum could grow in 
- 139 -
media made with artificial seawater and form a homogenous suspension, the culture was 
avirulent (Carson et al. 1993). The authors suggested that the medium did not allow expression 
of virulence factors. The non-pathogenic isolate (89/4747) in the current study was also an 
exception and it should be noted that it was less adherent on plate culture and produced a far 
more homogeneous suspension than all other Tasmanian isolates. The association between non-
pathogenic strains and the formation of homogeneous suspensions in culture provide further 
evidence of the connection between virulence and the cohesive nature of the T. maritimum 
isolates. 
The only other study that has successfully challenged fish via bathing required immersion for 
18 hours to induce disease in turbot; 1 or 2 hours duration was not sufficient (Avendafio-Herrera 
et al. 2004). Other successful methods of inducing disease are usually associated with direct 
application to various areas of the body and scarification through different means (Masumura 
and Wakabayashi 1977, Wakabayashi et al. 1984, Baxa et al. 1987, Carson et al. 1992, 
Bemardet et al. 1994, Powell et al. 2004). While intraperitoneal and intramuscular injections are 
ineffective (Campbell and Buswell 1982, Baxa et al. 1987, Carson et al. 1992), subcutaneous 
injection has worked on occasion which is probably a result of injecting into the dermal layer 
where bacteria are found in natural outbreaks (Masumura and Wakabayashi 1977, Wakabayashi 
et al. 1984, Alsina and Blanch 1993, Bemardet et al. 1994, Soltani 1995, Avendano-Herrera et 
al. 2006). It appears as though in some fish species direct contact is required between T. 
maritimum and host so that attachment and proliferation can occur. This is not the case for 
Tasmanian isolates and salmonids, which could be a result of the cohesive nature that has been 
observed in this study; the Tasmanian isolates possess a greater adherence factor which is 
displayed through the 'clumping' of the bacteria in broth. Other factors are likely to be involved 
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in the pathogenicity of T. maritimum, but the cohesive nature is significant and this property 
should be investigated along with other non-agglutinating isolates for comparison. 
A reproducible model of infection has been established in this study (Chapter 3), which will be 
useful for further pathogenicity and vaccination research. The most important aspect of this 
model is that it uses immersion to induce disease, which is comparable to the route of infection 
in natural outbreaks. At lower doses, the pathology exhibited under laboratory conditions was 
similar to that of naturally occurring infections. The progression of the disease, through gross 
pathology and histology, has been consistent with previous reports in other fish species 
including other salmonids (Mc Vicar and White 1979, Campbell and Buswell 1982, 
Wakabayashi et al. 1984, Baxa et al. 1986, Devesa et al. 1989, Alsina and Blanch 1993, Pazos 
et al. 1993, Chen et al. 1995, Handlinger et al. 1997, Ostland et al. 1999): scale loss occurs in 
discrete areas with disintegration of the epidermis, which precedes erosion of the dermis and 
exposure of the underlying ~usculature. Tenacibaculum maritimum most likely uses the mucus 
of the fish as a nutrient reservoir and since there appears to be no antimicrobial compounds 
within the mucus to inhibit T. maritimum growth (Magarifios et al. 1995), the bacteria can 
survive and proliferate. The bacteria can also be isolated from surviving fish; therefore a carrier 
state of the host is known to occur (Avendano-Herrera et al. 2006). Damage to the skin surface 
through handling, excessive UV exposure or competition between fish, coupled with optimal 
conditions for growth, allow the bacteria to colonise and proliferate (Wakabayashi et al. 1984, 
Alsina and Blanch 1993, Bemardet et al. 1994, Chen et al. 1995, Handlinger et al. 1997, 
Ostland et al. 1999). Younger fish are more susceptible to damage as the skin and scales are 
softer relative to older fish (Wakabayashi et al. 1984, Bemardet et al. 1994, Handlinger et al. 
1997). Higher water temperatures would cause stress, depressing immune function and making 
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fish more susceptible to infection (Wakabayashi et al. 1984, Bernardet et al. 1994, Handlinger et 
al. 1997). For salmonids, the transfer from freshwater to seawater would cause scale loss and 
provide stress and immunosuppression (Franklin et al. 1992). In the current study, not only were 
the fish moved from freshwater to seawater just before challenge, they were also young fish (80-
100 g), handled several times and were exposed to higher than normal water temperatures. 
These stressful conditions could be part of the reason why the immersion challenge with 
salmonids was so successful. 
Once the bacteria are able to invade the epidermal layer, they are able to dislodge scales from 
the dermis and break down the layers of the epidermis and dermis until they reach the 
musculature, at which time the necrotic material sloughs away and a lesion is exposed (Chapter 
3). Histology from the current study suggests that the bacteria are mainly found within this 
necrotic material as the lesion is formed. It is unlikely that they initially invade the musculature 
due to its highly vascular nature in which the bacteria cannot survive (Soltani 1995). Eroded 
areas can continue to expand with bacteria feeding from the periphery of the lesion. Invasion of 
the musculature has been observed in some studies (Chen et al. 1995), but it is possible that this 
was after mortality had occurred or that other bacteria, particularly Vibrio spp were present 
(Carson et al. 1992, Kimura and Kusuda 1993, Chen et al. 1995, Handlinger et al. 1997, Kusuda 
and Kawai 1998). The current study used immunohistochemistry to verify the presence of T. 
maritimum in gill, necrotic tissue and lesions. While gill and necrotic tissue showed clearly the 
presence of T. maritimum, there were insufficient numbers of bacteria in skin lesions to 
determine presence of the bacteria. There was also no evidence of large numbers of bacteria 
present in lesions in haematoxylin and eosin (H&E) stained sections. Since T. maritimum is 
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usually found with other opportunistic bacteria, the use of immunohistochemistry for histology 
was found to be useful. 
Lesions are usually found around the head, mouth, fins and flanks of infected fish with gill 
necrosis being a sporadic occurrence (Mc Vicar and White 1979, Campbell and Buswell 1982, 
Wakabayashi et al. 1984, Baxa et al. 1986, Devesa et al. 1989, Alsina and Blanch 1993, Pazos 
et al. 1993, Chen et al. 1995, Handlinger et al. 1997, Ostland et al. 1999). In the pathogenicity 
trials of the current study (Chapter 3), the same areas as described for naturally infected fish 
were affected with the addition of eye pathology on rare occasions; eye damage consisted of 
ruptured or missing eyes. However, the eye pathology was not definitively determined to be the 
result of a flexibacter infection as lesions were not associated with the eye, unlike reports of 
natural infections (Handlinger et al. 1997) and there was no obvious sign of other or previous 
trauma. Skin lesions appear to occur where there is constant movement of the fins or areas 
where abrasion can easily arise where fish are held captive. In the current study, larger lesions 
were found in association with pectoral and pelvic fins and it is suggested that this is the result 
of continual agitation of the fins against the body. The fins themselves are affected, displaying 
signs of damage and necrosis. Captive fish and more particularly those kept under laboratory 
conditions, consistently show signs of damage or inflammation to at least one fin. This is most 
likely the result of contact with netting, tank walls and possibly other fish. Mouths and heads are 
sites whJ!re fish can abrade themselves on nets/tanks (Chen et al. 1995) and the mouths, flanks 
and fins are areas that can be affected during aggressive behaviour through competition and 
feeding (Chen et al. 1995, Handlinger et al. 1997). Management is an obvious area where 
aggressive behaviour may be reduced through decreasing densities and improving conditions so 
that infectivity is minimised. This has proven an effective strategy for Atlantic salmon in 
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Tasmania where improvements in the feeding management and lower stocking densities resulted 
in a decrease in the incidence of the disease (Handlinger et al. 1997). 
Extracellular products (ECP) produced by T. maritimum have been proven to be toxic to red and 
black sea bream (Baxa et al. 1988c) and now for the first time to Atlantic salmon (Chapter 4). 
The ECP was shown to cause cellular necrosis of the internal organs, a similar response to that 
which occurs on external surfaces during the disease process with T. maritimum. Since lesions 
occur so rapidly and infection can cause mortalities within days without an inflammatory 
response, toxins have been suspected to contribute to the pathogenicity of T. maritimum 
(Handlinger et al. 1997). From the results of this study, it is suggested that ECP play a major 
role in the pathogenesis of T. maritimum. It is also suggested that the cohesive nature of the 
bacteria and surface binding properties allows direct contact and penetration of the toxin to the 
underlying, vascularised musculature. However, more informatio1:1 is required concerning the 
nature of the ECP. In the current study, eight different ECP patterns were found by gel 
electrophoresis (Chapter 2). Differences in ECP patterns have been found using the same 
technique in other bacterial species, for example Aeromonas salmonicida (Gudmundsd6ttir 
1996), but unfortunately there is no understanding of what this variation means. A more 
thorough study of the exotoxins of T. maritimum is required including elucidating the 
differences between protein profiles and testing more ECP isolates, preferably using immersion. 
An assessment of ECP activities such as proteases and hemolysins also warrant further 
investigation. It is also important not to overlook the endotoxins of pathogenic bacteria. In the 
current study, LPS analysis revealed at least two serotypes and chimeras within the visible 
serotype, while recent work in sea bass showed LPS of T. maritimum to be an immunogenic 
antigen (Salati et al. 2005). The use of LPS as a vaccine immunogen have been effective against 
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other bacterial diseases such as Vibrio anguillarum (Bogwald et al. 1992), Aeromonas 
salmonicida (Ackerman et al. 2000) and Aeromonas hydrophila (Baba et al. 1988). This 
suggests further work is required to understand the nature of toxins particularly if they are to be 
included in vaccine development. Handlinger et al. (1997) suggested that preparations of a 
vaccine against T. maritimum should include a toxoid form and the current study agrees that this 
is an area of future research. Vaccines against Aeromonas salmonicida (Hastings and Ellis 
1990), Vibrio harveyi, Photobacterium damselae subsp. piscicida (Arijo et al. 2005) and 
Pasteurella piscicida (Magarifios et al. 1994) all contain ECP toxoids. 
Vaccination of Atlantic salmon against flexibacteriosis using injection vaccinations with the use 
of an adjuvant (Freund' s incomplete) achieved high levels of protection in Atlantic salmon 
(Chapter 5). Lesions were evident on the few mortalities that were observed in the Vaccine+ 
Adjuvant treatment and this suggests that more work is required to produce a vaccine that is 
100% effective. The use of a killed whole cell bacterial preparation was ineffective as a vaccine, 
which is consistent with other studies using similar formulations for salmonids (Carson et al. 
1993, Carson et al. 1994). However, the same preparation in turbot and sole showed high 
relative percent survival (RPS) values (Romalde et al. 2005). There could be a difference in the 
host response with turbot and sole able to produce a more effective immune response than 
salmonids. Differences in immunity have been observed between salmon species (Johnson et al. 
1982), and therefore could exist between species that are not as closely related. However, there 
are still questions regarding the vaccine produced for turbot and sole, in particular the conditions 
under which the vaccine was tested. Host immune responses would be of great interest because 
of the differences observed between salmonids, turbot and sole (Carson et al. 1993, Carson et al. 
1994, Romalde et al. 2005). 
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All studies, including this thesis, investigating the vaccine efficacy against flexibacteriosis have 
been of a relatively short duration; no more than 8 weeks (Carson et al. 1993, Carson et al. 
1994, Romalde et al. 2005). Duration of immunity can be affected by size offish, the provision 
of a booster and the concentration of the bacterin (Johnson et al. 1982). There needs to be 
further investigation into the duration of immunity in order to produce an effective vaccine for 
use on a commercial farm. Also of interest are the side effects that were produced, which 
included a chronic inflammatory response and pigmentation in the pyloric caeca. As a short-
term measure to a potential outbreak, this vaccine formulation can provide an effective means of 
disease protection. However, the long-term adjuvant effects of this vaccine preparation are 
unknown and should be an area of further investigation particularly in regards to growth 
deformities and animal welfare (Poppe et al. 2002, Koppang et al. 2005). The next major step 
from this study is to investigate the duration of protection and the use of other adjuvants, with 
the goal of taking the vaccine preparation to a commercial level and test efficacy under field 
conditions. 
Vaccines for many fish species against a variety of bacterial pathogens are commonly used on 
commercial production fish farms around the world (Hastein et al. 2005) and are a preferred 
method of disease prevention. Understanding of the nature of the Tasmanian T. maritimum 
isolates provides a better means of developing a safe, immunogenic and viable vaccine for 
salmonids. By examining the similarities and differences of the isolates, in particular antigenic 
ones (Chapter 2), there is now further evidence of the heterogeneity of the antigenic 
characteristics (LPS) which has implications for further vaccine development. This study has 
provided greater insight into the pathogenicity of the disease in salmonids (Chapter 3), in 
particular the progression of the disease from a gross and histological point of view. The 
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cohesive nature of T. maritimum (Chapters 2 and 3) and the toxicity of the ECP that it produces 
(Chapter 4) are significant findings for pathogenicity but also for vaccine development. This 
study has also produced an experimental vaccine (Chapter 5), but requires further refining to 
confirm protection and minimise side effects. However, this thesis has been an invaluable step 
towards the goal of achieving a vaccine for Atlantic salmon against T. maritimum. 
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Appendix A 
Media formulations, solutions and buffers 
Marine Shieh's Medium 
Song, Y.L., Fryer, J.L., Rohovec, J.S., 1988. Comparison of six media for the cultivation of 
Flexibacter columnaris. Fish Pathology 23, 91-94. 
Peptone (Oxoid L37) 5.0 g 
Sodium acetate 0.01 g 
Sodium pyruvate 0.1 g 
Citric acid 0.01 g 
Yeast extract 0.5 g 
Distilled water lOOmL 
Seawater 900mL 
Agar 12.0 g 
Autoclave at 121°C for 15 minutes, pH: 7.4 +/- 0.2 at 25°C 
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Ordal' s Medium 
Anacker, R.L., Ordal, E.J., 1959. Studies on the myxobacterium Chondrococcus columnaris. I. 
Serological typing. Journal of Bacteriology 78, 25-32. 
Tryptone (Oxoid L42) 0.5 g 
Yeast extract 0.5 g 
Sodium acetate 0.2 g 
Beef extract 0.2 g 
Distilled water lOOmL 
Seawater 900mL 
Agar 11.0 g 
Autoclave at 121°C for 15 minutes, pH: 7.4 +/- 0.2 at 25°C 
Seawater Davidson's 
Shaw, B.L., Battle, H.I., 1957. The gross and microscopic anatomy of the digestive tract of the 
oyster, Crassostrea virginica (Gmelin). Canadian Journal of Zoology 35, 325-347. 
Formaldehyde (37-40%) 
Glycerol 
Glacial acetic acid 
Absolute alcohol 
Seawater 
Citrate Buffer Solution 
0.1 M Citric acid 
0.1 M Citrate 
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200mL 
lOOmL 
lOOmL 
300mL 
300mL 
9.5mL 
41.5 mL 
Phosphate Buffer pH 7.4 
0.1 M Sodium dihydrogen phosphate 
0.1 M Disodium hydrogen phosphate 
Phosphate Buffered Saline (PBS) 
0 .1 M Phosphate buffer pH 7.4 
Sodium chloride 
Alkaline Glycerol Mountant (pH 9) 
34mL 
166mL 
1000 mL 
9g 
Johnson, AM., Munday, B.L., 1993. Toxoplasmosis: pathology, histopathology and serology. 
In: Comer, L.A., Bagust, T.J. (Eds.), Australian Standard Diagnostic Techniques for Animal 
Diseases. Standing Committee on Agriculture and Resource Management, Commonwealth 
Scientific and Industrial Research Organisation Publications, Melbourne. 
Sodium hydrogen carbonate 
Sodium carbonate 
Distilled water 
Glycerol 
AppendixB 
0.0729 g 
0.016 g 
10.0 mL 
90.0mL 
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Experimental induction of gill disease in 
Atlantic salmon Salmo salar smolts with 
Tenacibaculum maritimum 
Mark Powell1·*, Jeremy Carson2, Rebecca van Gelderen1 
1School of Aquaculture, Tasmanian Aquaculture and Fisheries Institute, University of Tasmania, 
Locked Bag 1370 Launceston, Tasmania 7250, Australia 
2Fish Health Unit, Tasmanian Aquaculture and Fisheries Institute, Department of Primary Industries, 
Water and Environment, PO Box 46, Kings Meadows, Tasmania 7249, Australia 
ABSTRACT: An experunentally induced bacterial infection of manne Atlantic salmon Salmo salar 
smolt gills was developed using strains of Tenacibaculum maritimum onginally isolated from disease 
outbreaks m Tasmania. The gills of salmon were inoculated with a high concentration of bacteria (4 
x 1011 cells per fish) of either strain 00/3280 or 89/4747 T. maritimum. Gentle abrasion of the gills was 
used to enhance the progression of gill disease. One strain (00/3280) was highly pathogenic, causing 
morbidity and mortality within 24 h post-inoculation, and produced acute focal branchial necrosis 
associated with significant increases m plasma osmolality and lactate cqncentration compared with 
controls (non-inoculated) or strain 89/4747-inoculated fish. There were no differences in the whole 
body net ammonium flux between control (non-inoculated) and stram 00/3820~inoculated fish. Gill 
abrasion resulted in acute telangiectas1s and focal lamellar hyperplasia in all fish regardless of bac-
terial inoculation. This work provides the b<1;sis of a challenge model suitable for mveshgating the 
pathophysiological processes associated with acute branchial necrosis in marine fish, suggesting that 
osmoregulatory and possibly respiratory dysfunction are the primary consequences of infection. 
KEY WORDS: Atlantic salmon · Tenacibaculum maritimum · Pathophys10logy · Gill disease 
Osmoregulation · Respiration · 
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INTRODUCTION 
Bacterial diseases of freshwater fish epithelia have 
been extensively studied with the primary focus upon 
bacteria from the Cytophagales, such as bacterial gill 
disease caused by Flavobacterium branchiophilum 
(Ostland et al. 1994, 1995), and necrotizmg skin dis-
eases such as columnaris disease caused by F. colum-
nare (Thomas-Jinu & Goodwin 2004) and bacterial 
cold-water disease caused by F. psychrophilum (Cipn-
ano et al. 1996 and review by Nematollahi et al. 2003). 
However, in manne fishes relatively few bacterial skin 
and gill diseases have been characterised. Tenacibac-
ulum mantimum (formerly Fle:xibacter maritimus) has 
been reported to cause significant skin and gill 
pathology in a wide variety of species mcludmg red 
seabream Pagrus major, black seabream Acanthopa-
'Email: mark.powell@utas.edu.au 
grus schegeli, rock bream Oplegnathus fasciatus, 
Japanese flounder Paralichthys olivaceus (Baxa et al. 
1986, Wakabayashi et al. 19.86), Dover sole Solea solea 
(Bernardet et al. 1990), turbot Scophthalmus ma:ximus 
(Alsina & Blanch 1993), Atlantic salmon Salmo salar, 
rainbow trout Onchorynchus mykiss, striped trumpeter 
Latris lineata and greenback flounder Rhombosolea 
tapirina (Handlinger et al. 1997). Although primarily a 
skin infection causing ulcerative dermatitis (Hand-
linger et al. 1997), gill infections where a necrotizing 
branchitis occurs are not uncommon (Handlmger et al. 
1997). 
The aim of this research was to investigate whether 
expenmental inoculation of the gills of Atlantic salmon 
with Tenacibaculum maritimum could cause acute gill 
disease and to identify potential processes that may be 
responsible for mortality. 
© Inter-Research 2004 www.mt-res corn 
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MATERIALS AND METHODS 
Preparation of bacterial cultures. Cultures of 
Tenacibaculum maritimum were isolated by the De-
partment of Primary Industry, Water and Envrronment 
from the skin of farmed salmon from Tasmania, Aus-
traba, with clinical cases of cutaneous erosion disease. 
The cultures were designated 89/4747 (Atlanbc salmon) 
and 00/3280 (rainbow trout) and were isolated in 1989 
and 2000 respectively. The bacteria were isolated on the 
medium of Anacker & Ordal (1959), formulated with sea-
water. Isolates were identified using a 16S ribosomal 
RNA (rRNA) PCR pruner set specific for T. maritimum 
(Carson 1998). Cultures were stored frozen at-80°C on 
MicroBank beads (Pro-Lab Diagnostics) until required. 
Cultures for infection trials were prepared by inocu-
lating 200 ml of Sh1eh's medium (Song et al. 1988) for-
mulated with seawater (mineral salts buffer, MSB) in a 
1 1 conical flask and incubated with gentle agitation 
(30 cycles min-1) at 20 to 22°C for 48 h The cell sus-
pension was harvested by centrifugation at 2500 µg 
RCF (relative centrifugal force) for 20 min and the 
pellet washed twice with sterile seawater. Harvested 
cells were resuspended m 15 ml of stenle seawater. 
Experimental series 1: Infection study. Atlanbc 
salmon smolts of mean mass (±SE) 77.0 ± 2.9 gwere ac-
climated to full strength seawater (35 ppt) over a period 
of 10 d, then allocated to triplicate tanks ( 4 fish per tank, 
n = 12 per treatment) and allowed to habituate for 24 h 
prior to anaesthetization with AQUI-S (0.04 ml 1-1) or 
clove oil (0.03ml1-1). The gill arches were then sepa-
rated and all of the filaments abraded by stroking gen -
tly with a blunt spatula. Aliquots (0.5 ml) of Tenacibac-
ulum maritimum culture in sterile, filtered seawater 
were applied to the gill arches on each side of the fish 
(total 1 ml T. maritimum culture, -4 x 1011 cells per fish, 
n = 12 per treatment). Controls consisted of fish that 
were inoculated with filtered seawater only (n = 12, 
repeated twice). An additional group of fish was inocu -
lated with 1 ml of T. maritimum (strain 00/3280) culture 
onto the gills without prior filament separation or abra-
sion. Fish were allowed to recover in their respective 
tanks and monitored over the subsequent 5 d. Mori-
bund fish were removed and cultures made from the 
gills on Shieh's agar (Song et al. 1988) formulated with 
seawater mineral salts agar (MSA), and colorues were 
confirmed as T. maritimum by colony colour and shape, 
as well as indirect fluorescent antibody test (!FAT) 
usmg a rabbit antibody prepared with a whole cell 
formalin-inactivated cell suspension of T. mantimum 
89/0235 (rainbow trout). 
Experimental series 2: Comparative pathology of 
Tenacibaculum maritimum strains. In Expenmental 
series 1 there was an apparent dlfference in the patho-
gerucity of the 2 strams of T. maritimum used. Thus, it 
was decided to further examine the effects of acute 
exposure of smolts to the 2 different strains. 
Seawater-acclimated Atlanbc salmon smolts were 
allocated to '30 I round tanks (6 fish per tank, 3 tanks 
per treatment) following anaesthesia, gill abrasion 
and inoculation with either strain 89/4747 or 00/3280 
of Tenacibaculum maritimum. Controls consisted of 
fish that had the gill filaments separated but were 
moculated with seawater. Fish were allowed to 
recover and maintained in static aerated seawater at 
17.8 to 18.4°C (Fig. 1A), 79 to 95% 0 2 saturation 
(Fig. 1B) for 24 h post-inoculation. Total ammonium 
concentrations were measured using the method of 
Verdouw et al. (1978). During the exposure, mori-
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Fig. 1. (A) Mean (±SE) temperature, (BJ oxygen saturation 
and (C) water ammoruum concentrat10n for tanks contaming 
Atlanbc salmon Salmo salar smolts experimentally moculated 
w1th Tenadbaculum maritimum (•) strain 00/3280, (A) stram 
89/4747 or (O) controls over a 24 h stabc challenge 
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bund fish (unresponsive to touch) were removed, 
anaesthetised with 0.04 ml i-1 clove oil and bled from 
the caudal vein. Heparinised blood (100 IU ammo-
nium heparin, Sigma-Aldnch) was then centrifuged 
at 8000 x g, the plasma decanted and frozen at -20°C 
for further analysis. The gills were swabbed onto 
MSA for confirmation of the presence of T. mariti-
mum using colony morphology and !FAT. The gills 
were then removed and fixed in seawater Davidson's 
solution for histological examination. After 24 h of 
exposure, surviving fish were killed by anaesthetic 
overdose (clove oil >0.03 ml 1-1) and sampled as for 
monbund fish. 
Plasma osmolality was determined using a Vapro 
5520 vapour pressure osmometer (Wescor). Plasma 
chloride was detennined according to the method of 
Zall et al. (1956) and plasma lactate concentrations 
were determined using a commercial lactate assay kit 
(Sigma Diagnostics, protocol 735). Gills were embed-
ded in paraffin wax, sectioned at 5 µm and stained with 
haematoxylin and eosin. 
Experimental series 3: Eiiects oi Tenacibaculum 
maritimum infection on ammonium ilux. In Experi-
mental series 2, despite the removal of moribund fish 
inoculated with T. maritimum stram 00/3280, the total 
ammoruum concentrations m the water remained 
equivalent to that of fully stocked tanks that expen-
enced no morbidity (T. maritimum strain 89/4747 and 
control tanks). Therefore, the net ammonium flux was 
measured for fish moculated with T. mantimum stram 
00/3280 and controls. 
The gills of seawater-acclimated smolts were 
abraded and inoculated as described above with either 
strain 00/3280 or seawater (controls), and placed into 
md!vidual black acrylic flux chambers (mternal volume 
of 1 l) supplied with flowmg seawater and constant 
aeration (1 fish per chamber, 9 fISh per treatment). 
Following 24 h of recovery, the flow to the flux chambers 
was stopped and a water sample (5 ml) removed and im-
mediately frozen (-20°C) for later analysis. Following a 
3 h period, a second water sample was removed and sim-
ilarly frozen, after which the water flow to each flux 
chamber was remstated. Fish were then removed, killed 
by anaesthetic overdose (clove oil >0.03ml1-1) and the 
gills swabbed onto MSA for subsequent confirmation of 
the presence/absence of Tenadbaculum maritimum 
using colony morphology and !FAT. 
Plasma osmolality, chlonde concentrations and lac-
tate concentrations were compared statistically be-
tween strams (00/3280 and 89/4747) and controls usmg 
analysis of variance with a Bonferroru corrected t-test 
planried contrast relative to controls. p values of less 
than 0.05 were considered to be significant. 
Water samples were analysed for total ammonium 
concentration using the method of Verdouw et al. 
(1978). Whole body net ammonium flux was then 
calculated according to: 
J. NH + _ [NH/]1 =1 - [NH/]1 =o· V 
net 4 - M*T 
Where [NH4 +11 = x is the concentration of total 
ammonium (mmo11-1) m the water sample at the start 
or end of the flux period, Vis the volume of the flux 
chamber, M is the mass of the fish (g) and T is the 
duration of the flux penod (h). Net whole body 
ammonium fluxes were compared with zero and 
between inoculated and control fish usmg a t-test. 
p values of less than 0.05 were considered to be 
significant. 
RESULTS 
Experimental series 1: Infection study 
The highest rate of mortality (70 % ) occurred within 
48 h post-moculation in fish that had received gill 
abrasion and infection with strain 00/3280 (Fig. 2). Fish 
with non-abraded gills moculated with strain 00/3280 
had a maximum mortality rate of 50 % at 96 h, whereas 
fish inoculated with strain 89/4747 and controls had 
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Fig. 2. Salmo salar infected with Tenacibaculum mar1tnnum. 
Percent cumulative mortahty of Atlantic salmon smolts exper-
nnentally inoculated with (•) stram 00/3280 followmg a light 
abrasion, or (•) no abrasion of the gills, (.i.) stram 89/4747 
following hght abras10n or (0) controls (hght abrasion, no 
bacteria) 
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maximum mortality rates of 25 and 11 % at 48 h respec-
tively (Fig. 2). Bactenal colonies with charactenstics 
typical of Tenacibaculum maritimum were isolated 
from all fish within those groups inoculated with 
bactena. The 00/3280-moculated fish returned heavy 
bacterial growth from gill smears compared with the 
light bacterial growth from gill smears of control (non-
inoculated) fish (Table 1). 
Experimental series 2 and 3: Comparative pathology 
and ammonium flux experiments 
Fish moculated with stram 00/3280 showed a higher 
rate of morbidity than fish treated with strain 89/4747 
or controls over the 24 h challenge experiment 
(Fig. 3A). There was heavy bacterial growth from gill 
smears of fish inoculated with Tenacibaculum mariti-
mum bactena (both strains 00/3280 and 89/4747) and 
poor growth from smears taken from control fish 
(Table 1). Bacteria isolated from fish inoculated with 
strain 00/3280 returned a positive result when tested 
with IFAT, while bacterial smears from fish moculated 
with strain 89/4747 and control fish were negative 
(Table 1). Water ammonium concentrations mcreased 
in all tanks over the exposure duration; however, lev-
els remained below 200 µmo11- 1 (Fig. 1C). Moribund 
fish from the strain 00/3280 groups had significantly 
higher plasma osmolahty than fish that had been 
inoculated with strain 89/4747 or control animals 
at 24 h post-inoculation (F2, 19 = 8.61, p = 0.0022) 
(Fig. 3B). However, there were no significant differ-
ences in the plasma c1- concentration between the 
groups (F2, 19 = 2.99, p = 0.0742) (Fig. 3C). There were 
significantly elevated plasma lactate concentrations in 
moribund fish inoculated with strain 00/3280 com-
pared with either strain 89/4747-inoculated or control 
fish afte:r 24 h of exposure (F2,19 = 6.24, p = 0.0082) 
(Fig. 3D). There was a significant negative net whole 
body ammonium flux in both control and strain 
00/3280-inoculated fish. However, there was no sig-
nificant difference in the magnitude of the net 
ammonium flux between control and stram 00/3280-
inoculated fish (t31= 1.47, p = 0.1508) (Fig. 3E). Smears 
from fish inoculated with strain 00/3280 showed 
heavy growth of bactena typical of T. maritimum, 
whereas control (non-inoculated) fish showed no bac-
terial growth (Table 1). 
Histopathology 
Morbid salmon inoculated with strain 00/3280 but 
not 89/4747 exhibited gills with yellowish muc01d 
aggregations at the filament tips. Histologically, there 
was focal epithelial necrosis with extensive bacterial 
mats overlaymg necrotic tissue (Fig. 4A,B). Bacterial 
associated necrosis of the filaments occurred m what 
appeared to be a distal to proximal direction. There 
was very limited (only seen in 1 fish out of 6 exalnined) 
evidence of bacterial associated' necrosis with stram 
89/4747 and no necrosis in control (non-inoculated) 
gills (Fig. 4C). Abraded gills often showed signs of 
telangiectasis and congestion, irrespective of whether 
fish were inoculated with Tenacibaculum maritimum 
(Fig. 4E,F). 
DISCUSSION 
Gill abrasion enhances the susceptibility of catfish 
Ictalurus punctatus to infection with Flavobacterium 
columnare (Bader et al. 2003) and has been used to 
enhance the reliability of Tenacibaculum maritrmum 
challenge m salmoruds (J. Carson pers. comm.). In our 
study, abrasion enhanced the severity and rate at 
which the disease progressed leading 
to mortality. There were, however, 
Table 1. Tenacibaculum mantimum infecting Sahno salar. Recovery of bactena 
from gills following expenmental rnoculation and rndrrect fluorescent antibody 
test (!FAT) confirmation. ND= not determmed; - =no growth/negative; +/- = 
mconclus1ve; + = poor growth/positive; ++ = moderate growth; +++ = heavy 
clear differences in the susceptibility 
of fish to different strains of T. mariti-
mum. Strain 00/3280 was pathogenic, 
whereas strain 89/4747 was not. growth 
Indeed, stram 89/4747 failed to be 
89/4747 
detectable with IFAT. Failure or ambi-
T. mantimum strarn 00/3280 00/3280 Control gmty of IFAT techniques have been Scraped Non-Scraped Scraped 
reported with F. psychrophilum (Vatos 
Expt 1: Infection study et al. 2002). Both this species and its 
Culture +++ +++ +++ + warm water counter-part F. columnare 
Expt 2: Comparative pathology have a highly labile glycocalyx re-
Culture +++ ND +++ + sponsible for adhesion (Nematollahi et 
iFAT + ND +/- al. 2003) and F. columnare is also asso-
Expt 3: Ammomum flux +++ ND ND ciated with chondroitmase (AC lyase) 
activity (Stnnger-Roth et al. 2002). 
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Apart from the glycocalix, F. columnare adherence to 
gill tissue is also dependent upon the presence of D-
glucose or N-acetyl-D-glucosamine (Decostere et al. 
1999). It is possible that the requirements of stram 
8914141 T. maritimum for a~erence to gills were not 
fully met because of the cellular rmcroclimate of the 
salmon gill. Failure to detect strain 8914141 T. mariti-
mum using !FAT may also reflect a dlfference in the 
bacterial glycocalyx of this strain compared with the 
pathogenic strain 00/3280. 
The branchlal epithelial necrosis caused by strain 
00/3280, and less so with stram 89/4747 Tenadbacu-
lum maritimum mfection was sirm-
lar to that reported by Handlmger 
et al. (1997) for naturally infected 
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trolytes includmg chloride (Byrne et al. 1995). Plasma 
lactate concentrations were clearly elevated in mon-
bund salmon suggesting that acute respiratory failure 
may occur pre-mortem. It is not clear whether the 
probable limited oxygen transfer was due to diffusive 
limitations m the gill or reduced perfusion of the gill. 
Byrne et al (1991, 1995) did not demonstrate any 
reduchon in blood . p02 in freshwater brook trout 
Salvelinus fontinalis and rainbow trout expenmen-
tally mfected with F. branchiophilum. However, Fos-
cariru (1989) demonstrated a transient bradycardia 
and an acute branchial hyperplasia and oedema in F. 
24h Comparative pathology 
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Atlantic salmon and rainbow trout. 
However, in our study, telangiecta-
sis and focal hyperplasia of the 
branchlal epithehum due to gill 
abrasion was common m control 
fish (non-inoculated) and fish inoc-
ulated with both strains of T. mar-
itimum. Interestingly, llie hyper-
plastic lesions on the gills were 
sinlilar to those seen with amoebic 
gill disease, but with the difference 
that gill abrasion lesions were asso-
ciated with telangiectasis, not para-
some-containing amoebal tropho-
zoites (Adams & Nowak 2001, 
2003). It appears that the branchial 
necrosis causes a strong osmoregu-
latory disturbance m Atlantic 
salmon with significant mcreases in 
plasma osmolality. This osmoregu-
latory disturbance probably m-
volves 10noregulatory dysfunchon. 
Although the mean plasma chlo-
ride concentrations were elevated 
m moribund salmon inoculated 
with strain 00/3280, this was not 
statistically different from controls. 
In other situations where extensive 
branchial necrosis occurs, such as 
oxidative injury, sinnlar osmoregu-
latory disturbances may be present 
without any clear changes in 
plasma chloride levels (Powell & 
Harris 2004). Sinlilarly, reductions 
in plasma osmolality have been 
reported with experimental Flavo-
bacterium branchiophilum infec-
tions of freshwater rambow trout, 
although these were m association 
with a reduction m plasma elec-
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Fig. 3. Sahno salar mfected with 
Tenac1baculum mantnnum. (A) Percent 
cumulative morbidity, (B) mean (+SE) 
plasma osmolahty, (C) plasma chlonde 
concentration, (D) plasma lactate con-
centration and (E) whole body net am-
momum flux, Jnet NH4 • following expen-
mental gill moculation with strams 
00/3280 or 89/4747 or controls (non-
inoculated), followmg light abrasion 
Note data for strain 00/3280 are from 
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columnaris (now F. columnare)-exposed eel 
Anguilla japonica. It is, therefore , not possible 
to exclude either diffusive or perfusive limita-
tions to gas exchange as a cause of plasma 
lactate elevations in T maritimum-infected 
salmon. 
Despite the apparent deterioration in water 
quality, even with declining fish density, in the 
24 h comparative pathology trial of fish inocu-
lated with strain 00/3280, there were no signif-
icant differences in the rate of ammonium 
efflux. Increased ammonium effluxes have 
been reported in response to acute freshwater 
exposures of Atlantic salmon affected by 
amoebic gill disease (Roberts & Powell 2003). 
Similarly rainbow trout experimentally infec-
ted with Flavobacterium branchiophilum had 
elevated plasma ammonium tensions (Byrne et 
al. 1995). It would appear that in acute 
Tenacibaculum maritimum infection of salmon, 
ammonium excretion rates are not significantly 
affected. 
In conclusion, we have demonstrated that 
direct inoculation of high concentrations of 
Tenacibaculum maritimum directly onto the 
gills of Atlantic salmon smolts will induce a 
necrotic branchitis which appears to be en-
hanced by prior abrasion of the gill epithelium. 
Progression of the infection results in an acute 
and ultimately lethal osmoregulatory and 
potentially respiratory dysfunction. 
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Fig . 4. Salmo salar infected with Tenacibaculum maritimum. (A,B) 
Extensive branchial necrosis associated with filamentous bacterial mats 
(arrows) on the gills of Atlantic salmon smolts inoculated with strain 
00/3280. (C) Filamental necrosis associated with filamentous bacteria 
on the gills of salmon inoculated with T marilimum strain 89/4747 . 
(DJ Telangiectasis (large black arrow) associated with the gills of 
control, (E) strain 00/3280-inoculated and (F) strain 89/4747-inoculated 
fish. Note the hyperplastic lesions also associated with gill abrasion 
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